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ABSTRACT
OBJECTIVES : Extant experimental research implicates sleep disturbance as causal to 
dysregulation of emotional processes and neurocognitive functioning. Clinical research 
with psychiatric samples suggests that sleep disturbance may be an etiological or 
sustaining factor in certain conditions, rather than solely a symptom. Recently proposed 
models have hypothesized cognitive-affective processing (CAP) as a potential mediator 
for the relationship between sleep disturbance and depressed mood. This study 
investigated relevant neuropsychological and sleep-physiological variables to explore the 
applicability of this type of model within a sleep apnea referral sample.
METHODS: 61 participants referred for polysomnogram also completed self-report 
measures of mood and sleep, as well as a neuropsychological battery consisting of 
standard neurocognitive measures and novel cognitive-affective processing counterpart 
measures. 
RESULTS: Correlational and ANCOVA analyses suggested cognitive-affective 
processing measures were potentialy more sensitive toward dysfunction secondary to 
sleep-disordered breathing than standard neurocognitive measures. Regression analyses 
were mixed, while most of the a priori model was confirmed, unexpected null findings 
between sleep physiology and depression suggested poor fit for this sample. Exploratory 
analyses suggest there may be a more complex model relating the three constructs of 
interest, incorporating related sleep physiology and affective state constructs. 
iv
CONCLUSIONS: Within our sample, findings suggest dysfunctional sleep-breathing 
physiology impacts the affective valence of previously identified subcortical-frontal 
retrieval dysfunction. The relative absence of findings within standard measures suggests 
that cognitive-affective processing measures may be more sensitive to finer gradients of 
sleep disturbance severity. Additionally, this finding is independent of the incidental 
findings that the cognitive-affective processing is sensitive to negative mood and 
psychological distress about lack of sleep, suggesting the neurocognitive measure is 
sensitive to both physiological and psychological sequelae.  This study provides initial 
support for a neuropsychological measure of how humans process emotionally-laden 
information, which has significant potential for use in research and clinical fields. Future 
research will generate normative data for the novel cognitive-affective processing 
measures, as well as explore the original and expanded model of negative mood within 
other psychiatric and neurological samples. 
Keywords: Sleep, Cognitive Processing, Emotional Processing, Depression, Obstructive 
Sleep Apnea
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CHAPTER 1
INTRODUCTION
Relevance & Importance
Deficits in sleep quality and associated sleep loss are experienced by nearly all people at 
some point during life, whether from lifestyle or disorder, and whether chronic or acute. 
These periods of disturbed sleep are usually limited in their length and incidence, but for 
many individuals they can last for extended lengths of time, and often re-emerge at 
various points of a lifetime. Even relatively mild and limited periods of disturbed sleep 
are associated with a myriad of daytime behavioral impairments. Research has estimated 
that the overall prevalence rate of adults obtaining insufficient sleep is 20% (Hublin, 
Kaprio, Partinen, & Koskenvuo, 2001). Additionally, a study of over 1,000 young adults 
over 5.5 years found that the degree of this partial sleep deprivation was proportional to 
the amount of daytime sleepiness experienced (Breslau, Roth, Rosenthal, & Andreski, 
1997). Neurocognitive functioning is thought to mediate the relationship between 
sleepiness and behavioral performance decrements, which in turn are directly related to 
the occurrence of functional accidents in everyday life. 
Overall, accidents related to some degree of sleep deprivation have been 
estimated to have an economic impact ranging between $43 and $56 billion (U.S.; Leger, 
1994). Motor vehicle collisions are the most commonly associated cost of sleep 
deprivation, yet are thought to be highly underestimated (Horne & Reyner, 1999; 
McCartt, Ribner, Pack, & Hammer, 1996; Mitler, Carskadon, Czeisler, Dement, Dinges, 
& Graebner, 1988). In addition to motor vehicle collisions, sleep deprivation research has
repeatedly found that airline pilots (Bourgeois-Bougrine, Casrbon, Counelle, Mollard, & 
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Coblentz, 2003; Price & Holley, 1990), truck drivers (Lyznicki, Doege, Davis, & 
Williams, 1998; McCartt, Rohrbaugh, Hammer, & Fuller, 2000), medical residents 
(Landrigan, Rothschild, Cronin, Kaushal, Burdick, Katz, et al., 2004; Lockley, Barger, 
Ayas, Rothschild, & Czeisler, 2007), shift workers (Richardson, Miner, & Czeisler, 1989-
1990), and other professions are at high risk for making high-damage accidents due to 
sleepiness and its related sequelae. Blood alcohol content (BAC) is a useful comparison 
metric for sleep deprived populations. Driving performance for those deprived of one 
night of sleep was found to be equivalent to those non-sleep deprived individuals driving 
with a BAC of 0.07% (Fairclough & Graham, 1999); for comparison, driving in the state 
of Michigan or Ontario with a BAC of 0.08% or higher is illegal. Multiple other studies 
have found that as uninterrupted waking periods exceed 16 hours, psychomotor 
performance impairments progressively increase to levels comparable to BACs ranging 
between 0.05% and 0.1% (Dawson & Reid, 1997; Williamson & Feyer, 2000).
In addition to functional accidents, disturbed sleep is demonstrated to cause 
significant quality of life decrements, which strongly drive patients to seek assistance. 
Reimer and Flemons (2003) conducted a literature review investigating how sleep quality
and quantity correlated with a wide range of domains that contribute to quality of life. 
They found that across all measures and etiologies of disturbed sleep, quality and 
quantity of sleep were related to some or all measures. For instance, the large Sleep Heart
Health Study (n = 5816), in which 90% of participants received an in-home 
polysomnograph, found that those suffering from excessive daytime sleepiness had 
significantly poorer quality of health in all subscales measured (Baldwin, Griffith, Nieto, 
O’Connor, Walsleben, & Redline, 2001). In clinical sleep-disordered breathing 
2
populations (of which obstructive sleep apnea is the predominant diagnosis), 
symptomatic fragmented sleep (meaning many sub-conscious arousals from deep sleep 
throughout a night) has been associated with increased mortality, abnormal waking 
electroencephalograms (EEG), metabolic and endocrine dysregulation, decreased 
immune and inflammatory responsivity, and cardiovascular sequelae (Dinges, Rogers, & 
Baynard, 2005). In sum, sleepiness secondary to poor sleep is associated with 
neurocognitive dysfunction, behavioral accidents, and quality of life decrements (both 
mood and functional). 
 Relatively recent improvements in the methodology available for sleep research 
(e.g. polysomnogram, functional imaging) have allowed for more detailed investigation 
of the relationship between quality and quantity of sleep and daytime behavioral 
outcomes. The following sections will briefly review the current understanding of sleep 
physiology, explain how it relates to neurocognitive processing, cognitive-affective 
processing, and mood, and finally introduce a published cognitive model of sleep-
dependent emotional processing in order to guide proposed investigation of 
neuropsychological functioning in obstructive sleep apnea.  
Sleep
The following section is a significantly condensed overview of sleep physiology, 
emphasizing the introduction and definition of terminology that is relevant to the present 
study. An expanded version of this section is available in Appendix A.
Sleep Stages and Characteristics
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Sleep in mammalian species has been generally categorized into two separate types - 
rapid eye movement (REM) sleep, and non-rapid eye movement (NREM) sleep, which 
has predominantly been further subdivided in primates into four, progressively deeper, 
stages (Rechtschaffen & Kales, 1968). Research in human sleep patterns has identified a 
90 minute alternating, ultraradian cycle between NREM and REM sleep. The American 
Academy of Sleep Medicine (AASM; Iber, 2007) recently updated the terminology used 
to break sleep down based on electroencephalograph (EEG) readings into REM sleep, 
and NREM stages labeled N1, N2, N3. 
Table 1 summarizes the EEG (AASM, 2007; Steriade & Amzica, 1998), 
neurochemical (Rosenthal, 1998; Saper, Chou, & Scammell, 2001), and functional 
anatomic characteristics (Nofzinger, 2005) associated with each stage.
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Table 1
Summary of EEG, Neurochemical, and Neurofunctional Characteristics of Sleep Stages
State EEG EEGmarkers Sleep Characteristics Neurochemical Functional 
Awake
Desynchronized 
beta waves (12-30 
Hz)
RAS efferents to 
HT, THAL, BFB
Use CA, HTM, 
ACh, Asp, Glu
N1
Transition from 
alpha waves (8-12 
Hz) to theta waves 
(4-7 Hz)
Drowsiness
If woken, will report 
not having been asleep
GABAergic 
neurons in cortex, 
THAL, and HT 
highly active
Decreased 
subcortical 
cholinergic 
systems of 
forebrain and 
brainstem
Reduced activity
of the PFC, TL, 
BG, THAL, 
brainstem
Reduction level 
intensifies with 
progression 
through N1-N3
N2
11-16 Hz, but 
predominately 12-
14 Hz
Sleep 
spindles
K-complexes
Tranquil state 
maintained
50% of total sleep time
N3
0-4 Hz, at least 
20% delta waves 
(0.5-2 Hz)
Slow-wave 
sleep (SWS)
Mass cortical 
synchronization 
(organization 
processing related to 
daytime cognition)
REM
Theta wave 
reemergence (4-7 
Hz)
High frequency 
gamma waves (30-
80 Hz)
PGO waves 
(originating 
from pons, 
LGNT, & 
OC)
Rapid eye movement 
bursts in rhythm with 
PGO waveforms
20-25% of total sleep 
over 4-5 periods
Descending muscle 
atonia & increased 
variability of 
heart/breathing rate & 
temperature
ACh neurons of 
PT = "REM-on 
cells," highly 
active
5HT & NE 
neurons of Raphe 
& LC = "REM-off 
cells," are 
deactivated
Increased 
activity of the 
mbPFC, OC, 
Thalamic nuclei,
PT, ACC, 
AMYG, HPC
Decreased 
activity of the 
PCC, PL, dlPFC
Note, top-bottom & left-right: PGO - Ponto-geniculo-occipital, LGNT - lateral geniculate
nucleus of the thalamus, OC - occipital cortex, RAS - reticular activating system, HT
- hypothalamus, THAL - thalamus, BFB - basal forebrain, CA - catelcholomines, 
HTM - histamine, ACh - acetylcholine, Asp - asparate, Glu - glutamate, GABA - 
gamma-aminobutryic acid, PT - pontine tegmentum, 5HT - serotonin, NE - 
norepinepherine, LC - locus coeruleus, (mb/dl) PFC - (mediobasal/dorsolateral) 
prefrontal cortex, TL - temporal lobe, BG - basal ganglia, OC - occipital cortex, 
ACC - anterior cingulate cortex, AMYG - amygdala, HPC - hippocampus, PCC - 
posterior cingulate cortex, PL - parietal lobe
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Sleep-Wake Cycle
Three separate yet networked neuroanatomical systems regulate the sleep-wake cycle in 
humans (Borbely & Achermann, 1999; Pace-Schott & Hobson, 2002). 
A homeostatic regulation system is responsible for intensity, length, and quantity 
of sleep. Adenosine has been identified as a molecular-level somnogen integral to this 
system at the cellular level. During wakeful periods, it is hypothesized to naturally 
accumulate to levels that impact sleep/wake related areas of the brain. This nucleoside 
has an activating effect on ventrolateral preoptic area neurons bordering the basal 
forebrain and an inhibitory effect on wake-promoting areas of the basal forebrain 
(Porkka-Heiskanen, Strecker, Thakkar, Bjorkum, Greene, & McCarley, 1997). Thus, 
during wakeful accumulation of adenosine, a drive towards sleep accrues. Preoptic neural
circuitry has been associated with the homeostatic functions.
A circadian system manages the timing of sleep and wake periods within the 
overall day-night cycle, promoting both wakefulness and sleep - at opposite phases. The 
anterio-hypothalamic elements are associated with circadian functions. The circadian 
timing system (CTS) is comprised of three components, the central of which is the 
suprachiasmatic nucleus (SCN) of the anterior hypothalamus, which acts as a circadian 
pacemaker - coordinating circadian oscillator subcomponents via control over melatonin 
secretion by the pineal gland (Rossenwasser & Turek, 2005). The SCN is responsible for 
establishing the sleep-wake circadian rhythm. The SCN is entrained (i.e., synchronized) 
via physiological and environmental signals. The subcomponent circadian-oscillators in 
peripheral tissues are in turn entrained by physiological signals from the pacemaker 
component. Peripheral circadian oscillators are understood also to contain endogenous, 
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cellular-level pacemaker "clock cells," independent of the circadian system as a whole 
(Herzog, 2007). The SCN is thus thought to entrain the various peripheral cellular 
oscillators rather than sustain their rhythmic activity (Okamura, 2004). The third 
component of the CTS are the efferent projections that serve to regulate otherwise non-
rhythmic physiological and behavioral systems (e.g., body temperature, 
autonomic/endocrine systems, feeding, sleep/wake state, locomotor activity).
The cyclical vacillation between REM and NREM sleep within each sleep period 
is controlled by an ultradian system. Mesencephalic and pontine rostral brainstem areas 
are associated with REM/NREM regulation; Table 1 offers more details.
Saper, Chou, and Scammell (2001) reviewed recent literature on sleep regulation 
and identified a substantial amount of evidence that a reciprocal inhibition model of sleep
and arousal systems exists; they termed it a sleep-wake switch. GABAergic and 
galaninergic neurons of the ventrolateral preoptic nucleus (VLPO) are active and 
necessary for normal sleep. In contrast, hypocretin/orexin (exchangeable names) neurons 
within the posterior lateral hypothalamus (PLHT) are necessary for maintaining normal 
wakefulness. These two systems are thought to exist in a sustained state of balanced 
reciprocal inhibition (a bi-stable feedback loop) when not influenced from external 
pressures. Once either of the systems is excited, it inhibits the other, thereby resulting in 
further excitation due to decreased inhibitory afferents from its partner. In sum, human 
sleep physiology can be conceptualized as three gears nested within each other, with the 
transition between sleep and wakefulness occurring in rapid fashion when the 
homeostatic and circadian gears align. 
Sleep Deprivation
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Basal sleep need is defined as habitual sleep duration in the absence of any sleep debt. 
Sleep debt is conceptualized as "the fundamental duration of sleep below which waking 
deficits begin to accumulate" (Dinges, Rogers, & Baynard, 2005, p. 68). Both 
experimental and epidemiologic research has found high interindividual variance in 
amount of sleep habitually obtained. A large study found that after long-duration sleep 
designed to eliminate sleep debt, average sleep length stabilized at 8.17 hours (Wehr, 
Moul, Barbato, Giesen, Seidel, Barker, & Bender, 1993); another large, dose-dependent 
sleep deprivation study statistically estimated a daily requirement of 8.16 hours of sleep 
to avoid negative impacts on functioning during the subsequent wake period (Van 
Dongen, Maislin, Mullington, & Dinges, 2003). The following section will discuss a 
number of past and present theoretical frameworks for understanding sleep deprivation.
Models
In the 1980's, a two component hypothesis of sleep gained popularity - core and optional 
sleep (Horne, 1988). The analogy of appetite was cited by its proponents, in which 
hunger cues consumption of food until satiation, but additional food can be consumed 
beyond the body's immediate need. Core sleep is composed of primarily slow wave sleep,
and it is the quality and length of this period of sleep that determines the degree of 
daytime cognitive functioning and alertness. Optional sleep is conceptualized as 
superfluous, or a luxury without confirmed function; one proposed possibility is that 
optional sleep serves as an evolutionary behavioral carry-over meant to keep the 
individual withdrawn and safe during the remaining hours of darkness. Proponents 
redefined the average amount of core sleep required each night from 4-5 hours to 6 hours.
However, if this were true, chronic sleep restriction of 6 hours would not be expected to 
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result in detrimental functional impacts in humans, which  is not the case (Van Dongen, 
Maislin, Mullington, & Dinges, 2003). That study will be addressed in more detail below.
Another hypothesis proposes that at the onset of a chronic restriction of sleep 
time, acute neurobehavioral functioning decrements occur, but that over time individuals 
are able to adapt to the new, reduced sleep period. Research has shown that self-reports 
of sleepiness drop after an initial spike when sleep time is chronically restricted to 4-6 
hours per night, up to 8 months (Belenky, Wesensten, Thorne, Thomas, Sing, Redmond, 
et al., 2003; Lubin, 1967). Abruptness of sleep restriction is an important moderating 
factor within this hypothesis, with research demonstrating that gradual (versus 
precipitous) accumulation of a set amount of sleep debt resulted in neurobehavioral 
performance decrements smaller in magnitude (Van Dongen, Maislin, Mullington, & 
Dinges, 2003). Other research suggests that adaptation to sleep deprivation may differ 
depending on which neurobehavioral outcomes are measured. It appears that waking 
EEG and non-REM slow-wave sleep (SWS) show the most and quickest adaptation, 
subjective sleepiness shows slower and less adaptation, and that neurocognitive 
functioning shows the slowest and least adaptation to sleep deprivation (Van Dongen, 
Rogers, Dinges, 2003; Van Dongen, et al., 2003).
A bio-mathematical two-process model taps the well-researched regulation 
components of sleep: (1) the homeostatic process that exponentially builds during waking
periods and exponentially declines during SWS periods, and (2) a near-24 hour circadian 
regulation process. The hypothesis proposes that wakeful cognition is primarily based on 
alertness (A), and that this construct could be mathematically modeled as the quantitative 
difference between the homeostatic process (S) and the circadian process (C): A=S-C. In 
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a blind study, this model was found to accurately predict neurobehavioral responses 
based on total sleep deprivation, but failed to accurately predict cognitive performance 
and sleepiness across a chronic sleep deprivation paradigm (Borbely & Achermann, 
1999). 
All of the prior hypotheses and models share a common feature in their 
conceptualization of chronic sleep deprivation, which is an emphasis on cumulative sleep
time lost. The "wake extension" hypothesis approaches alterations of the sleep-wake 
cycle from a different angle, instead emphasizing cumulative wake-time cost. Proponents
attempted to reconcile the neurocognitive results found in complete sleep deprivation and
those from chronic sleep deprivation by positing that during periods of wakefulness, 
neurobiological costs/consequences accumulate (Van Dongen, Maislin, Mullington, & 
Dinges, 2003). 
Researchers used a sleep dose-response experiment (8, 6, or 4 hours in bed across 
two weeks, and a 0 hours in bed condition across 3 days) to investigate their hypothesized
model. Results showed a near-linear accumulation of cognitive performance deficits 
across all conditions. The rate (slope) of deterioration was inversely related to amount of 
sleep time; the 0 hour condition demonstrated the highest rate of deterioration. At the two
week period, the 4 hours time in bed (TIB) condition was performing with similar 
cognitive decrements to the 0 hours TIB at the three day mark. Calculating the 
cumulative sleep loss for each condition reveals that the 4 hour TIB group had lost 
approximately 55 hours of sleep, whereas the 0 hours TIB group had lost approximately 
25 hours. To reconcile this inconsistent observation, the wake-extension time (defined as 
"continuous wake duration" - "habitual wake duration") was calculated for each group. 
10
This approach resulted in the same values across the restricted sleep conditions as the 
previous approach. However, for the full sleep deprivation condition, each day after the 
end of the first "habitual wake duration" added a full 24 hours to the wake extension 
time, thereby bringing the observed deficits into alignment with quantification of 
sleep/wake disruption (for visual representation of this phenomenon, see Figure 4 within 
the Van Dongen et al., 2003 paper). This study clearly demonstrates that cumulative 
wake extension and cumulative sleep loss are different constructs with different 
quantitative values dependent on how sleep loss occurs. Further, it suggests that the field 
should conceptualize sleep debt as an accrual of wakefulness beyond roughly 16 hours 
with an associated neurobiologic cost. 
Disturbed Sleep & Neurobehavioral Functioning
Sleep deprivation results in increased sleep propensity, as measured by reduced sleep 
onset latency and reduced latency between the transition from lighter NREM sleep to 
SWS on polysomnograms (PSG; Carskadon & Dement, 1987). After one night of 
complete sleep deprivation, average sleep onset latency drops to less than 1-2 minutes, 
and the time to progress from sleep onset to deep SWS is halved (Dinges, 1986). 
Progressive reductions in daytime sleep onset latency has also been demonstrated in a 
week long, 5 hour sleep restriction paradigm (Carskadon & Dement, 1981). Increased 
sleep propensity, even when being resisted, results in the occurrence of microsleeps 
intruding into wakefulness (Akerstedt, 1987). The state instability hypothesis posits that 
neurocognitive performance becomes progressively more variable as homeostatic 
pressure accumulates and increasingly disrupts normal neurocognitive processing, which 
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begins to become more dependent on compensatory mechanisms (Doran, Van Dongen, &
Dinges, 2001). Behavioral examples of these compensatory mechanisms include sleep-
deprived individuals falling asleep while walking and "semidreaming" while performing 
verbal cognitive tasks (Kleitman, 1963; Dinges, 1990). Errors of commission are 
explained as ineffective compensatory efforts initiated during the resistance of sleep 
(Durmer & Dinges, 2005). Thus, at any given moment, sleep deprived individuals 
produce widely varied neurocognitive and neurobehavioral performance.
Effects of Disturbed Sleep on Cognitive & Behavioral Functioning
There are several broad findings in the research addressing cognitive performance in 
sleep deprived and partial sleep deprived healthy individuals that must be considered 
before reviewing domain-specific findings. Research suggests that sleep deprivation often
has unexpectedly measure-specific performance impacts; for example, a study found that 
after a 5 night, 40% reduction of habitual sleep time, performance decrements on a 
measure of vigilance and simple reaction time were observed but no deficits were noted 
on a measure of choice reaction time (Herscovitch & Broughton, 1981). This may be due 
to psychometric properties of different measures, or perhaps that the impact of sleep 
deprivation is nuanced and focal rather than broad, even within traditionally internally 
consistent cognitive domains (Dinges, Rogers, & Baynard, 2005). Cognitive decrements 
have generally been found to be dose-dependent to the amount and length of sleep 
restriction (Belenky, Wesensten, Thorne, Thomas, Sing, Redmond, et al., 2003). As 
previously discussed, extended periods of restricted sleep have an accumulating 
impairing effect that can eventually become equivalent to acute sleep deprivation (Van 
Dongen, Maislin, Mullington, & Dinges, 2003). Finally, neurobehavioral performance 
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deficits associated with sleep deprivation vary significantly between individuals, above 
and beyond differences in sleep histories. In fact, it appears that vulnerability or 
resiliency to sleep deprivation is a trait, though no neurobiological correlates have been 
identified thus far (Van Dongen, Baynard, Maislin, & Dinges, 2004). Though average 
deficits scores are stable within-subjects, a hallmark of sleep deprivation is a significant 
increase in variability of test performance, between and within measures; this is thought 
to reflect the transitory nature of attentional lapses (Waters & Buck, 2011). 
To offer a launching point for the following discussion, consider the following. A 
large meta-analysis has concluded that upon collapsing measures of three areas of 
functional level (cognition, mood and fatigue, and motor functioning), "any sleep-
deprived individual is estimated to be comparable to the 9th percentile of non-sleep-
deprived subjects" (p. 120, Durmer & Dinges, 2005). Effect sizes for the impact of sleep 
loss have generally been classified in the moderate range (Lim & Dinges, 2010). Meta-
analysis also found that cognition and mood were affected worse by partial sleep 
deprivation than total, though the reverse is true for behavior (Pilcher & Huffcutt, 1996). 
In general, performance on cognitive tasks becomes progressively worse as task 
engagement time is extended, in an exacerbated "fatigue" effect phenomenon (Kribbs & 
Dinges, 1994). Conversely, brief measures with an emphasis on speed or time also are 
sensitive (Dinges, 1992). Finally, early theories on cognitive decrements following 
disrupted sleep hypothesized that decreased motivation mediated the performance 
deficits. However, sleep deprived populations have been demonstrated to pass 
neuropsychological measures of adequate effort, as well as perform poorly on high 
novelty tasks designed to be intrinsically engaging, suggesting that interest and effort are 
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not significant etiological factors in explaining cognitive performance declines (Harrison 
& Horne, 2000; Wilkinson, 1961).  
Durmer and Dinges (2005) reviewed the literature on the neuropsychological 
performance impact of sleep deprivation and identified a number of reliably affected 
cognitive processes. This section summarizes the majority of their findings, and includes 
more recent research findings to expand upon their review. First, there will be a 
discussion of the cognitive findings associated with large amounts of sleep deprivation 
(i.e. 4 or less hours per night), then these will be related to partial sleep deprivation and 
fragmented sleep. 
Individuals who have been deprived of sleep demonstrate slowing on subject-
paced tasks, and make increased errors when a time pressure component is present. Not 
unexpectedly, this processing speed deficit is also reliably demonstrated in reaction time 
measures. Speed of information processing has been demonstrated to be reliably 
impacted by any disruption of normal sleep, with a 27 study meta-analysis finding that 
speed was the most impacted cognitive construct, followed by accuracy (Koslowsky & 
Babkoff, 1992; Waters & Bucks, 2011). Eye-hand coordination and psychomotor 
performance consistently show decrements of roughly 30% in speed and accuracy after 
sleep deprivation (Williamson & Feyer, 2000).
Tasks that require continued attention and vigilance are negatively impacted by 
sleep deprivation, with increases in omission and commission errors. The functional 
impact of increased attentional fatigue negatively affects performance on sustained 
attention measures, as well as on other neuropsychological measures that require 
extended periods of attention. In fact, a meta-analysis of 70 studies concluded that 
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extended simple attention is more significantly impacted than performance on tasks 
requiring divided attention (Lim & Dinges, 2010). For example, on cognitive tasks with a
learning component, sleep deprived individuals are less efficient at reaching equivalent 
levels of acquisition, though often can reach normative expected performance levels 
when given additional time and exposure to the stimuli. Short-term recall for successfully
encoded information has also been shown to suffer post-sleep deprivation. After 1 night 
of sleep deprivation, individuals scored worse on measures of visual and verbal short-
term memory, and performance was related to the magnitude of abnormally decreased 
intraparietal sulcus and hippocampal activity (Chee & Chuah, 2007; Chen, Hardy, Zhang,
LaHoste, & Bazan, 2006; Van der Werf, Altena, Schoonheim, Sanz-Arigita, Vis, De 
Rijke, et al., 2009). Working memory tasks that require maintenance and manipulation of 
information from multiple modalities are compromised as well, resulting in difficulty 
with temporal organization of information, decreased ability to maintain flexible 
thinking, and decreased ability to filter distractions and maintain focus on relevant 
information and cues. One study estimated working memory performance drops 
averaging 37% after large amounts of sleep deprivation (Turner, Drummond, Salamat, & 
Brown, 2007). 
Neuropsychological measures thought to rely on more complex cognitive 
processes have often been considered insensitive to partial sleep deprivation. It is thought
that problem-solving and critical thinking based tasks allow for convergent skills being 
tapped in parallel, permitting intact performance via compensatory support from less 
affected systems (Waters & Bucks, 2011). However, consistent with the weaknesses 
previously noted in more simple working memory tasks, sleep deprived individuals have 
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impaired performance on certain complex cognitive tasks that require executive functions 
such as mental flexibility and multitasking, perhaps reflecting the increased variability in 
general cognitive performance following sleep deprivation. More specifically, divergent 
thinking tasks that require lateral thinking, assimilation and utilization of feedback, and 
risk assessment all show decrements after sleep deprivation. Executive processing errors 
such as decreased insight into performance decrements, suppression of inappropriate 
responses, and increased ineffective response perseveration are also well-documented. 
Associated with the decrements in executive functioning, sleep deprived individuals rely 
more heavily on compensatory effort to maintain adequate performance; this comes at the
cost of situational awareness, as neglect for activities and stimuli judged to be 
nonessential increases (Durmer & Dinges, 2005).
The deficits discussed have led researchers to conclude that deprivation of sleep 
negatively impacts performance on tasks believed to originate from or mediated through 
the prefrontal cortex (PFC) - for those tasks that are attention-rich, more specifically, the 
dorsolateral PFC (Kane & Engle, 2002). When sleep restriction is increased to complete 
deprivation for 36 hours, research found that young participants produced 
neuropsychological deficit profiles comparable to an elderly habitual sleep group 
(Harrison & Horne, 2000). This is consistent with current attribution of documented 
neurocognitive deficits in aging to declines in PFC functioning (Corey-Bloom, 
Wiederholt, Edelstein, Salmon, Cahn, & Barrett-Connor, 1996). Functional neuroimaging
research suggests that two elements of the functional network connected to the PFC are 
disrupted after sleep deprivation (Harth, 1995; Posner, 1994). The first is an anterior 
network consisting of the PFC, basal ganglia, and anterior cingulate, which are involved 
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in selective attention and the mental maintenance of a memory for immediate 
manipulation (i.e. working memory). The second is a posterior network consisting of the 
superior parietal lobes, pulvinar, and superior colliculus, which is thought to control 
attentional switching and divided attention. The anterior cingulate has afferent 
projections to the superior parietal lobes, and is innervated by the PFC, connecting the 
three network components. 
Significant-to-complete sleep deprivation is a useful paradigm to research the 
neurocognitive correlates of decreased sleep; however, the ecological application is 
limited. Sleep decrements in vivo generally take the form of partial sleep deprivation or 
fragmented sleep. Recent research that has improved methodological controls for sleep 
history and external influencing factors has found that 4 or more days of 7 or less hours 
of sleep restriction per night results in measureable decrements in neurobehavioral 
functioning and performance (Belenky, Wesensten, Thorne, Thomas, Sing, Redmond, et 
al., 2003; Dinges, Pack, Williams, Gillen, Powell, Ott, et al., 1997). Restriction between 6
and 3 hours per night results in increased sleep propensity, working memory deficits, and 
impaired sustained attention and vigilance (Carskadon & Dement, 1981; Drake, Roehrs, 
Burduvali, Bonahoom, Rosekind, & Roth, 2001). The most extensive study on sleep 
deprivation and restriction to date, conducted by Van Dongen and colleagues (2003), was
previously discussed, confirming that sleep restriction induced neurocognitive 
performance decrements accumulate to levels equivalent to acute complete sleep 
deprivation. While occupational research on partial sleep deprivation is relatively 
common (e.g., for air traffic control, heavy machinery operators, etc.), a relatively under-
researched area is the impact of sleep deprivation on everyday complex tasks with high 
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potential risk, such as driving. An epidemiological study found an elevated occurrence of 
sleep-related vehicle crashes in those individuals who reported an average of less than 7 
hours of sleep per night (Strutts, Wilkins, Osberg, Vaughn, 2003). Driving simulator 
research has found that 1 night of restricted sleep (5 hours) results in decrements of 
performance in simulated normal driving conditions and situations requiring emergency 
maneuvers (Horne & Baulk, 2003). Another two studies found that chronic restriction of 
sleep (time in bed between 4 and 6 hours) is associated with a significant increase in 
number of accidents, and rates increase further after 2 nights of this degree of sleep 
restriction (Dorrian, Dinges, Rider, Price, & Rogers, 2003; Rupp, Arnedt, & Carskadon, 
2003). 
Fragmented sleep refers to repeated arousals (3+ seconds of disrupted EEG 
frequency in NREM or increased electromyographic frequency during REM) occurring 
throughout a sleep period. Arousals do not result in awakenings. However, multiple 
studies have demonstrated that persistent fragmentation of sleep results in the same 
effects on daytime somnolence, mood alteration, and cognitive performance decrements 
as partial sleep deprivation (Bonnet, 1985; Bonnet, 1986; Bonnet, 1989; Martin, 
Engleman, Deary, & Douglas, 1996). In fact, arousals occurring at an average rate of 
once per minute throughout a sleep period of normal duration result in neurocognitive 
performance decrements equivalent in pattern and magnitude to that of 1 night of 
complete sleep deprivation (Bonnet, 1986; Downey & Bonnet, 1987). This is not an 
unusual fragmentation pattern for those suffering from intrinsic sleep disorders such as 
obstructive sleep apnea (Durmer & Dinges, 2005). These findings hold true in quasi-
experimental studies measuring cognitive performance of those with endogenous 
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fragmentation of sleep, as well as experimentally fragmented sleep using aural 
stimulation (Martin, Wraith, Deary, & Douglas, 1997). A detailed discussion of 
cognitive, behavioral, and mood decrements in the obstructive sleep apnea (OSA) 
population is provided later in this review. Finally, of considerable importance is the 
finding that across all domains, cognitive deficits are reversible following a period of 
normal sleep, which means that cognitive dysfunction attributed to disrupted sleep should
be framed in remediable terms and highlights the clinical importance of sleep 
intervention (Waters & Buck, 2011). 
Sleep & Affect
Affective Processing
The ability to effectively and efficiently process affective-based stimuli is crucial for 
human functioning from a socio-evolutionary perspective, as suggested first by Charles 
Darwin in 1872 (Norris & Cacioppo, 2007). The generation and regulation of emotions 
and the guidance provided by emotional content and cues is fundamental to individual 
mental health, interpersonal functioning, and societal structure. In the past decade, 
cognitive neuroscience and clinical neuropsychology have rapidly embraced and 
investigated the domain of emotional or affective processing as a critical element of 
normal and abnormal cognition, and recognized the relationship between affective 
processing and clinical mental health (Labar & Cabeza, 2006). The following will 
provide a brief outline of a systems-level framework of affective informational 
processing.  
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To discuss affective processing, a few terms and constructs should be clarified. 
For the purposes of this review, the term emotion is meant to represent a complex 
physiological, behavioral, and cognitive experience associated with the onset and 
maintenance of mood/s. Affective is a descriptor meant to refer to characteristics that 
conveys emotionally-relevant information, and affect is meant to refer to the process or 
state of consciously labeling and experiencing internal emotional states (generally 
resulting in phenotypic expression of the emotion, as often commentated on clinically). 
Thus, affective processing is a form of information processing whereby emotionally-
relevant information is gleaned from a stimulus, analyzed, and then utilized in order to 
facilitate correct/adaptive/appropriate reaction. Suchy (2011) posits that there are three 
theoretical properties that are necessary for an affective processing system (APS). First, 
the brain's APS needs the ability to detect emotionally-germane stimuli and judge the 
affective qualities and characteristics (e.g., valence and intensity) quickly (likely 
incorporating aspects of preconscious detection) in order to facilitate an immediate, 
adaptive reaction. Second, an APS must also be able to initiate and maintain 
physiological, behavioral, and cognitive events that comprise the response. Third, an 
association and memory component is required to learn emotionally relevant 
characteristics of a stimulus that was initially emotionally-neutral. Two related neural 
circuits are involved in triggering emotional responses to stimuli - the amygdala 
processes and responds to external stimuli, and the hypothalamus processes and responds 
to disruption to internal homeostasis. The following will focus on the amygdala, as this 
process involves the reviewed and proposed research methodologies.
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Two information processing routes exist, with both sharing an input pathway and 
the amygdala acting as a mediator for behavioral and physiological responses (Suchy, 
2011). The "fast route" (≈10-12 msec.) of affective information processing begins with 
the sensory organ input projecting to the thalamus and primary visual cortex, where 
crude, basic information (i.e., valence and intensity) regarding the stimuli is perceived. 
The fast route next consists of this affective information being received by the basolateral
amygdala which projects to the orbitofrontal cortex and striatum involved with emotional
learning circuitry, and also to the central nucleus of the amygdala which in turn projects 
to the hypothalamus and brainstem nuclei to generate physiological and behavioral 
responses. The "slow route" (≈30-40 msec.) involves primary association cortices that 
supply information about the perceived stimuli and supramodal association cortices that 
supply more abstract and contextual meanings about the stimuli. These  include the 
secondary sensory cortex, tertiary sensory cortex, and hippocampus.
The integration of affective processing and cognitive research has resulted in 
some domain-specific findings. Attentional blink paradigms have shown that responding 
to a target during rapid stimuli presentation causes momentary depletion of attentional 
resources, resulting in missed targets that immediately follow a first target. Strong 
affective valence of the second target ameliorates this depletion. However, individuals 
with amygdala damage cannot benefit from this phenomenon (Anderson & Phelps, 
2001). Significantly faster psychomotor response speed has also been found for 
negative/threatening valenced stimuli, above and beyond that which can be explained by 
increased provision of attentional resources to the stimuli (Flykt & Caldara, 2006; LoBue 
& DeLoache, 2008). The amygdala has also been found to facilitate episodic memory for 
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affectively salient stimuli (Frank & Tomaz, 2000). This occurs due to improved encoding
via amygdala modulation of the perceptual cortical areas and improved consolidation of 
affective stimuli in proportion to the relative survival importance of the associated 
outcome (Phelps, 2004). Individuals with damaged or dysfunctional amygdala do not 
benefit from the memory facilitation by affective characteristics of emotional stimuli as 
found in healthy controls (Dolan & Fullam, 2010). 
The Role of Sleep in Affective-cognitive Processing
The domain of learning and memory is a useful cognitive domain to research as it relates 
to the affective processing system (APS), as it is understood to tap elements of attention, 
working memory, and executive functions such as organization. Impact of sleep quality 
on memory recall has focused on two stages, the initial formation of new memories 
(encoding), and then the subsequent solidification of the memories (consolidation). Both 
will be addressed with an emphasis on encoding as it is more germane to this dissertation 
(Marshall & Born, 2009; Walker, 2009). 
Affective Memory Encoding and Sleep
The elicitation of emotional states can strongly modulate the initial stages of learning 
(i.e., encoding). Stimuli with emotionally arousing affective traits are recalled better than 
those considered neutral (Buchanan & Lovallo, 2001; Heuer & Reisberg, 1990; Phelps, 
2004). The modulation effect of emotionally arousing stimuli on encoding occurs in 
different ways depending on the affective stimuli's valence (positive, neutral, negative) 
and arousal level (calm to excitement). High arousal affective characteristics enhance 
memory encoding through the adrenergic system. Introduction of propanolol (a beta-
adrenoceptor antagonist) to individuals prior to exposure to a gradient of different 
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emotionally arousing stimuli (narratives, individual words) results in a disappearance of 
the enhancing effects of affect on learning found in control groups (Cahill, Prins, Weber, 
& McGaugh, 1994; Strange, Hurlemann, & Dolan, 2003). Lesion and functional 
neuroimaging has identified the amygdala, anterior hippocampus, ipsilateral 
parahippocampus, and ventrolateral prefrontal cortex as being involved with the 
formation of memory for affectively-valenced information (Cahill, Haier, Fallon, Alkire, 
Tang, & Keator, 1996; Dolcos, Labar, Cabeza, 2004; Kilpatrick & Cahill, 2003). In the 
absence of high arousal, valence of stimuli (versus neutrality) still positively modulates 
encoding, though this is primarily governed by frontally-mediated strategic and semantic 
processes outside of the amygdala and paralimbic system (Labar & Cabez, 2006). High 
arousing stimuli with a negative valence have been found to have the strongest enhancing
effect on encoding compared to positive and neutral stimuli (Kensinger & Corkin, 2003).
The above findings relate to individuals under normal sleeping conditions. 
Beginning at a cellular level, in rodent studies REM sleep deprivation (24-72 hours) has 
been found to reduce hippocampal neuron excitability and significantly impair long-term 
potentiation (LTP), a process demonstrated to be a critical mechanism for memory 
formation (Davis, Harding, & Wright, 2003). The LTP observed after REM sleep 
deprivation decays within 1.5 hours, suggesting significant impairment in hippocampal 
plasticity. Behaviorally, avoidance learning, passive avoidance learning, and taste 
aversion processes are all significantly impaired in rodents following both general sleep 
deprivation and specific REM deprivation (McGrath & Cohen, 1978; Smith, 1985). 
Deficits in performance are present even when the deprivation is limited to 5 hours, and 
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continued practice trials do not result in performance improvements (Gruart-Masso, 
Nadal-Alemany, Coll-Andreu, Portell-Cortes, & Marti-Nicolovius, 1995). 
In one thorough human study, participants were either deprived of sleep for 36 
hours or allowed a habitual sleep period, then exposed to emotionally arousing and 
neutral stimuli (Walker, unpublished results, most recently cited in Saletin & Walker, 
2012). All participants then were allowed two habitual sleep periods before recall was 
tested, thereby controlling for impaired recall due to sleep deprivation confounds; 
retention of material was thus deemed to represent encoding processes. Control group 
individuals demonstrated significantly superior retention for positive and neutral stimuli 
relative to the experimental group. Sleep deprived individuals had significantly impaired 
retention for neutral stimuli, but even worse retention of positively valenced stimuli (59%
reduction relative to control group for positive stimuli) compared to controls. Retention 
of negative stimuli was not significantly different from that of the control group. In 
effect, sleep deprivation led to skewed encoding sessions, with the experimental group 
ending the session with a prevailing dominance of memory for negative material, and far 
fewer neutral and positive memories. Explanations for this sleep deprivation and affective
valence interaction range from suggestions that the arousal levels differ significantly at 
the neural level of the stimuli (rather than the reported level) which interact with the post-
sleep deprivation hypo-activation of the prefrontal cortex and hyper-activation of the 
amygdala to bias toward successful encoding of negative stimuli versus neutral/positive 
stimuli (Chee & Chuah, 2008; Kensinger & Corkin, 2004; Yoo, Gujar, Hu, Jolesz, & 
Walker, 2007). Additionally, as discussed later, the negative affective state in sleep-
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deprived individuals could lead to a mood-congruent encoding bias (Lewis, Critchley, 
Smith, & Dolan, 2005).
Affective Memory Consolidation & Sleep
Currently, research suggests that emotion and affective characteristics of stimuli have a 
modulating impact on subsequent memory consolidation. Behavioral human studies have 
found decreased forgetting of affectively valenced material versus neutral material. This 
retrieval benefit emerges more strongly as the delay between encoding and retrieval 
attempt increases, as demonstrated in a variety of different delay contrast methodologies: 
immediate versus 1 hour or 24 hours (LaBar & Phelps, 1998; Sharot & Phelps, 2004, 
respectively), 20 minutes versus 1 week (Kleinsmith & Kaplan, 1963), and 15 minutes 
versus 2 weeks (Anderson, Yamaguchi, Grabski, & Lacka, 2006). Research has 
demonstrated that using pain manipulation and stress hormone introduction (adrenaline 
and corticosterone) post-learning trials increases amygdala activity and selectively 
improves long-term memory for affectively valenced stimuli (Cahill & Alkire, 2003; 
Cahill, Gorski, & Le, 2003). Neurotransmitter research in this area has identified 
adrenergic transmitters and acetylcholine as co-regulators of the consolidation of memory
for affective stimuli. Acetylcholine augments amygdala-reliant memory consolidation; 
antagonist and agonist introduction into the amygdala of rodents impairs and enhances 
(respectively) memory for previously learned, valenced material (e.g., fear-conditioning 
and alteration of reward magnitude paradigms; Power & McGaugh, 2002; Schroeder & 
Packard, 2002). 
In humans, REM sleep characteristics have been noted to be altered after shock-
avoidance tasks and contextual fear learning tasks, suggesting that consolidation 
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mechanisms impact sleep-stage characteristics (Sanford, Silvestri, Ross, & Morrison, 
2001; Sanford, Tang, Ross, & Morrison, 2003). Next-day memory retention has been 
demonstrated to be impaired after sleep deprivation between learning and testing, which 
is thought to reflect a disruption of memory consolidation (Walker & Stickgold, 2004). 
Sensitivity to fear-conditioning consolidation deficits appears to be limited to paradigms 
that disrupt/deprive sleep 0-6 hours after the learning task, suggesting that negatively 
valenced memory consolidation occurs shortly following learning (Graves, Heller, Pack, 
& Abel, 2003; Ji, Wang, & Li, 2003). Emerging research suggests a REM-sleep-
dependent hypothesis of affective human memory consolidation, elements of which were 
proposed by both Cahill (2000) and McGaugh (2004). Consolidation of affectively 
arousing stimuli across a 12 hour day, or a 12 hour period including a habitual sleep 
period, results in a benefit in consolidation of the affective information only when sleep 
occurs between learning and testing (Hu, Stylos-Allan, & Walker, 2006). Total sleep 
deprivation for only the first night after exposure to neutral and valenced visual stimuli 
resulted in significant decrements in retention for all stimuli at testing 1 week later, 
however, the greatest decrement was for neutral stimuli (Atienza & Cantero, 2008). The 
authors hypothesized that the consolidation process for emotionally-relevant memories 
may be intrinsically more resilient to sleep disruption. Speed of recognition for 
affectively valenced facial stimuli is increased after a period of sleep, in proportion to the 
amount of REM sleep experienced. In a separate study the power of right-dominant 
prefrontal theta activity during REM sleep in a nap following a learning task for 
neutral/negatively valenced stimuli was also proportionally related to emotional memory 
increase (Nishida, Pearsall, Buckner, & Walker, 2009; Wagner, Kashyab, Diekelmann, &
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Born, 2007). This supports the conclusion of neurophysiological reviews that posit REM 
sleep representing a brain environment especially amenable to consolidation of memory 
for affective material, based on its pro-cholinergic (forebrain ACh levels up to four times 
higher when compared to NREM) characteristics (Marrosu, Portas, Mascia, Casu, Fa, 
Giagheddu, et al., 1995; Pare, Collins, & Pelletier, 2002; Walker, 2009). One limitation 
of this area of research is the absence of human investigation using positively valenced 
stimuli (van der Helm & Walker, 2009).
Emotional Experience, Regulation, & Sleep
Research on the impact of sleep deprivation, or loss, on emotion is limited, despite the 
fact that nearly all psychiatric and neurological condition involving disturbed mood also 
have documented, co-occurring sleep disruption. Affective volatility, lability, and 
irritability are subjectively increased following sleep deprivation (Horne, 1985). 
Emotional disturbance due to chronic restricted sleep (5 hours per night across 1 week) 
has been demonstrated to have an accruing impact (Dinges, Pack, Williams, Gillen, 
Powell, Ott, et al., 1997). Furthermore, restricted sleep has been found to blunt intrinsic 
positive reactions to rewarding/goal-oriented activities and increase negative emotional 
reactions toward experiences that disrupt the achievement of goals or rewards (Zohar, 
Tzischinsky, Epstein, & Lavie, 2005). 
Only recently have researchers investigated the interaction between sleep and 
psychophysiological/emotional reactivity. One functional MRI study exposed controls 
and sleep deprived (1 night) individuals to images spanning a gradient between negative, 
neutral, and positive valences (Yoo, Gujar, Hu, Jolesz, & Walker, 2007). Both groups 
demonstrated increased amygdala activation in proportion to the gradient of the negative 
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images, but the sleep deprived group showed a 60% increase in extent of activation and 
three times the volume of amygdala recruitment compared to the control group. 
Researchers noted decreased functional connectivity between the medial prefrontal cortex
and the amygdala, a pathway normally thought to represent frontal inhibition of 
amygdala reactivity. This finding suggests that sleep is crucial to appropriate top-down 
inhibitory functioning within the mPFC-amygdala circuit, and that this circuit 
significantly governs appropriate emotional responses to affectively loaded stimuli. 
Functional imaging research on populations with mood disorders that commonly have co-
occurring disturbed sleep patterns have also identified abnormalities in this circuit 
(Davidson, Pizzagalli, Nitschke, & Putna, 2002). Little conclusive research findings exist 
for positively valenced material (van der Helm & Walker, 2009).
Current conceptualization of mood disorders almost universally includes sleep 
disturbance as a common feature or formal symptom (American Psychiatric Association, 
2013), with reviews of the research into the relationship generally concluding mood and 
sleep disturbances are bi-directional (Bliwise, 2004; Harvey, 2001). However, a massive 
(N = 18,631) longitudinal twin-study offered strong evidence that poor sleep predates 
onset of depression, though the methodology could not confirm a mechanistic causal 
relationship (Paunio et al., 2009). Depression is a clinical condition that is highly relevant
to the intersect between abnormal affective processing and disturbed sleep. Depression 
has comorbidity rates of disturbed sleep as high as 90%, with polysomnogram (PSG) 
profiles indicating increased sleep latency and arousals, along with decreased REM sleep 
latency and increased REM time and density (American Psychiatric Association, 2013; 
Waller, Hardy, Pole, Giles, Gullion, Rush, 1989; Armitage, 2007; Gottesmann & 
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Gottesmann, 2007). Depressed individuals exhibit heightened activity in the anterior 
paralimbic cortex and midbrain reticular formation while awake, which researchers have 
suggested may reflect a predisposition to encode negatively valenced experiences and 
consolidate them more easily (Nofzinger, Price, Meltzer, Buysse, Villemagne, Miewald, 
et al., 2000). 
Walker and Van der Helm (2009) proposed a clinical model of sleep-dependent 
emotional processing, based upon their literature review, concluding that under 
conditions of sleep loss, the brain has a tendency toward encoding negatively valenced 
stimuli and emotional memories, hyper-active limbic reactivity toward negatively 
valenced events, and that negative memory consolidation is increased during REM sleep 
(which tends to be higher density post-sleep deprivation). Their model proposes a "sleep 
to forget and sleep to remember (SFSR)" hypothesis to explain the consistent finding that
emotional memory initially is comprised of both affective (generally amygdala-
associated activity) and informational (hippocampal-associated activity) components, but 
that over time (many months) the affective component is stripped from the informational 
component of the memory (Dolcos, LaBar, Cabeza, 2004, 2005). The SFSR hypothesis 
posits that this decoupling predominately takes place during sleep, with the end result 
being sleeping to forget the affective/emotional component but sleeping to remember the 
informational component. Failure to strip the affective component due to disturbed sleep 
results in potential mood impacts during wakeful hours. Further, their model argues that 
REM sleep offers a distinctly advantageous neurobiological environment for the 
information-association facilitation of core memories and the depotentiation and 
elimination of an affective charge associated with memories. The authors also point out 
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that the findings that affective valence impacts cognitive processing and memory across 
waking periods absent of sleep suggest that sleep may be a preferential period for 
consolidation but that a mechanism similar to REM sleep or completely independent 
occurs during waking periods. How this segment of affective-processing relates to sleep 
in both healthy controls and mood disorder populations requires further elucidation. 
However, in effect, these authors suggest that there may be an alternate or 
complementary conceptualization of how depression relates to sleep and neurocognitive 
processes (see Figure 1).
Figure 1. Two Conceptualizations of the Interaction between Depression, Sleep, and 
Cognitive Impairments. 
Note, NP: Neuropsychological. A) Common neuropsychological conceptualization of 
cognitive difficulties for a chronic depressive patient. B) Modified neuropsychological 
conceptualization, *cognitive processing dysfunction includes a negative bias in 
processing emotionally-valenced information (i.e., cognitive-affective processing).
Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) is a common sleep disorder, estimated to affect roughly 2 
to 4% of the adult population (Bresnitz, Goldberg, & Kosinski, 1994; Kripke, Ancoli-
Israel, Klauber, Wingard, Mason, & Mullaney, 1997; Olson, King, Hensley, & Saunders, 
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1995). Base rates vary slightly based on demographics; 4% of middle-aged men versus 
2% of middle-aged women are thought to suffer, with a large spike after the age of 65 
resulting in estimates of up to 42% of this age group suffering (Ancoli-Israel, Kripke, 
Klauber, Mason, Fell, & Kaplan, 1991; Young, Dempsey, Skatrud, Weber, & Badr, 
1993). The pathophysiology of OSA is characterized by repeated episodes of momentary 
(10+ seconds) incomplete (hyponea event, 50+%) or complete (apnea event, 100% 
reduction) cessation of airflow. In OSA, the decreases in airflow are attributable to 
obstruction or restriction of the breathing airway by the tongue and/or soft palate. The 
near complete attenuation of skeletal muscle tone that occurs in N2 (intermittently) and 
REM sleep is true for neck musculature as well, making these stages a common period 
for the breathing events to occur. During apnea/hyponea events, blood oxygen saturation 
(SaO2) can fall to dangerous levels and physical exertion to breathe by the diaphragm and
chest muscles increases. These trigger neurological mechanisms that cause a neurological
arousal to resume muscle tone and breathing almost never completely awakens an 
individual, but does result in fragmented sleep and disturbed sleep architecture (Bassiri &
Guilleminault, 2000). Diagnosis of OSA is usually done with a polysomnography (PSG), 
which also allows for an apnea-hyponea index (AHI; based on average number of apnea 
or hyponea events occurring each hour) to be assigned as an indicator of severity; a score 
of <5 is considered normal, a score of 30+ is severe. 
OSA is associated with a cluster of cardiovascular health complications such as 
hypertension, heart disease and stroke (Guilleminault & Robinson, 1997). Individuals 
diagnosed with OSA are estimated to have annual health care costs twice as high as 
age/sex-matched controls (Kapur, Blough, Sandblom, Hert, de Maine, Sullivan, et al., 
31
1999). Finally, this population also has a higher accident morbidity rate, thought to in 
part be related to attentional performance comparable to mildly to moderately intoxicated
controls (George & Smiley, 1999; Powell, Riley, Schechtman, Blumen, Dinges, & 
Guilleminault, 1999). Unfortunately, the compliance rates for the primary treatment 
option for OSA (Continuous Positive Airway Pressure; CPAP) is low; non-compliance 
(less than 4 hours per night) rates range from 46-83% (Weaver & Grunstein, 2008). The 
same study found that patient perception of symptoms is a significant factor in non-
compliance. The sub-awakening arousals and fragmented sleep found in OSA patients are
inherently difficult for the patients to perceive. Alternative routes of educating identified 
OSA patients about the health and functioning impacts of their condition is a prime area 
for the clinical neuropsychologist to contribute to treatment.  
Neurocognitive Deficit Correlates
One meta-analysis of peer reviewed OSA articles with neuropsychological findings 
between the years of 1985 and 2002 identified 37 peer-reviewed articles related to 
neuropsychological performance in OSA populations (excluding non-clinically 
diagnosed, cognition-related comborbid, non-adult, and central apnea populations or 
studies using non-validated measures), which were subsequently divided into non-
mutually exclusive pre-treatment, treatment efficacy, and correlational study groups 
(Aloia, Arnedt, Davis, Riggs, & Byrd, 2004). Pre-treatment results suggest spared global 
cognition and language functioning, consistent with sleep deprivation findings that 
crystallized knowledge remains intact and compensatory recruitment allows for well-
preserved general cognitive functioning. Attention (especially vigilance), memory, and 
executive functioning performance was found to be significantly lower in over two-thirds
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of the studies reviewed. While motor speed was found to be intact, fine motor control 
suffered in 80% of measures. Residual impairment after continuous positive air pressure 
(CPAP) treatment revealed that only fine motor control did not improve with treatment. 
Severity rating based on hypoxemia (i.e. amount of sleep time where SaO2 <80%) was 
related to global cognition, whereas a rating based on sleep fragmentation (AHI) was 
associated with attention/vigilance performance. One area that the present study hopes to 
address were methodological concerns that Aloia and colleagues (2004) developed during
the process of article collection, which included clarifying the exact diagnostic criteria 
used, quantifying and specifying degree of treatment compliance (and treatment 
compliance history), and finally ideally including a contrast group when possible (i.e., a 
group examined by polysomnogram and not diagnosed with OSA). 
Another thorough meta-analysis by Fulda and Schulz (2001) identified 24 articles,
with 28 patient groups (total N = 893) related to cognitive functioning in sleep-related 
breathing disorders (unfortunately without inclusion criteria). The authors found 
moderate to large effect sizes for decrements in sustained attention performance, delayed 
visual memory, working memory, and driving simulation tasks. Small to moderate effect 
sizes were noted in tests of verbal fluency, vigilance, and delayed recall for verbal 
stimuli. Reasoning and concept formation showed no significant difference. Executive 
functioning measures were too diverse and limited to make a quantifiable estimate. 
Beebe and colleagues (Beebe, Groesz, Wells, Nichols, & McGee, 2002) found 25 
studies that met their meta-analysis review criteria, and set out to investigate 
neuropsychological performance in OSA populations compared to normative data as well
as OSA population performance compared to control groups (two sets of effect sizes). 
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The authors' analysis accumulated reviews that represented 1,092 OSA patients and 899 
healthy controls. Both the norm-referenced and the case-controlled data indicated that 
untreated OSA had a non-significant impact on verbal and intellectual functioning, but a 
substantial impact on vigilance and executive functions. Motor and visual functions 
produced mixed results, with post-hoc analysis indicating that fine-motor control and 
drawing measures were significantly sensitive to OSA, whereas motor speed and visual 
perception were not. Memory functions were the most variable, which the authors 
attributed to the wide variability in methodologies and measures used. It should be noted 
that the previous meta-analyses had nine overlapping studies. 
Mood Correlates
Obstructive sleep apnea patients have been demonstrated to have increased rates of 
diagnosed depression. The degree of increase and the relationship between the two 
diagnostic constructs is less clear, but a few large scale and meta-analytic findings will be
reviewed here to offer the generally accepted comorbidity parameters. A recent 
epidemiologic study investigating comorbidity between sleep-related breathing disorders 
and major depressive disorder estimated that of the 18,980 individuals reviewed, 17.6% 
of those presenting with one diagnosis also presented with the other; the odds of having a 
sleep-related breathing disorder was 5.26 for those diagnosed with a major depressive 
disorder. Furthermore, this relationship was not significantly changed when obesity and 
hypertension were controlled (Ohayon, 2003). A longitudinal study of men and women (n
= 1, 408) that repeatedly collected polysomnogram diagnostic data and self-reported 
depressive symptoms found that an increase in 1 degree of sleep-related breathing 
disorder severity (e.g., mild to moderate) was associated with a 1.8-fold increase in 
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adjusted odds for presenting with depression (Peppard, Szklo-Coxe, Hla, & Young, 
2006). Combining the longitudinal data with cross-sectional data resulted in 1.6, 2.0, and 
2.6 fold increased odds of developing depression compared to controls for minimal, mild,
and moderate or worse sleep-related breathing disorder severity ratings respectively. 
Research has proposed and investigated multiple potential mechanisms 
underlying the relationship between OSA and depression. As discussed, two hallmark 
symptoms of OSA are sleep fragmentation and hypoxemia. Research has found that 
within OSA populations, amount of sleep fragmentation correlates proportionally with 
excessive daytime sleepiness and self-report of depressive symptoms, with some 
researchers proposing that the impact to quality of life and functioning that EDS has is 
responsible for the depression (Sforza, de Saint Hilaire, Pelissolo, Rochat, Ibanez, 2002). 
Severity of hypoxic event occurrence has been found to correlate with cognitive 
performance impairments with effect sizes ranging from .3 standard deviations in mild 
AHI to 2-3 for moderate to severe AHI ratings, (Engleman, Kingshott, Martin, & 
Douglas, 2000). Additionally, imaging studies have observed cerebral metabolic 
disruption during periods of nocturnal hypoxemia in OSA patients, both findings 
suggesting a disrupting effect to normal neural functioning (Kamba, Inoue, Higami, Suto,
Ogawa,&  Chen, 2001). Depressive symptoms have been independently associated with 
white matter hyperintensities in those with affect disorders (Taylor, MacFall, Steffens, 
Payne, Provenzale, & Krishnan, 2003; Thomas, O'Brien, Barber, McMeekin, & Perry, 
2003). Unfortunately, only one study with a small sample size could be reviewed that 
combined these intersecting findings, and concluded that amongst older OSA patients, 
more subcortical white matter hyperintensities were found in those with severe OSA 
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versus mild, and that there existed a positive correlation between white matter 
hyperintensities and reported depressive symptoms (Aloia, Arnedt, Davis, Riggs, & Byrd,
2004).  
It is possible that the relationship between OSA and depression exists but that 
methodologically lax investigations have resulted in literature reviews overstating the 
strength of this relationship. For instance, one review of 16 studies that examined this 
relationship strength found that 9 found a strong relationship, five suggested that 
depression is secondary to OSA (or that depression resolved after OSA treatment), and 
two indicated the comorbidity rate of OSA and depression does not significantly exceed 
that of other diagnoses with similar base rates (Andrews & Oei, 2004). Additionally, 
though it logically makes sense that rises in depression would follow OSA 
symptomatology, clinical researchers have pointed out that some sedating medication 
prescribed to depressed individuals (e.g., benzodiazepines for sleep or comorbid anxiety) 
may adversely affect oral skeletal muscle tone, increasing risk for the onset of OSA 
(Guilleminault, 1990).
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CHAPTER 2
THE PRESENT STUDY
Rationale, Objectives, & Hypotheses
Walker and Van der Helm posit that their model of sleep-dependent emotional processing
may be clinically useful when applied to understanding the etiology of psychiatric 
disorders and comorbid sleep complaints through a cognitive conceptualization. 
Obstructive sleep apnea is a medical condition with (1) a better understood mechanism 
than psychiatric disorders, (2) well documented cognitive deficits as demonstrated on 
standard neuropsychological measures of attention, memory, and executive function 
domains, and (3) fairly well established research supporting increased risk and rate of 
depressed mood. Walker and Van der Helm's model thus provides a framework to 
investigate this medical condition as it relates to cognitive-affective processing which 
could possibly add insight into the relationship the disorder has with depressed mood.
To that goal, this study hopes to accomplish a number of objectives of varying 
inter-relation. They can be summarized under four major themes, listed below, with 
specific hypotheses and justification following each theme. 
1. To determine whether results from past investigations into the 
interrelationships between sleep physiological indicators, subjective sleep measures, 
cognitive performance, and mood could be replicated; (a) objective indicators of sleep 
quality (i.e., polysomnogram), self-reported sleep quality, mood, and standard measures 
of neuropsychological performance that have been shown to be related to sleep and mood
will be correlated with one another; (b) using  clinical cutoffs, more severe OSA severity 
groups will perform significantly worse than less severe OSA groups on a learning and 
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memory task as well as on executive measures of verbal divergent production; (c) using 
objective clinical cutoffs, more severe OSA severity groups will report significantly more
negative mood than less severe OSA groups on both depression and positive/negative-
affect self-report inventories.
2. To document the psychometric properties of two novel measures of cognitive-
affective processing; (a) created measures of cognitive-affective processing will 
demonstrate acceptable psychometric properties.
3. To investigate how the sleep and mood measures relate to the novel cognitive-
affective measures; (a) cognitive-affective processing measures designed to parallel 
standard neuropsychological measures will be significantly related to objective indicators
of sleep quality (i.e., polysomnogram), self-reported sleep quality, and mood; (b) more 
severe OSA severity groups will perform significantly worse than less severe OSA 
groups on cognitive-affective processing measures; (c) more severe OSA severity groups 
will demonstrate significantly more negative (or less positive) processing independent of 
quantitative production within the cognitive-affective processing memory measure.
4. To investigate whether the novel cognitive-affective measures help explain the 
relationship between sleep disturbance and mood; (a) the relationships between objective 
sleep disruption and negative mood will be partially explained by this cognitive-affective 
processing  valence bias.
The selected traditional neuropsychological measures were selected largely based 
upon published performance decrements in OSA populations. Additionally, these 
measures, sleep indicators, and mood indicators have been demonstrated to relate 
individually and in subgroups to each other multiple times within samples similar to the 
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present study's, as well as with other clinical and non-clinical samples. There is strong 
evidence for physiological sleep disruption impacting neurocognitive functioning, and 
subjective report of sleep quality being related to mood.
One cognitive-affective measure has already been piloted and demonstrated 
appropriate psychometric properties; it is expected to do the same in this population. 
Another cognitive-affective measure is new, but has been created with statistically 
analogous properties to a well researched and validated memory measure for neutral 
words. Thus, it is expected to demonstrate appropriate properties as well. 
The described cognitive, sleep, and mood constructs have all been found to relate 
to each other to varying degrees in the literature, though no research has looked at all of 
this project's variables within one sample. It is expected that these individual and smaller 
subsets of relationships will all be found within the present sample. There are mixed 
findings on how strong of a relationship polysomnogram indicators (e.g., fragmented 
sleep, hypoxemia) have with a variety of cognitive performance measures and mood. 
Similar findings exist for self-reported sleep. The neuropsychological domains and 
aspects of mood this study measures were selected with the goal of maximizing statistical
power for demonstrating predictive utility of the sleep indicators.  
Portions of this study are exploratory in nature. As such, the relationships between
the newly constructed measures, cognition, self-report/physiological sleep quality, and 
mood will be investigated. These analyses will guide future research focusing on OSA 
populations, affective-cognitive processing, and sleep quality.
The exploratory analyses will be used to explore whether the aforementioned 
clinical model appears to explain observations in the obtained sample. Affective 
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characteristics of stimuli should interact with OSA severity, and have an enhancing effect
on tasks tapping memory for negatively valenced stimuli independent of memory 
production, and an interfering impact with tasks of fluency. Additionally, qualitatively 
negative valence of affective-processing should predict depressive symptoms and 
possibly mediate the relationship between OSA and/or sleep disturbance severity and 
depressive symptoms. 
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CHAPTER 3
DESIGN AND METHODOLOGY
Participants
Participants were recruited from a database of outpatients referred for evaluation of 
possible obstructive sleep apnea at the Windsor Regional Hospital. A power analysis was 
conducted, and set a sample-size goal of N = 59, see below for statistical details. 
Inclusion criteria included: a referral for polysomnograph (PSG) sleep study (with or 
without CPAP titration), and 18 years of age or older. Exclusionary criteria included: 
history of traumatic brain injury or stroke, history of/current neurological conditions 
affecting functioning (aside from other sleep disorders), presence of moderate-severe 
chronic pain, a psychiatric condition aside from depression, current recreatinoal 
substance use, or alcohol use reaching “hazardous levels” (21+ drinks per week for men, 
14+ drinks per week for women, per gender-specific cutoffs accepted by the National 
Institute of Alcohol Abuse and Alcoholism and reported in Reid, Fiellin, O’Connor, 
1999). Recruitment of pre-diagnosis/pre-treatment referrals, along with patients with 
confirmed OSA who used their CPAP during the polysomnogram, allowed for the 
maximal range of sleep fragmentation dysfunction. This strategy also allowed for treated 
versus untreated comparisons.
Approval from the Research Ethics Board of the Windsor Regional Hospital was 
obtained in addition to the Research Ethics Board of the University of Windsor prior to 
data collection. Participants were incentivized to participate by the offer of a gift 
certificate for a small Tim Horton's item and validated hospital parking. Recruiters also 
explained that by participating in the research, the individual will be assisting in 
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contributing to the body of clinical research related to their disorder, which will hopefully
assist in future treatments and symptom management for the clinical group as a whole.
Additionally, participants were informed of an opt-in offer for the neurocognitive 
test results to be compared to a priori conservative cut-offs, with the understanding that if
the profile contained a significant number of significantly low enough test scores, the 
participant would be contacted and provided instructions regarding the general referral 
process required (i.e., discussing cognitive health options with their primary care 
physician or their sleep/respiratory physician), as well as referral source groups 
associated within the Windsor Regional Hospital, and local independent groups. The cut-
off for an abnormal profile was set at two scores of the ten battery items falling at or 
below two standard deviations below zero. Research on the frequency of abnormal test 
scores in healthy adults, as a function of battery size and normative adjustments, has 
demonstrated that only 3.4 to 4.6% of healthy adults are observed scoring at the described
conservative cut-off (Schretlen, Testa, Winicki, Pearlson, & Gordon, 2008). The 
advantage of this approach included removing clinical judgment from the decision 
making process, and instead relied solely on a statistically validated and a conservative 
decision tree. 
The opt-in procedure meant that by default, the participant was not contacted with
the feedback. Opt-in participants who produced profiles within normal limits were 
contacted and informed of that fact. All opt-in participants were also reminded that their 
participation in this study was not the same as a clinical neuropsychological assessment, 
and that their opting-in to the screen did not equate entering into a patient-clinician 
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relationship. Participants who remained in the opt-out category were still offered referral 
information if they wished. 
The risks of participating were minimal, but explained in full to potential 
participants. Depressed mood and some general psychiatric screening questions were 
used during data collection. Discussing symptoms associated with depressed mood can 
sometimes draw attention to them, resulting in psychological distress. If a participant 
endorsed clinically significant levels of depression, suicidal ideation, or other psychiatric 
symptoms, similar referral process information and options were provided (along with 
encouragement for contacting emergency services if suicidal ideation arose).  
As with all clinical research, there was the ethical question of the researcher 
incidentally gaining healthcare provider responsibilities. The extensive explanation 
provided to potential participants regarding the purpose and limitations of the 
neurocognitive profile review, along with encouragement to contact two of their already 
established healthcare providers in addition to a referral to clinical psychological service 
providers, prevented the research team entering a healthcare provider role with the 
participant. As such, information gained from the data collection phase of this project 
was not and will not be provided to any of the aforementioned healthcare providers, as it 
was not gathered for that purpose. 
Measures
Sample Characteristics and Self-report Measures
Demographic and self-report data was collected through administration of a series of 
questionnaires and measures. The assembled measures were chosen with the goal of 
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assessing three constructs: 1) the sample's medical history and demographic 
characteristics, 2) subjective reports of sleep quality, and 3) mood and emotional state. 
Demographics and General Medical Background
A self-report form was created and included questions related to: gender, date of birth, 
country of birth, first language, education, average household income, military service, 
list of medications, CPAP use and compliance, sleep habit information, and 
medical/psychiatric history questions. It also inquired as to presence and degree of any 
pain, along with questions about the participants' previous night of sleep. Medical 
conditions and age were translated into a Charlson Comorbidity Index score per 
published formulas (Charlson, Pompei, Ales, & Mackenzie, 1987; Charlson, Szatrowski, 
Peterson, & Gold, 1994). See Appendix B for this form.
Pittsburgh Sleep Quality Index (PSQI; Buysse, Reynolds, Monk, Berman, & 
Kupfer, 1989)
The PSQI is a self-report questionnaire designed to assess sleep quality and disturbances, 
and currently is the most widely used general measure of sleep quality. It measures a 
broad array of domains associated with sleep quality. It consists of 19 questions regarding
sleep characteristics over the past month. These scores form seven equally-weighted 
components, 1) Subjective Sleep Quality, 2) Sleep Latency, 3) Sleep Duration, 4) 
Habitual Sleep Efficiency, 5) Sleep Disturbances, 6) Use of Sleeping Medication, and 7) 
Daytime Dysfunction. These in turn provide a global score ranging from 0-21 (0 = no 
reported sleep disturbance, 21 = maximum amount of sleep disturbance). 
The creators validated the measure over an 18 month period with a group of 
healthy controls ("good sleepers"), a group of patients with depression and a group of 
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patients with sleep disorders ("poor sleepers"). A global score over five (6+/21) had high 
sensitivity (89.6%) and specificity (86.5%) for distinguishing good versus poor sleepers 
(kappa = 0.75, p < .001). Traditional norms are not available, but research has been 
published on a variety of groups. These include, healthy controls (n = 52, 2.67 ± 1.70), 
OSA (n = 127, 7.5 ± 3.9), major depression (n = 34, 11.09 ± 4.31), disorders of initiating 
and maintaining sleep (n = 45, 10.38 ± 4.57), and disorders of excessive daytime 
somnolence (n = 17, 6.53 ± 2.98). Scores increase with age, even in healthy controls over
the age of 80 (n = 44, age = 4.75 ± 3) (Buysse, Reynolds, & Monk, 1991; Park et al., 
2007). It is suggested that the PSQI be supplemented with a measure of daytime fatigue 
and sleepiness.
Test-retest reliability demonstrated no significant changes in global score and 
internal homogeneity was acceptable (Cronbach's alpha = .83). The PSQI significantly 
correlates with some polysomnogram (PSG) data (e.g., sleep onset latency, total sleep 
time, sleep efficiency, and % of stage 2 sleep), but was found to overestimate PSG 
estimates of usual sleep duration and sleep efficiency (Buysse, Hall, Strollo, Kamarck, 
Owens, Lee, et al., 2008). See Appendix C for this form.  
Epworth Sleepiness Scale (ESS; Johns, 1991)
The ESS is a self-report questionnaire designed to measure the likelihood an individual 
has of falling asleep in various situations, and has been widely validated in the sleep 
disorder literature. It consists of 8 questions requiring the individual estimate how likely 
they might doze or fall asleep in different daily living situations (e.g., sitting and reading, 
while stopped at a traffic light, etc.). Each question is rated on a scale of 0-3 (0 = would 
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never doze, 3 = high chance of dozing), and a total score above 10 suggests significant 
sleepiness. 
Test-retest reliability was found to be high (r = .82), and internal consistency was 
also found to be appropriate (Cronbach's alpha = .88), when given to a group of medical 
students. Validation research has found that ESS scores are correlated with number of 
obstructive sleep apnea (OSA) events but not to degree of hypoxemia in OSA patients. 
After 3-9 months treatment with CPAP, the OSA group's ESS scores significantly 
decreased. Factor analysis of both groups found one factor. More recent research suggests
that the ESS and PSQI measure orthogonal dimensions of sleep/wake symptoms. Both 
have also been found to differ from some polysomnogram measured constructs, and thus 
an emphasis should be placed on these tools as a measure of  subjective elements of the 
various sleep constructs (Buysse et al., 2008). See Appendix D for this form.
Center for Epidemiologic Studies Depression Scale (CESD; Radloff, 1977)
The CESD is a self-report questionnaire designed to measure symptoms associated with 
depression. Previously validated depression scales were used as the source for 300 items, 
which was narrowed to 20 items, each inquiring about the frequency an individual has 
experienced a symptom over the past week. All items use a 4-point scale (0 = rarely or 
none of the time [<1 day] to 3 = most or all of the time [5-7 days]; four items are reverse-
scored), with total scores ranging from 0-60. These items comprise six scales, each 
associated with a major dimension of depression: Depressed Mood, Feelings of Guilt and 
Worthlessness, Feelings of Helplessness and Hopelessness, Psychomotor Retardation, 
Loss of Appetite, and Sleep Disturbance. Scores ranging from 15-21 suggest mild to 
moderate amounts of depressive symptoms and scores over 21 suggest the possibility of 
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major depression. A score of 16 or higher is commonly used as a cut-off for clinical 
depression, with 85% of those diagnosed with a depressive disorder by a clinician scoring
between 16 and 60. However, 21% who scored within this range had rapid resolution of 
their symptoms and/or did not fit criteria for a depression diagnosis. Other researchers 
have suggested using a higher cut-off if the goal is the identification of a clinically 
depressed population or individual (Zich, Attkisson, & Greenfield, 1990). The CESD is 
useful with chronically ill groups who complain of fatigue (e.g. cancer, HIV), including 
OSA populations (Bardwell, Moore, Ancoli-Israel, & Dimsdale, 2003; Cockram, Judd, 
Mijch, & Norman, 1999; Hann, Winter, & Jacobsen, 1999).
High internal consistency scores were reported, with Cronbach's alpha 
coefficients ranging from .85 to .90 across studies. Good reliability scores have been 
reported across multiple groups of varied ethnicity and geographic location, age, and 
gender (Knight, Williams, McGee & Olaman, 1997; Radloff, 1977; Roberts, Vernon, & 
Rhoades, 1989). Test-retest correlations are generally moderate, ranging from .45 to .70; 
this is attributed to scores reflecting the past week and therefore being more liable to shift
depending on intervening events. The CESD is not intended as a diagnostic tool, but was 
constructed based upon symptoms reported in clinical cases. Furthermore, the CESD 
correlates with severity ratings made by clinicians (correlation coefficient = .56), and 
with Hamilton Clinician Rating scale scores (.44 to .75), which are based on self-report 
of symptoms (Radloff, 1977). Past research using the CESD has found high rates of 
depressed symptoms in those diagnosed with OSA, both for community and clinical 
samples (17% and 21-41%, respectively). Scores on the CESD scores have been found to 
account for a large amount of the fatigue OSA patients experience (24.5% above and 
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beyond the 13.4% that OSA severity does; Thomas, Bardwell, Ancoli-Israel, & 
Dimsdale, 2006). High CESD scores are also associated with higher percentage of time 
spent in REM sleep in OSA patients compared to OSA patients who scored low on the 
CESD (Bardwell, Moore, Ancoli-Israel, & Dimsdale, 2000). In women, but not men, 
high CESD scores were associated with increased observed apneas (Harris, Glozier, 
Ratnavadivel, & Grunstein, 2009). In a different study, controlling for gender, age, and 
ethnicity, CESD scores were positively correlated with the number of instances blood 
saturation levels dropped by greater than 4% (r = .14, p = .011; Kripke, Ancoli-Israel, 
Klauber, Wingard, Mason, & Mullaney, 1997). Across multiple studies on OSA 
populations, mood disorder incidence was 33%, with a mean CESD score of 12.6 (SD = 
11.3; Bardwell, Ancoli-Israel, Dimsdale, 2001; Bardwell, Moore, Ancoli-Israel, 
Dimsdale, 2000 & 2003). Longitudinal research is limited. With regard to the use of this 
measure and the OSA construct, one prospective study found that OSA onset/increased 
severity was associated with higher CESD scores, but more research needs to be done in 
order to investigate the reverse possibility (Harris, Glozier, Ratnavadivel, & Grunstein, 
2009). See Appendix E for this form.
Positive and Negative Affective Schedule - Expanded (PANAS - X; Watson & 
Clark, 1994)
The PANAS-X is a self-report questionnaire designed to measure affect at the present 
moment, or over the past days to weeks to months, depending upon the instructions. It 
consists of 60 items, each asking the individual to rate the extent to which they have felt 
that emotion over the decided upon time-frame using a 5-point scale (1 = very slightly or 
not at all, 5 = extremely). The measure is an expanded version of the original PANAS, 
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which was limited to positive emotionality and negative emotionality scales (Watson, 
Clark, Tellegen, 1988). These items comprise two broad scales, one positive, the other 
negative (PA and NA), each is comprised of multiple, correlated, yet distinguishable 
affective states. The PA and NA scales represent valence of emotion, whereas the 
specifier states represent the content of affect. These dimensions are thought to be 
orthogonal. High NA is representative of unpleasant engagement and subjective distress, 
whereas low NA is the absence of these experiences. High PA is epitomized by alertness 
and enthusiasm, with low PA representing sadness and lethargy. The specific emotional 
states measured include Fear, Sadness, Guilt, Hostility, Shyness, Fatigue, Surprise, 
Joviality, Self-Assurance, Attentiveness, and Serenity. The measure was selected to 
supplement the CES-D mood information, as the PANAS-X captures a larger variety of 
moods (including positive affect), which might be of interest for aspects of the 
exploratory analyses.
The expanded measure was developed on a variety of undergraduate and adult 
samples ranging in size from 114 to 3,622 (Watson & Clark, 1994). Internal reliabilities 
(Cronbach's alpha values) were high for both higher order scales (PA = .83-.90; NA = .85
- .90). The correlations between the PA and NA scale appear to be quasi-independent, 
ranging from -.05 to -.35, an advantage for analysis purposes. Looking at the largest 
community sample, mean daily scores for the higher order scales are 28.3 (SD = 2.9) for 
the PA and 16.4 (SD = 4.1) for the NA. Factor analysis revealed a two factor solution, 
with both scales correlating strongly with each respective factor (from .89 to .95), and 
correlating weakly with the other (-.02 to -.18). Self-rating is strongly associated with 
peer-rating on the measure, with correlations ranging from .35 to .48 for the PA and .21 
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to .36 for the NA. Multifactorial design analysis revealed clear and clean contributors to 
each of the specific emotional states measured, with almost all items loading exclusively 
on their respective emotional state at strengths generally ranging from .50 - .75. Internal 
consistency reliabilities for the 11 lower order scales ranged from .70 to .94, across all 
temporal phrasing conditions. The PA and NA scales correlate moderately to strongly 
with measures of both trait and state affect, with appropriate temporal phrasing given. 
Little research has been conducted using the PANAS in OSA populations, with no 
comparative norms available. See Appendix F for this form.
General Cognitive Measures
A series of well-established neuropsychological measures was assembled. The decision 
to include each depended on a number of criteria: (1) performance of sleep apnea 
populations on the measure in prior research, (2) breadth of domains, and (3) depth of 
domains (i.e. multiple measures for domains, measures that tap multiple aspects of a 
domain). Additionally, the advice that Dorrian, Rogers, and Dinges (2005) published 
concerning neurocognitive battery assemblage that is sensitive to sleep deprivation was 
considered. Of their recommendations, most relevant for the present study were that 
measures included (1) reflect fundamental features of neurocognitive functions (e.g., 
attention over time), (2) are straightforward and are only minimally affected by aptitude, 
(3) have relatively short durations, to avoid extraneous variables (e.g., decreased interest),
(4) consist of a high signal load, to increase opportunity for behavioral sampling within 
the limited assessment time, (5) demonstrate good reliability and validity, and (6) have 
readily interpretable results (e.g., functional or related to sleep cycle physiology). 
However, only those measures discussed in detail below were the focus of the present 
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dissertation. Please note the summary of additional measures and justification for their 
inclusion at the end of this section.
North American Adult Reading Test (NAART; Blair & Spreen, 1989)
The NAART is a measure used to estimate premorbid verbal intelligence. Participants are
given a sheet containing 61 words of varying pronunciation difficulty. Total words 
pronounced correctly can be entered into a predictive equation for Wechsler Adult 
Intelligence Scale - Revised Full Scale, Verbal, and Performance IQ scores (SEE's = 7.63,
6.56, 10.67, respectively; Blair & Spreen, 1989). The NAART is one of the most reliable 
measures in clinical use, with a test-retest reliability coefficient of .92, and an interrater 
reliability coefficient of .99 (Blair & Spreen, 1989; Raguet, Campell, Berry, Schmitt, & 
Smith, 1996). The authors also found moderate to high correlations (.40 - .80) between 
the NAART and other measures of general intellectual performance. Additionally, it has 
been found to be robust against changes following neurological insults, disease, and 
decline related to old age, making it a good measure of premorbid IQ (Anstey, Luszcz, 
Giles, & Andrews, 2001). Thus, it is not surprising that the NAART scores in OSA 
research are average unless the researchers were seeking out impaired subpopulations 
(e.g., Naismith, Winter, Hickie, & Cistulli, 2005). See Appendix G for this form.
California Verbal Learning Test - Second Edition (CVLT-2 Delis, Kaplan, 
Kramer, & Ober, 2000)
The CVLT-2 is a measure of learning and memory for verbal stimuli. A 16 word list is 
read aloud five times, with the individual attempting to recall all the words after each 
presentation. This target list is made up of four animals, four vegetables, four items of 
furniture, and four modes of traveling. Next, a distractor list is read aloud with the same 
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recall task following. This list is composed of four animals, four vegetables, four parts of 
a house, and four instruments; it therefore shares two semantic categories (though made 
up of different words) with the target list. Immediately after the recall attempt of the 
distractor list is complete, the individual is prompted to recall the target list without a 
presentation. After this short-delay free recall, the individual is again asked to recall 
target words, but prompted with the four target list's semantic categories. After a 20 
minute delay, this free and cued recall process is repeated. Following the long delay 
recall, the individual is read a list of 48 words and asked to positively identify those 
words that were on the target list. The recognition list is composed of the 16 target words,
the 16 distractor list words, eight novel distractors that fit into a target list semantic 
category, and eight novel distractors that do not fit into target list or distractor list 
semantic categories. Finally, after another 10 minute delay, individuals are presented with
16 forced-choice items, where a target word is paired with a distractor word unrelated to 
any semantic categories used in the test. 
Strauss, Sherman, and Spreen (2006) suggest that the CVLT-2 is overall a strong 
neuropsychological measure in their psychometric review, which the following 
information discusses. For instance, this measure has very high split-half reliability in the
normative sample (r = 0.94) and a clinical sample (r = 0.96). Word category recall across 
learning trials were similarly high for the two samples (r = 0.82, 0.83, respectively). Test-
retest reliability is high (r's = 0.80 to 0.89) for overall measures of achievement (e.g., 
Trials 1-5 Correct, Short Delay Free Recall Correct, Long Delay Free Recall Correct, and
Total Recognition Discrimination). Validity, as measured by correlation coefficients 
between the CVLT and the CVLT-2 are generally adequate to high (e.g., r = 0.76 for 
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Trials 1-5 Correct); the CVLT normative data were likely too stringent, with the CVLT-2
sample being more representative of the educational population of the U.S. A five-factor 
model was found for the CVLT-2, with all 16 of the selected variables used falling into 
appropriately representational factors (i.e., general verbal learning, response 
discrimination, recall efficiency, organization, and primacy-recency reliance). In clinical 
samples, temporal lesion populations have demonstrated learning deficits across Trials 1-
5 and short/long delay recall (Alexander, Stuss, & Fansabedian, 2003). Additionally, 
focal frontal lesions have been demonstrated to be significantly related to self-monitoring
(repetitions, intrusions) and organizational strategies of encoding. 
Research investigating OSA population performance on the CVLT-2 is limited, 
and research conclusions regarding this clinical group's learning and memory 
performance is mixed. One study compared 28 OSA patients with 24 healthy controls 
using the original California Verbal Learning Test (CVLT; Delis, Kramer, Kaplan, & 
Ober, 1987; Salorio, White, Piccirillo, Duntley, & Uhles, 2002). Though an older version,
the two tests differ only in stimulus words/categories and the newer inclusion of a forced-
choice paradigm. Also, the study was methodologically strong (i.e. included women and 
men; heterogeneous AHI; PSG diagnosis used; exclusion of medical and learning 
disorder comborbidities). The researchers found the OSA group to score significantly 
worse on trial 1 recall, trial 5 recall, and trial B recall, but not on delayed recall or 
recognition. They interpreted these results to be indicative of encoding deficits rather 
than maintenance decrements existing in this population. The researchers also found that 
OSA groups used less semantic grouping in free recall and benefited less from semantic 
cues than controls. This demonstrated an impaired use of either internally or externally 
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sourced executive organization strategies. Finally, they note that though the difference in 
performance was statistically significant, OSA performance decrements generally fell 
within 1 SD below the control group. This suggests that, from a clinical perspective, the 
deficits are subtle. However, the authors also note that even with treatment, the deficits 
are persistent, suggesting that OSA's impact on cognition is more significant when 
viewed as a contributor to a multi-etiology decline. A meta-analysis found significantly 
worse long term verbal memory (including the CVLT and other measures with similar 
paradigms) for OSA populations when compared to a normative-reference set (Cohen's d 
= 0.52, p = .010), but only a trend for a control-reference set (Cohen's d = 0.27, p = .085; 
Beebe, Groesz, Wells, Nichols, & McGee, 2003). A more recent study by Lau, Eskes, 
Morrison, Rajda, and Spurr (2010) using the CVLT-2 only found a trend in the OSA 
population to demonstrate worse performance across total learning (trials 1-5), (Cohen's d
= 0.45, p = 0.086). See Appendix H for this form.
FAS/Animal Naming verbal fluency tasks (FAS/Animals; Spreen & Benton, 
1977; Rosen, 1980)
Verbal fluency was measured using two related tasks. The FAS task is a measure of 
phonemic fluency, requiring an individual to generate as many words as possible that 
begin with a specific letter, within 60 seconds. Using the instructions first published by 
Spreen and Benton (1977) and detailed in Spreen and Strauss (1991), participants are also
instructed that they should not provide proper nouns or multiple words using a stem with 
varying suffixes (e.g. eat, eats, eating). A similar measure, that taps semantic fluency, is 
the Animal Naming task. The instructions published by Rosen (1980) were used, 
requiring the individual to list as many types of animals as they can, within 60 seconds.  
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According to Strauss, Sherman, and Spreen (2006), the FAS task has good 
internal consistency between letters (Cronbach's alpha = .83) and test-retest reliability (r 
= .74, p < .01). Furthermore, the Animal Naming task did not differ significantly in test-
retest reliability, and correlated with FAS scores significantly (r = .52, p < .01). Age and 
education account for small to moderate amounts of variation in both measures, and thus 
appropriate norms should be used when comparing between individuals (see Tombaugh, 
Kozak, & Rees, 1999). Verbal fluency has been found to be sensitive to injury to 
temporal and frontal lobes, as well as the caudate nucleus (for review of articles see, 
Tombaugh, Kozak, & Rees, 1999). Additionally, phonemic fluency deficits are related to 
cognitive decrements in nondemented individuals, whereas semantic fluency appears to 
be more related to a dementia process (e.g. Alzheimer's) (Steenhuis & Ostbye, 1995). 
Verbal fluency deficits are not clearly evident in meta-analysis, aside from severely 
affected OSA populations (e.g., Bédard, Montplaisir, Richer, Rouleau, & Malo, 1991; 
Fulda & Schulz, 2001). However, there is evidence that suggests phonemic fluency 
decrements with intact semantic fluency within the OSA research, which may have 
confounded meta-analyses that use a unified fluency construct (Salorio et al., 2002). 
Despite the potential insensitivity of this measure within an OSA referral sample, it was 
included as a measure of interest due to its analogous status compared to a cognitive-
affective processing measure described below. See Appendix I for these forms.  
Other Measures
Participants were given other well researched and validated measures of cognitive 
performance in traditionally investigated domains of neurocognitive functioning. 
However, these were not the focus of the present dissertation. Instead, the data will be 
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used for other research projects associated with the primary investigator, his supervisor, 
and the lab. The data will also be used in the previously discussed cognitive screen 
decision. The full battery was be approved by both University and Hospital ethics boards.
Other battery measures include: Stroop Color-Word Test (Stroop; Golden, 1978), Trail 
Making Test A & B (TMT A& B; Reiten, 1955), Symbol Digit Modalities Test-Written 
(SDMT-W; Smith, 1982), Digit Span Forward & Backward (DSF & DSB; Wechsler, 
1981), Digit Vigilance Test (DVT; Lewis, 1995), and the Grooved Pegboard (GPT; 
Matthews & Klove, 1964).
Neurocognitive Measures of Emotional Processing
As previously discussed in the literature review, there has been extensive research 
conducted regarding traditional neurocognitive domain deficits associated with 
obstructive sleep apnea. Far less research has been conducted on the emotional 
processing deficits associated with poor sleep, even less so with regards to a specific, 
though common, sleep disorder such as obstructive sleep apnea. 
The extant neuropsychological literature on emotional processing as a domain of 
neurocognitive functioning is limited with regards to published tests and measures. Often,
the researchers use a self-constructed measure, including a general description of its 
characteristics, but limited protocol and psychometric information (for an example of 
some current emotional processing measures see Suchy, 2011). Further complicating the 
evaluation of this construct (though not unique to emotion) is the presumed broad impact 
affective-processing has across all traditional cognitive domains. These characteristics 
unfortunately result in problems with wide-spread measurement of emotional processing 
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in research (for replication studies) and clinical settings (assisting in diagnosis and 
functional intervention).
With this in mind, a counterpart measurement approach was used to supplement 
the more traditional neurocognitive measures described above. Thus, tasks were selected 
or constructed with the goal of contrasting the traditional domains (e.g., memory for 
neutral verbal stimuli versus memory for affect-based stimuli). In this way, the 
researchers hope to distinguish between potential performance differences unique to 
either non-emotional or emotional stimuli and processing. The previously described 
considerations recommended by Dorrian and colleagues (2005) were again consulted 
during the construction of measures. Again, only those measures discussed in detail 
below will be the focus of the present dissertation, but there is a summary of additional 
measures and justification for their inclusion in the battery at the end of this section.
Cognitive-Affective Verbal Learning Test (CAVLT)
Instructions and construction of this measure were based upon the CVLT-2, which was 
described previously. The protocol for this task is exactly the same as the CVLT-2, with 
only the stimuli words changing and removal of the forced-choice aspect of the task 
(which was not conducted during CVLT-2 testing).  Sixteen positively valenced emotion 
words, sixteen negatively valenced emotion words, and sixteen neutral words were 
selected from the Affective Norms for English Words (ANEW) database (Bradley & 
Lang, 1999). Of the sixteen neutral words, half were concrete, the other half abstract. 
Mean distances from neutral were averaged for the positive and negative valence groups 
and a t-test was conducted to ensure no significant difference. ANOVAs were conducted 
across the positive, negative, and neutral groups to ensure that average word length and 
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word frequency did not differ. An ANOVA with contrasts was also conducted to ensure 
the average valence of each group was significantly different from each other group. Four
words from the positively valenced group, negatively valenced group, abstract-neutral 
group, and concrete-neutral group were selected to form a target list. Each neutral group 
had a semantic organizational rule. Another four words from each group were selected 
for the distractor list. The remaining 16 words were mixed with target and distractor 
words to form the 48-word recognition task, meaning eight novel words that fit into 
either of the emotion semantic categories and eight novel distractors that do not. Order of 
all words in each list was randomized. ANOVAs were conducted across the target list, 
distractor list, and supplemental recognition list to ensure no significant difference 
between word length and word frequency. Finally, t-tests were conducted to ensure no 
significant differences existed in word length or frequency between CAVLT lists and 
their corresponding CVLT-2 lists. See Appendix J for this form.
Emotion Word Fluency Test (EWFT; Abeare, Chauvin, Kaploun, Chu, 
Dumitrescu, & Pascual-Leone, 2009)
Instructions and construction of this measure were based upon the FAS phonemic fluency
task, which was described previously. Examinees are asked to list as many emotion 
words as they can within one minute. Number of emotion words, perseverations, and 
rule-breaks (i.e. non-emotion words), are calculated. Emotion versus non-emotion word 
determination is done by clinical judgment and consensus judgment for words that 
scorers determine to not clearly be addressed by the following rules. Scoring criteria is 
inclusive, with any word unambiguously referring to an emotional state (e.g. happy, 
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smiling) being counted as a correct response. Words that refer to cognitive states (e.g. 
confusion) or somatic states (e.g. tired) are not counted. 
Abeare and colleagues (2009) reported that EWFT inter-rater reliability is strong 
(Pearson's r = .91), and intra-class correlation coeffcient for agreement was similarly 
strong (rICC = 0.806). The measure demonstrates good test-retest reliability across multiple
intervals (r = .74 for five hours, r = .676 for one week). Reliability values for this 
measure are comparable to those values found with other measures of verbal fluency. 
This measure is in the process of being examined with clinical samples, but has not been 
used with OSA populations. See Appendix K for this form.
Other Measures
Participants were also given other newly constructed measures hypothesized to measure 
affective-cognitive processing. However, these were not the focus of the present 
dissertation. Instead, that data will be used for other research projects associated with the 
primary investigator, his supervisor, and the lab. The full battery was approved by both 
University and Hospital ethics boards. Other measures will include the Emotion Stroop 
Test (EST; emotion-stimuli matched to the Stroop Color-Word Test; Gardizi & Abeare, 
not yet published), Emotion-Digit Coding Test (EDCT; emotion-stimuli matched to the 
Symbol-Digit Modalities Test), and the Emotion Vigilance Test (EVT; emotion-stimuli 
matched to the Digit Vigilance Test).
Physiological Measures
As part of the sleep disorder referral process, the participants underwent 
polysomnography (also known as PSG), a hospital lab-based, polymetric measurement of
the biophysiological characteristics of an individual's sleep session. The polysomnogram 
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data was collected and analyzed by hospital staff, then provided to the research team. 
Both pre-diagnosis/pre-treatment  and post-diagnosis/CPAP polysomnograms were 
collected, depending on the patient's progress through the referral and treatment 
procedure. The polysomnogram data from the study immediately prior to, or subsequent 
to, the neuropsychological evaluation was used, in order to match the data as close 
temporally to the cognitive/mood data as possible. The polysomnogram is widely used in 
sleep research and sleep disorder diagnosis. This data was accessed from participants' 
health records after consent was gained. A subset of polysomnogram indicators was 
selected for investigation, per the American Academy of Sleep Medicine scoring manual 
(AASM, 2007). All of the below physiological indicators have been found to be aberrant 
in a variety of OSA samples, as well as associated with cognitive performance variance 
to varying degrees (reviewed by Aloia, Arnedt, Davis, Riggs, & Byrd, 2004). See 
Appendix L for an example of a polysomnogram report.
Percentage of time spent in each sleep stage (%N1, %N2, %N3, %REM)
Time spent in, non-REM stage 1, 2, 3 (N1, N2, N3), and REM sleep, divided over total 
sleep time.
Sleep efficiency
Total time asleep divided by time in bed.
Sleep apneas/hypneas
Number of apneas (>= 10 second cessation of air-flow) and hypneas (>= 10 second 
reduction of air-flow of >= 50%). 
AHI
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The sleep apnea and hypnea counts are used to create an Apnea/hypnea Index (AHI), an 
indicator of apnea severity.
REM-AHI
This is an index of AHI frequency during REM stage sleep.
Oxygen Saturation
Arterial O2 saturation (%) is measured throughout sleep. Less than 85% O2 saturation is 
considered of clinical significance 
Procedure
Recruitment
Patients who had already undergone a recent OHIP-covered polysomnogram, along with 
patients who were scheduled for an upcoming one, were contacted via telephone or in 
person at the Hospital's clinic.  Each individual was provided with information about the 
purpose, benefits, and risks of participating in the study, and then scheduled for 
assessment if they voiced interest in volunteering. A script was used for most of the 
interaction (Appendix M). Additionally, brochures describing the study and providing 
contact information were provided to the physician collaborators, to be given out to those
patients they deemed potentially eligible for the study (Appendix N). Both the graduate 
principal investigator (PI) and trained undergraduate research assistants (RA) conducted 
recruitment.
Evaluation
Each participant underwent a single evaluation session taking place at Windsor Regional 
Hospital, lasting roughly two hours. Each session began with the researcher once again 
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covering the consent form with the participant, explaining the purpose, content, and 
benefits associated with the study. Additionally, the participant was informed of their 
right to discontinue testing at any time. After signing, the participant filled out the 
demographic questionnaire (for reassurance that the participant did not meet exclusionary
criteria). Afterward, the participant filled out the PSQI, ESS, CESD, and PANAS, in that 
order. Next the researcher administered the battery of neuropsychological measures in the
following order (measures that are the focus of this dissertation project are underlined; 
brackets indicate two sections of the battery that were counter-balanced to control for 
potential practice effects from parallel measures): 1) NAART, {{2) CVLT-2, 3) TMT 
A&B, 4) SDMT -W, 5) DVT, 6) DigSpn, 7) FAS/Animals/EWFT 8) Stroop,}} {{9) 
CAVLT, 10) EDCT, 11) EVT, 12) GPT 13) EST}}. 
At the conclusion of testing, the researcher asked the participant whether he or she
had any questions or concerns with the evaluation. If the participant made any statements 
regarding suicidal ideation, or scored above a 15 on the CES-D, referral information for 
psychological counseling was provided on the spot (see Appendix O for both versions). 
The researcher  explained that the participant would be contacted with cutoff score 
feedback in the near future if  the participant opted into the cognitive-screen feedback at 
the onset of the testing. When necessary (e.g., offered to those not opting-in to the 
cognitive screen protocol or those with a positive result on the cognitive screen), referral 
information for these services was also provided, as previously discussed. Refer to Figure
2 for details on recruitment, evaluation, and selection for analysis.
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 Figure 2. Flow-chart detailing the recruitment process.
Measures, Scoring, Data Storage
Participants were assigned a participant number upon arrival at the evaluation; this 
number was only linked to their name and phone number on a password protected key-
list, stored on a password protected folder, in order to keep track of those who had 
completed the study and those that required follow-up contact. At no point were any 
participant names placed on any measure.
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The measures were scored and placed within the locked research lab's storage. 
The hard copies will be kept for a minimum of one year after dissertation defense. Raw 
scores and demographically matched normative data were entered into an electronic 
database. This database and password protected key-list will be kept for a minimum of 
seven years after dissertation defense or five years after study publication. 
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CHAPTER 4
ANALYSIS OF RESULTS
Statistical Analyses
Analyses of the data were conducted using IBM SPSS Statistics Version 22. 
There were four overarching objectives for the analyses; (1) to determine whether results 
from past investigations into the interrelationships between sleep physiological 
indicators, subjective sleep measures, cognitive performance, and mood could be 
replicated; (2) to document the psychometric properties of two novel measures of 
cognitive-affective processing; (3) to investigate how the sleep and mood measures relate
to the novel cognitive-affective measures; (4) to investigate whether the novel cognitive-
affective measures help explain the relationship between sleep disturbance and mood. 
SPSS software analyses were used to investigate the first three objectives (i.e., 
correlation, ANOVA and repeated measures ANOVA, and regression, respectively). 
However, for the fourth objective, a macro developed by Preacher and Hayes (2008) was 
also incorporated, as an alternative to hierarchical regression to analyze the path 
coefficients in the multiple mediator model. The macros uses a bootstrapping 
methodology to produce confidence intervals for the specific indirect, and total, effects of
an independent variable on a dependent variable via multiple potential mediators. The 
authors outline multiple advantages to this method. First, the analysis is exploratory in 
both its operationalization of a theoretical model (i.e., van der Helm & Walker, 2009), as 
well as the novel measures created, while hierarchical regression is difficult to use 
without clear theoretically based, a priori, variable-block-entry order. The Preacher and 
Hayes (2008) method is specifically useful in this situation, as the bootstrapping 
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approach controls for error and maximizes power. Second, the method is argued to be 
superior to the common method of using a SOBEL test after individual mediation 
analyses. The SOBEL method is too liberal with small samples, and thus interpretation 
would be limited within the present study. Third, the macro is capable of handling groups
of mediators as well as covariates, allowing for a more efficient number of analyses and 
minimization of a compounding familywise error rate. In the following analyses, 1000 
iterations and a 95% confidence interval were selected, per recommendation of the 
authors.
Given the number of hypotheses and planned analyses, consideration was given to
concern of familywise error (i.e., type 1 error due to multiple comparisons). With regard 
to correlations, all construct interrelationships had specified a priori directionality within 
the hypotheses. Furthermore, this type of approach (i.e., multiple correlation matrices) is 
a logical first step toward identifying a priori hypotheses that do not warrant follow up 
analyses. With regard to the multiple means comparisons, MANCOVA is conducted first,
prior to subgroup comparisons. Finally, the model testing via regression is exploratory 
(though based on extant research and framed with a priori hypotheses), therefore there 
were no additional measures taken to decease the probability of type 1 error for these 
analyses.
Assumptions
Before data collection, a power analysis was conducted using G*Power, a free 
software program that allows for a priori sample size estimation for specific statistical 
tests (Erdfelder, Faul, & Buchner, 2007). Almost all the cognitive and affective-cognitive
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measures included in this study tap some form of working memory, mental flexibility, 
inhibition, or associated executive processes. Extant sleep research does not have reliably
obtained cognitive-affective effect sizes, thus, a collection of review studies that reported 
effect sizes for cognitive domains such as complex attention, mental flexibility, working 
memory, executive functioning, and frontal processing in OSA samples compared to 
healthy controls were collected, and these effect sizes (d's = .70, .75, .79) were then 
averaged, resulting in d = .747, or f2 = .140 (Beebe & Gozal, 2002; Fulda & Schulz, 
2001; Naegele, Thouvard, Pépin, Lévy, Bonnet, Perret, Pellat, & Feuerstein, 1995). User 
settings for hierarchical regression were as follows (since planned F statistic tests would 
require the largest sample), a power value of 0.8, an alpha value of 0.05, a total possible 
maximum of 7 predictors (age, gender, education, polysomnogram, subjective sleep, 
cognitive measure, cognitive-affective measure), and a numerator df of 1 (representing 
the experimental variable of interest in each analysis). Of note, the liberal predictor value 
was selected in an effort to protect against concerns of an underpowered sample in the 
case of the model requiring more predictors and covariates than hypothesized. This 
results in an estimated required total sample size of 59.
To investigate normality of data, Shapiro-Wilk tests, skewness and kurtosis cut-
offs (-2/2 and -3/3, respectively), Q-Q plots, and boxplots were investigated. All of the 
analyzed variables demonstrated a normal distribution, with a few exceptions. Splitting 
the sample by OSA cut-offs resulted in non-normal Shapiro Wilk results for the PSQI, 
CESD, and PNA measures within the non-OSA group and the PSQI for the severe OSA 
group. However, visual inspection of the plots strongly suggested equivalent normality 
compared to the other groups. Additionally, the Shapiro-Wilk test is statistically 
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conservative with small groups (i.e., subgroups of the present sample). Finally, all 
planned analyses are considered robust against violations of normality. Given these 
factors, no transformations were conducted. Multiple extreme outlier scores were 
identified (>3*inter-quartile range), including two CESD data points and one Sleep 
Efficiency % data point, were removed from analyses. Homogeneity of variance was 
confirmed for all variables via use of Levene's test. Variance sphericity was safely 
assumed for all relevant measures, with the exception of the CVLT learning trials (1-5); 
thus, for this analysis, epsilon tests output was interpreted. Twelve (12) cases contained at
least one missing value, spanning 4 variables, which represented 2.31% of the overall 
data. Thus, no statistical procedures to further evaluate or address the missing values was 
deemed necessary. 
For multivariate regression analyses, a 5:1 (n:predictors) ratio is considered a 
minimum standard (Tabachnick & Fidell, 2001). As covariates could be accounted for via
the regression macro selected, and not entered into a control-variable block, the 
maximum expected number of predictors (4) resulted in a 15:1 ratio, surpassing this 
standard. Standardized residual plot inspection indicated appropriate linearity between 
variables of interest, as well as an appropriate homoscedastic distribution. The data 
passed a Durbin cut-off (>1), a multicollinearity check (Tolerance < 0.9), Cook's value 
cut-off (>1), and a Leverage Value determined by using a sample-specific cut-off ([2 x 
number of predictors]/N = 0.13). Lastly, a Mahalanobis’ distance cut-off using df = 4, p =
.01, with a chi-squared table cut-off of 13.277, identified no multivariate outliers.
Neurocognitive data collected for research contains similar validity concerns as 
within clinical contexts. While there were no alterior motives for disengenious 
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performance with these participants (in fact, most were highly motivated to engage, as all
were attracted to participation due to subjective cognitive complaints), it was thought 
advisable to check two embedded performance validity indicators within the database. 
Using empirically-derived digit span (7+; Greiffenstein, Baker, & Gola, 1994), verbal 
fluency regression (Sugarman & Axelrod, 2015), and 3-variable CVLT regression (Wolfe
et al., 2010) cut-offs, no sub-optimal performance participants were identified (i.e., above
cut-off on 2+ of the three indnicators). 
Demographic and Descriptive Data
The demographic descriptives of the whole sample, as well as the AHI severity 
subgroups, are summarized in Table 2. Chi-squared analyses found no significant gender 
distribution differences, χ² (3, N = 61) = 6.40, p = 0.09. The same non-significance was 
found for reported household income, χ² (24, N = 61) = 13.70, p = 0.95. Over a third of 
the sample (n = 22) reported the highest bracket of income ($75,100+), followed by 
“prefer not say” (n = 10), $50,100-$75,000 and $40,100-$50,000 (both n's = 7), $20,100-
$30,000 (n = 5), $30,100-$40,000 (n = 4), $15,100-$20,000 (n = 3), $0-$10,000 (n = 2), 
and $10,100-$15,000 (n = 1). No significant differences were identified between groups 
for age, education, or estimated IQ, p's > 0.10. No analyses were run for ethnicity due to 
the limited number of non-white participants (n = 3).
Table 2 
Sample Demographic Descriptives by OSA Clinical Severity Group
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Gender Age
Mean 
(SD)
Education
Mean 
(SD)
NAART IQ
Mean
(SD)
Ethnicity
Whole 
Sample 
     (N=61)
   29 females
47.5%
52.74
(14.40)
13.86
(3.07)
103.63
(8.04)
58 White
2 Black
1 Asian
No OSA 
     (n=22)
15 females
68.2%
49.64
(15.18)
15.18
(3.46)
106.46
(6.60)
22 White
Mild 
     (n=11)
4 females
36.4%
58.64
(13.55)
13.27
(4.20)
106.67
(8.31)
11 White
Moderate 
     (n=11)
3 females
27.3%
54.00
(12.51)
13.65
(2.76)
106.1
(8.05)
10 White
1 Black
Severe 
     (n=17)
7 females
41.2%
52.74
(14.40)
13.65
(2.76)
105.38
(7.78)
15 White
1 Black
1 Asian
Note: NAART IQ: North American Adult Reading Test Estimated Premorbid IQ
Correlational Analyses
Demographic Investigation 
As only a minority of the variables of interest provided demographically-corrected 
normative scores, a bivariate correlation analysis was used to determine potential 
covariates for the planned analyses. Participant age was found to significantly correlate 
with the following measures, p's < 0.01: CVLT Learning, r = -0.41; CVLT Short Delay 
Recall, r = -0.39; Animals Fluency, r = -0.37; CAVLT Learning, r = -0.44; CAVLT 
Short Delay Recall, r = -0.53; CAVLT Long Delay Recall, r = -0.55; Sleep Efficiency, r 
= -0.27. Gender and Education did not significantly correlate with any self-report, 
cognitive, cognitive-affective processing (CAP), or sleep study (PSG) variables. Thus, 
the decision was made to use raw scores across all measures and to control for age in all 
subsequent analyses, unless otherwise noted.
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Variables of Interest Investigation 
Six partial correlations, controlling for age, were conducted to both investigate a number 
of hypotheses as well as assist in guidance for subsequent regression analyses. Results of 
each are summarized below. Additional variables were calculated for CAVLT subtests, in
order to quantify response bias with regard to the emotional words versus non-emotional 
words, as well as positive-versus-negative valence response bias within emotional word 
recall responses. These factors were designed to represent response bias controlling for 
the actual learning or memory production performance itself. With regard to the former, 
an Emotionality Factor (EF) was  calculated by using positive emotion word responses 
(PE), negative emotion word responses (NE), and non-emotion word responses (NEF, 
i.e., the two remaining word groups), where EF = ((PE+NE)-NEF)/(Total Words))*100. 
However, due to the non-emotion word response categories containing a concrete non-
emotion word category (i.e., body parts) and an abstract non-emotion word category (i.e.,
units of time), a corrected EF was calculated in order to parse out recall variance 
impacted by the abstractness-versus-concreteness of the words. This resulted in 
Emotionality Factor = ((Positive Emotion Words+Negative Emotion Words)-(2*Abstract
Non-Emotion Words)/(Positive Emotion Words+Negative Emotion Words+(2*Abstract 
Non-Emotion Words)))*100. For the CAVLT Emotionality Factor, values can range 
between -100 and 100, with positive values representing a tendency towards emotional-
word response, a negative value representing a tendency toward non-emotional word 
response. 
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With regards to positive-versus-negative valence response bias, the following was
used to calculate a Valence Factor (VF) = ((Positive Emotion Words-Negative Emotion 
Words)/(Positive Emotion Words+Negative Emotion Words))*100. For VF, positive or 
negative values (-100 to 100) represent the corresponding valence tendency in responses 
given, designed to represent response bias controlling for the actual learning or memory 
production performance itself. For purposes of reporting, VF differences are phrased as 
“bidirectionally diverged” if the group difference's midpoint is near 0 and “more 
negative/positive” if one group's factor score is near 0 and the contrasting group is 
significantly higher/lower.
Sleep & Mood
Self-report sleep measures, polysomnogram sleep measures, and self-reported mood 
interrelationships were analyzed (see Table 3 for details related to correlation strengths 
and significance values). Overall, subjective sleep disturbance measures were more 
widely and strongly associated with mood reports compared to objective sleep measures. 
Specifically, sleepiness and sleep disturbance were associated with increased depressive 
symptoms and negative affect, along with less positive affect. Objective sleep disturbance
measures demonstrated more limited results. Higher sleep efficiency was associated with 
less negative affect and less depressive symptoms, and fragmented REM sleep also was 
associated with less negative affect.
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Table 3
Partial Correlation Matrix (controlling for age) of Mood, Subjective Sleep Measures, 
and Sleep Study Indicators 
1 2 3 4 5 6 7 8 9
1.CESD --
2. PPA -0.69 --
3. PNA 0.68 -0.39 --
4. ESS 0.39 -0.38 0.30 --
5. PSQI 0.20 -0.13 0.23 0.18 --
6. AHI 0.21 -0.27 0.01 0.01 -0.4 --
7. R-AHI -0.10 -0.07 -0.25 -0.02 0.04 0.45 --
8. SE% -0.20 0.08 -0.37 0.15 0.07 -0.25 -0.04 --
9. lowO2% 0.19 -0.15 0.06 -0.03 0.12 0.41 -0.08 -0.07 --
10. REM% -0.04 0.11 0.20 0.14 0.02 -0.27 0.23 0.04 -0.28
p   <0.05, p <0.01, p   <0.001
Note: CESD: Center for Epidemiological Study – Depression Scale, PPA: PANAS 
Positive Affect Scale, PNA: PANAS Negative Affect Scale, ESS: Epworth Sleepiness 
Scale, PSQI: Pittsburgh Sleep Quality Index (high scores = high sleep disturbance), AHI: 
Apnea-Hypnea Index, R-AHI: REM Sleep Apnea-Hypnea Index, SE%: Sleep Efficiency,
Low O2%: Proportion of sleep time spent in hypoxia, REM%: proportion of sleep spent 
in REM. 
Sleep and Cognition
Self-report sleep measures, polysomnogram sleep measures, and cognitive performance 
interrelationships were analyzed; see Table 4 for details related to correlation strengths 
and significance values. Self-reported sleepiness (ESS) and sleep quality (PSQI) had no 
significant correlational findings with the cognitive measures. Sleep apnea severity (AHI)
had small (based on Cohen, 1988) negative correlations with the CVLT's Long Delayed 
Recall and Recognition trials (r's = -0.23, -0.25, respectively). There were moderate-to-
strong negative correlations between hypoxia (low O2%) and Long Delayed Recall and 
73
Recognition (r's = -0.42, -0.29 respectively), and hypoxia was moderately correlated with
worse category-fluency for Animals (r = -0.31). In sum, objective measures of sleep 
disturbance demonstrated wider and stronger correlations with impaired cognitive 
performance measures than subjective sleep disturbance reports. 
Table 4 
Partial Correlation Matrix (controlling for age) of Subjective Sleep Self-Report 
Measures, Sleep Study Indicators, and Standard Cognitive Measure Performance
CVLT
Learnin
g
CVLT
Short Delay
Recall
CVLT
Long Delay
Recall
CVLT
Recognition
Verbal
Fluency:
FAS
Verbal
Fluency:
Animals
ESS -0.01 -0.09 -0.18 -0.14 0.04 0.13
PSQI -0.11 -0.21 -0.11 -0.11 -0.09 -0.12
AHI -0.07 -0.05 -0.23 -0.25 -0.01 -0.03
R-AHI 0.11 0.20 0.12 0.12 0.09 0.09
REM% -0.09 -0.14 0.01 0.01 -0.11 -0.16
SE% 0.04 0.04 0.07 0.07 0.12 0.06
Low O2% -0.02 -0.10 -0.42 -0.29 -0.15 -0.31
p  <0.05, p <0.01
Note: ESS: Epworth Sleepiness Scale, PSQI: Pittsburgh Sleep Quality Index (high scores 
= high sleep disturbance), AHI: Apnea-Hypnea Index, R-AHI: REM Sleep Apnea-
Hypnea Index, SE%: Sleep Efficiency, Low O2%: Proportion of sleep time spent in 
hypoxia, REM%: proportion of sleep spent in REM, CVLT: California Verbal Learning 
Test-2
Sleep and Cognitive-Affective Processing
Self-report sleep measures, sleep study (polysomnogram) measures, and cognitive-
affective processing (CAP) performance interrelationships were analyzed; see Table 5 for
details related to correlation strengths and significance values. Self-reported sleep 
disturbance (PSQI) correlated moderately with increased negatively biased (VF) CAVLT 
Long Delayed Recall (r = -0.32) and to a lesser degree with a bias away from emotional 
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words in the CAVLT Recognition trial (Emotionality Factor, r = -0.24). Self-reported 
sleepiness (ESS) demonstrated no significant correlations with cognitive-affective 
processing measures.
For sleep study measures,  sleep fragmentation severity (AHI) negatively 
correlated with CAVLT Short and Long Delay Recall (r's = -0.23, -0.28, respectively). 
Furthermore, AHI was correlated with a bias toward recall for negative words in Short 
Delay Recall (Positive Emotion Words, r = -0.30)  and in Long Delay Recall (Positive 
Emotion Words, r = -0.29; Valence Factor, r = -0.26).  Sleep fragmentation in REM (R-
AHI) was not associated with reduced word recall, but was associated with a bias  toward
negative valence (VF) within the CAVLT Learning (r = -0.23), Short Delay Recall (r = 
-0.32), and Long Delay Recall (r = -0.28) trials. Percentage of REM sleep  (REM%) 
correlated with lower CAVLT Short Delay Recall (r = -0.23), and a bias away from 
negative emotion word production in that subtest (SDR NE, r = -0.24). Time asleep spent
in a hypoxic state (Low O2%) impacted long delay recall (CA-LDR) qualitatively, in a 
pattern similar to the AHI findings increased amount of negative emotion words (NE, r = 
-0.23) and negative valence for those recalled (VF, r = -0.28). Hypoxia was also 
correlated with reduced CAVLT Recognition (r = -0.24). Higher sleep efficiency (SE%; 
i.e., sleep time regardless of fragmentation) was associated with more emotionality of 
those words recalled after short and long delay (Emotionality Factor, r's = 0.38, 0.22, 
respectively), as well as increased initiation and fluency for emotion words (EWFT, r = 
0.27). 
Overall, the analysis reveals a pattern whereby objective sleep study measures 
(and to a lesser extent, subjective measures) of sleep disturbance were associated with 1) 
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lower short and long delayed recall, recognition, but not initial learning performance, and
2) recall responses (and to a lesser extent learning) biased away from positive words and 
emotion-related words.
Table 5
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Partial Correlation Matrix (controlling for age) of Subjective Sleep Self-Report 
Measures, Sleep Study Indicators, and Cognitive-Affective Processing Performance 
Measures
ESS PSQI AHI R-AHI REM% SE% lowO2%
EWFT 0.07 -0.01 0.02 -0.08 0.05 0.27 0.08
CAVLT
  Learning -0.08 0.01 0.01 0.01 -0.15 -0.01 0.02
    (+) Words -0.17 0.05 -0.17 -0.12 0.01 0.09 -0.10
    (-) Words -0.12 0.09 0.04 0.05 -0.16 -0.09 0.07
    Valence Factor 0.05 0.07 -0.18 -0.23 0.12 0.20 -0.22
    Emotionality Factor 0.07 -0.03 -0.01 -0.01 0.01 0.25 0.17
  Short Delay Recall -0.08 -0.07 -0.23 0.01 -0.23 -0.05 -0.19
    (+) Words -0.20 -0.10 -0.30 -0.19 -0.17 0.18 -0.06
    (-) Words 0.05 0.18 0.06 0.29 -0.24 0.15 -0.12
    Valence Factor -0.16 -0.2 -0.20 -0.32 -0.09 -0.12 0.04
    Emotionality Factor 0.10 0.08 -0.06 0.10 -0.09 0.38 0.19
  Long Delay Recall -0.17 0.13 -0.28 0.07 -0.02 0.08 -0.17
    (+) Words -0.17 0.16 -0.29 -0.06 0.04 0.22 -0.23
    (-) Words -0.02 0.22 0.08 -0.19 -0.16 0.09 -.080
    Valence Factor -0.22 -0.32 -0.26 -0.28 0.09 -0.02 -0.28
    Emotionality Factor 0.14 0.14 0.11 0.28 -0.16 0.22 0.01
  Recognition -0.11 0.03 -0.18 -0.06 -0.12 -0.20 -0.24
    (+) Words 0.01 -0.02 -0.13 -0.15 0.08 -0.07 -0.11
    (-) Words -0.21 0.01 0.16 0.17 -0.26 -0.08 0.19
    Valence Factor 0.19 -0.01 -0.20 -0.25 0.32 -0.06 -0.22
    Emotionality Factor 0.07 -0.24 -0.20 -0.16 0.06 -0.15 0.21
p  <0.05, p <0.01, p   <0.001
Note: ESS: Epworth Sleepiness Scale, PSQI: Pittsburgh Sleep Quality Index (high scores 
= high sleep disturbance), AHI: Apnea-Hypnea Index, R-AHI: REM Sleep Apnea-
Hypnea Index, SE%: Sleep Efficiency, Low O2%: Proportion of sleep time spent in 
hypoxia, REM%: proportion of sleep spent in REM, EWFT: Emotion Word Fluency 
Test, CAVLT: Cognitive-Affective Verbal Learning Test, (+) Words: Positive Emotion 
Words, (-) Words: Negative Emotion Words
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Mood and Cognition
Self-report mood measures and cognitive performance were analyzed; see Table 6 for 
details related to correlation strengths and significance values. Overall, depressive 
symptom report was associated with small-to-moderate range decrements in delayed 
recall and verbal fluency measures. Neither positive nor negative affect report scores 
were correlated with cognitive performance. 
Table 6
Mood and Cognitive Performance Partial Correlation Matrix (controlling for age)
CVLT
Learning
CVLT
SDR
CVLT
LDR
CVLT
Recognition
Verbal
Fluency: FAS
Verbal
Fluency: Anm
CESD -0.14 -0.16 -0.39 0.07 -0.23 -0.23
PPA 0.01 0.02 0.14 0.01 -0.03 0.01
PNA -0.03 -0.08 -0.15 -0.03 -0.11 -0.12
p   <0.05, p   <0.001
Note: CESD: Center for Epidemiological Study – Depression Scale, PPA: PANAS 
Positive Affect Scale, PNA: PANAS Negative Affect Scale, CVLT: California Verbal 
Learning Test-2.
Mood and Cognitive-Affective Processing 
Self-report mood measures and cognitive-affective performance were analyzed; see Table
7 for details related to correlation strengths and significance values. Depressive symptom 
report (CESD) correlated with CAVLT Learning for Negative Emotion Words (r = 0.26),
lower Short Delay Recall for Positive Words (r = -0.34) and Valence Factor (r = -0.25), 
lower overall Long Delay Recall (r = -0.20), and a negative bias for the Recognition 
Valence Factor (r = -0.23). Positive Affect scores were conceptually similar, correlating 
with lower CAVLT Learning for Negative Emotion Words (r = -0.21), higher Short 
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Delay Recall for Positive Words (r = 0.38), and a positive bias for the Short Delay Recall
Valence Factor (r = 0.34) and Recognition Valence Factor (r = 0.24) trial. Contrary to the
pattern, higher Positive Affect had a small correlation with negatively biased Learning 
trial Valence Factor (r = -0.25). Negative Affect had no significant correlations with 
cognitive-affective processing measures. 
Overall, the depression scale (CESD) demonstrated a correlational pattern 
consistent with more negative Valence Factors/Negative Emotion Word production 
across Learning, Short Delay Recall, and Long Delay Recall trials of the CAVLT. The 
PANAS Positive and Negative Affect scales demonstrated less consistent and less strong 
pattern of correlations with the CAVLT subtests and qualitative factors. None of the 
mood variables correlated with Emotion Word Fluency Test scores.
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Table 7
Partial Correlation Matrix (controlling for age) for Self-Reported Mood Scores and 
Cognitive-Affective Processing Performance
CESD PPA PNA
EWFT -0.18 -0.09 0.11
CAVLT
  Learning -0.14 -0.09 -0.07
    (+) Words -0.03 -0.13 0.08
    (-) Words 0.26 -0.21 -0.07
    Valence Factor 0.09 -0.25 0.11
    Emotionality Factor 0.20 -0.03 0.10
  Short Delay Recall -0.14 0.06 -0.01
    (+) Words -0.34 0.38 -0.10
    (-) Words -0.34 0.37 -0.01
    Valence Factor -0.25 0.24 0.07
    Emotionality Factor -0.09 0.10 -0.06
  Long Delay Recall -0.20 0.05 -0.18
    (+) Words -0.15 0.11 -0.03
    (-) Words -0.11 -0.04 -0.13
    Valence Factor -0.04 0.16 0.14
    Emotionality Factor -0.01 -0.03 0.03
  Recognition -0.02 0.06 0.06
    (+) Words 0.14 -0.06 0.10
    (-) Words -0.10 0.27 -0.11
    Valence Factor -0.23 -0.25 0.20
    Emotionality Factor 0.14 0.08 0.05
p  <0.05, p <0.01
Note: ESS: Epworth Sleepiness Scale, PSQI: Pittsburgh Sleep Quality Index (high scores 
= high sleep disturbance), AHI: Apnea-Hypnea Index, R-AHI: REM Sleep Apnea-
Hypnea Index, SE%: Sleep Efficiency, Low O2%: Proportion of sleep time spent in 
hypoxia, REM%: proportion of sleep spent in REM, EWFT: Emotion Word Fluency 
Test, CAVLT: Cognitive-Affective Verbal Learning Test, (+) Words: Positive Emotion 
Words, (-) Words: Negative Emotion Words
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Cognition and Cognitive-Affective Processing Performance
Standard cognitive performance and cognitive-affective processing performance 
intercorrelations were analyzed, see Table 8 for details related to correlation strengths 
and significance values. All standard cognitive measures and subtests demonstrated 
significant positive correlations with the counterpart cognitive-affective processing 
measures and subtests. Correlations for the Learning measures were generally in the 
strong range, and correlations for the Short/Long Delay Recall measures were in the 
moderate-to-strong range. The standard measure of semantic fluency (Animals) 
correlated strongly with the cognitive-affective processing fluency task (EWFT), 
compared to the phonemic fluency measure (FAS), which was significant but statistically
less strong (Fisher's z = 2.76, p < 0.01). The small-to-moderate range positive correlations
found between the CVLT and the standard verbal fluency measures were slightly less 
strong (i.e., small range exclusively), and less broad, for the CAVLT and the EWFT. The 
NAART intelligence estimate did not significantly correlate with the CAVLT or EWFT, 
p's > 0.10.
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Table 8
Cognitive and Cognitive-Affective Processing Performance Partial Correlation Matrix 
(controlling for age)
1 2 3 4 5 6 7 8 9 10
CVLT
1. Learning .
2. SDR 0.87 .
3. LDR 0.72 0.75 .
4. Recognition 0.39 0.42 0.43 .
CAVLT
5. Learning 0.63 0.53 0.42 0.26 .
6. SDR 0.64 0.61 0.49 0.33 0.76 .
7. LDR 0.57 0.51 0.48 0.35 0.72 0.75 .
8. Recognition 0.46 0.47 0.26 0.37 0.54 0.49 0.57 .
Fluency
9. FAS 0.18 0.20 0.25 -0.03 0.23 0.22 0.15 .
10. Animals 0.34 0.35 0.46 0.32 0.26 0.27 0.20 0.25 0.25 .
11. EWFT 0.20 0.22 0.34 0.10 0.24 0.11 0.29 0.08 0.12 0.56
p  <0.05, p <0.01, p   <0.001
Note: CAVLT: Cognitive-Affective Verbal Learning Test, CVLT: California Verbal 
Learning Test-2, SDR: Short Delay Recall, LDR: Long Delay Recall, EWFT: Emotion 
Word Fluency Test
Mean Comparisons for Sleep Apnea Severity Subgroups
A one-way MANCOVA using OSA severity group (AHI) as the IV, and cognitive 
(CVLT: Learning, SDR, LDR, Recognition; FAS, Animals), cognitive-affective 
processing (CAVLT: Learning, SDR, LDR, Recognition, VF for each previous subscore; 
EWFT), and mood dependent variables (CESD, PNA, PPA) as DV's, with age as a 
covariate, was significant, Wilk's lambda = 0.52, F(45, 107.73) = 1.52, p = 0.04. Though 
a conservative approach would use the MANCOVA contrasts to determine differences 
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for specific measures, the small amount of missing values combined with list-wise 
deletion significantly reduced the available n for each contrast, which was judged to be 
too restrictive on power for such an exploratorially driven study. Thus, the previously 
listed dependent variables were entered into an ANCOVA, controlling for age, in order to
compare OSA severity group profiles. The following tables (10-13) contain unadjusted 
means and standard deviations, as these are more easily interpretable. Tukey's contrasts 
were used to investigate pattern of subgroup differences, and those p-values were 
reported where applicable. Additionally, below each table, the pattern of contrast 
differences will be specified where applicable. Limitations on the interpretations that 
follow this course of analysis are appropriately addressed in the discussion.
Polysomnogram Indicator Comparisons
Apnea-hypnea Index (AHI) scores significantly differed between groups (see Table 9 for 
details), in the expected direction given that this indicator is the clinical classifying 
criteria, F(3, 61) = 167.24, p < 0.001, ES = 0.90, with contrasts indicating all groups 
significantly differing amongst each other, p’s < 0.001. AHI severity during REM sleep 
(R-AHI) significantly differed between groups, F(3, 57) = 6.29, p = 0.001, ES = 0.27. A 
Post-hoc contrast indicated that AHI severity during REM sleep was significantly lower 
for the No OSA groups compared to the Moderate and Severe OSA groups, p's < 0.01. 
Sleep Efficiency (SE%) also differed significantly, F(3, 60) = 3.58, p = 0.03, ES =0.10, 
with higher efficiency in the No OSA group compared to the Severe group, p = 0.05. 
Percentage of sleep time spent in REM (REM%) significantly differed amongst groups, 
F(3, 61) = 3.68, p = 0.02, ES = 0.17. Specifically, it was significantly lower for the No 
OSA and Severe groups compared to the Moderate group, an unexpected finding without 
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obvious explanation, p's < 0.05 . Finally, hypoxia during sleep (Low O2%) differed 
amongst the severity groups, F(3, 60) = 7.38, p < 0.001, ES = 0.29. Clinically low oxygen
blood saturation time was significantly higher for the Severe OSA group compared to the 
other groups, which did not differ amongst themselves, p's < 0.01. Overall, a general 
pattern of significant polysomnogram abnormality was demonstrated across indicators for
the Severe OSA group compared to the others, with Moderate OSA less frequently 
distinguished as significantly more abnormal than the lower-severity groups, and the 
Mild group not differing from the No OSA group across any, aside from AHI (a finding 
expected as AHI was used to create clinical groups).
Table 9
ANCOVA (controlling for age) Comparison of Polysomnogram Sleep Quality Indicators 
by AHI Diagnostic Category
AHI*
Mean
(SD)
R-AHI^
Mean
(SD)
SE%#
Mean
(SD)
REM%&
Mean
(SD)
Low O2%+
Mean
(SD)
No OSA 
(n=22)
2.45
(1.38)
8.91
(11.20)
85.20
(12.07)
14.58
(8.30)
0.39
(1.20)
Mild 
(n=11)
10.03
(3.24)
23.36
(14.13)
81.28
(8.27)
15.52
(3.66)
5.15
(13.69)
Moderate 
(n=11)
23.48
(3.75)
37.18
(19.35)
84.46
(7.74)
21.44
(3.56)
2.78
(3.14)
Severe 
(n=17)
66.76
(16.93)
37.74
(34.34)
76.10
(19.04)
11.21
(11.01)
18.50
(14.21)
*: No < Mild < Moderate < Severe; 
^: No < Moderate & Severe; 
+: No, Mild, & Moderate < Severe
#: No > Severe; 
&: No & Severe < Moderate
Note: AHI: Apnea-Hypnea Index, R-AHI: REM Sleep Apnea-Hypnea Index, SE%: Sleep
Efficiency, Low O2%: Proportion of sleep time spent in hypoxia, REM%: proportion of 
sleep spent in REM
Self-Reported Mood and Sleep Quality Score Comparisons
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No significant group differences emerged upon comparison of self-reported mood or 
sleep quality measures, p's > 0.10 (see Table 10 for details).
Table 10
ANCOVA (controlling for age) Comparison of Self-Reported Mood and Sleep Quality 
Scores by AHI Diagnostic Category
CESD PNA PPA ESS PSQI
No OSA 
(n=22)
10.28
(6.91)
16.55
(7.76)
30.42
(8.51)
9.14
(4.74)
8.16
(5.69)
Mild 
(n=11)
13.77
(8.83)
16.36
(5.95)
30.73
(8.06)
8.09
(3.83)
8.91
(4.25)
Moderate 
(n=11)
13.36
(9.50)
15.73
(2.80)
32.82
(9.63)
9.45
(4.50)
8.64
(4.13)
Severe 
(n=17)
16.00
(13.14)
15.59
(4.71)
26.88
(8.18)
9.12
(4.50)
9.09
(5.37)
Note: CESD: Center for Epidemiological Study – Depression Scale, PNA: PANAS 
Negative Affect Scale, PPA: PANAS Positive Affect Scale, ESS: Epworth Sleepiness 
Scale, PSQI: Pittsburgh Sleep Quality Index (higher scores = more reported sleep 
disturbance).
Cognitive Performance (Raw Scores) Comparisons
No significant group performance differences emerged upon analysis for any of the 
standard cognitive test measures (p's > 0.10; see Table 11). No significant differences 
were found when repeated measure ANCOVAs were used to evaluate whether significant
patterns of performance differences existed (p's >0.10) within the CVLT learning trials 
(i.e., Trials 1, 2, 3, 4, 5) or across time-increments within the verbal fluency tasks (i.e., 
total output at 15 seconds, 30s, 45s, 60s; output during increments 1-15 seconds, 16-30s, 
31-45s, 46-60s).
Table 11
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ANCOVA (controlling for age) Comparison of Cognitive Raw Score by OSA Diagnostic 
Severity Category 
No OSA
n=22
Mean
(SD)
Mild
n=11
Mean
(SD)
Moderate
n=11
Mean
(SD)
Severe
n=17
Mean
(SD)
CVLT
     Learning 49.05
(12.70)
47.00
(13.73)
45.91
(8.83)
45.53
(10.42)
     Short Delay Recall 10.29
(3.57)
10.18
(5.33)
9.18
(2.79)
9.35
(3.39)
     Long Delay Recall 10.19
(2.99)
10.36
(5.26)
9.00
(2.65)
8.29
(4.04)
     Recognition 14.33
(1.80)
14.45
(2.02)
14.50
(1.35)
14.00
(1.66)
Verbal Fluency
     FAS 35.73
(9.36)
40.00
(11.23)
36.36
(17.97)
38.69
(7.61)
    Animals 17.91
(4.00)
18.27
(5.33)
19.09
(4.06)
18.56
(3.60)
Note: CVLT: California Verbal Learning Test-2
Cognitive-Affective Performance (Raw Scores) Comparisons
For the CAVLT, total number of words recalled across learning trials was significantly 
different across OSA severity groups, F(3, 60) = 2.98, p = 0.04, ES = 0.14. Specifically, 
the number of words recalled was higher for the No OSA group compared to the three 
diagnostic groups,  p's < 0.05, which did not differ amongst themselves (see Table 12). 
No significant performance differences were found for total recall after short delay, but 
positive-emotion word recall was different, F(3, 59) = 3.25, p = 0.03, ES = 0.15 with the 
No OSA group demonstrating greater Short Delay Recall for Positive Words than the 
Moderate and Severe groups, p's < 0.05. Similarly, the Valence Factor for Short Delay 
86
Recall (i.e., controlling for overall amount of recall) was significantly different, F(3, 59) 
= 3.35, p = 0.03, ES = 0.16, with more positive affective bias for the No OSA and Mild 
groups compared to the more negative bias for the Moderate and Severe groups, p's < 
0.05. 
Long Delay Recall on the CAVLT differed significantly across OSA severity 
groups, F(3, 59) = 2.97, p = 0.04, ES = 0.14. Specifically, the No OSA group recalled 
significantly more words after a long delay than the Moderate and Severe groups, p's < 
0.05. For the Long Delay Recall subtest, significant group differences were found for 
Positive Emotion Words, F(3, 59) = 3.02, p = 0.04, ES = 0.14, and the valence factor, 
F(3, 59) = 3.62, p = 0.02, ES = 0.17. The No OSA group recalled more Positive Emotion 
Words than the Severe group, p = 0.004, and the Valence Factor was significantly lower 
(more negatively biased, controlling for amount of recall) for the Severe group compared 
to all other groups, p's < 0.05. No recognition subtest differences were found (p's > 0.10).
No significant differences were noted across any of the submeasures for the Emotionality
Factor, which was designed to measure bias toward recall of emotional words versus non-
emotional words (p's > 0.10). Similar to the standard verbal fluency tests, no EWFT 
performances differed significantly. Repeated measure ANCOVAs did not reveal 
significant differences between AHI severity groups in CAVLT learning trial 
performance, nor EWFT quartile-sum and quartile-production performances (p's > 0.10). 
Table 12
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ANCOVA (controlling for age) Comparison of Cognitive-Affective Raw Scores by OSA 
Diagnostic Category
No OSA
n=22
Mean
(SD)
Mild
n=11
Mean
(SD)
Moderate
n=11
Mean
(SD)
Severe
n=17
Mean
(SD)
CAVLT
  Learning* 52.27
(10.49)
43.30
(13.01)
40.91
(8.80)
45.35
(10.50)
    (+) Words 12.14
(3.80)
9.40
(2.76)
9.64
(3.85)
9.88
(3.87)
    (-) Words 11.95
(3.19)
10.60
(2.50)
10.55
(3.59)
10.41
(3.08)
    Valence Factor -0.40
(16.01)
-7.18
(8.36)
-6.14
(31.01)
-9.94
(19.66)
    Emotionality Factor 13.48
(31.83)
39.60
(12.52)
36.77
(11.09)
41.23
(10.00)
  Short Delay Recall 10.86
(3.18)
8.10
(4.04)
7.91
(2.21)
8.18
(3.01)
    (+) Words^ 2.38
(1.16)
1.70
(1.16)
1.36
(1.03)
1.35
(0.93)
    (-) Words 2.10
(0.89)
1.30
(1.16)
1.82
(0.75)
1.82
(1.02)
    Valence Factor# 4.53
(27.81)
24.33
(47.97)
-27.27
(49.84)
-24.18
(44.40)
    Emotionality Factor 11.06
(47.11)
12.19
(64.56)
26.88
(64.26)
28.02
(76.38
  Long Delay Recall^ 10.52
(3.43)
8.00
(4.52)
7.82
(2.56)
7.41
(3.03)
    (+) Words@ 2.19
(1.33)
1.50
(1.27)
1.55
(0.93)
1.00
(1.06)
    (-) Words 1.90
(1.18)
1.30
(1.25)
1.55
(1.04)
1.59
(1.00)
    Valence Factor& 5.44
(29.52)
6.00
(24.59)
1.52
(49.70)
-35.69
(57.10)
    Emotionality Factor -7.03
(42.42)
-11.25
(50.67)
18.18
(58.64)
13.08
(73.09)
  Recognition 14.67
(1.71)
14.60
(1.78)
13.90
(1.29)
13.60
(1.77)
    (+) Words 3.33
(1.02)
3.50
(1.08)
3.40
(0.70)
3.20
(0.68)
    (-) Words 3.43
(0.75)
3.50
(0.85)
3.20
(0.63)
3.33
(0.72)
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    Valence Factor -3.24
(16.91)
-1.90
(19.72)
2.76
(15.08)
-1.90
(14.07)
    Emotionality Factor -45.47
(16.17)
-24.00
(28.56)
-31.68
(22.26)
-33.22
(33.47)
EWFT 10.00
(2.93)
11.27
(3.47)
9.36
(3.96)
10.44
(3.03)
*: No > Mild, Moderate, & Severe
^: No > Moderate & Severe
@: No > Severe
#: No & Mild > Moderate & Severe
&: No, Mild, & Moderate > Severe
Note: CAVLT: Cognitive-Affective Verbal Learning Test, EWFT: Emotion Word 
Fluency Test, (+) Words: Positive Emotion Words, (-) Words: Negative Emotion Words
Mean Comparisons for Subjective Sleep Report Clinical Groups
Both subjective sleep self-report measures (ESS and PSQI) significantly and strongly 
correlated with depressive symptom report (CESD), and demonstrated more sporadic and
weaker correlations with cognitive and cognitive-affective performance, suggesting there 
may be important subjective sleep quality group differences. Clinical cut-offs supported 
within the literature were used to create “good” versus “bad” reported sleep quality 
(PSQI > 5 and 7; Buysse et al., 2008) and sleepiness (ESS > 7 and 9; Rosenthal & Dolan,
2008) groups. These four variables (i.e., two sets of bivariate cut-offs for each of the two 
subjective sleep self-report measures) were used as independent variables in a four-way 
MANCOVA, with  the same cognitive, cognitive-affective processing, and mood 
variables used previously as dependent variables, with age as a covariate. The analysis 
was non-significant, Wilk's lambda = 0.20, F(54, 87.25) = 1.16, p = 0.26. However, Roy's
Largest Root, a liberal estimate of lower bound significance, was significant, p = 0.03. 
Given the liberal significance indicator, exploratory ANCOVA's were used to explore 
whether there were any underlying contrast findings that might partially direct study 
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interpretations. Only the use of the ESS cut off of over 7 showed significant differences 
for performance measures, though they were all in one measure, the CAVLT. Those 
judged to be excessively sleepy at the described cutoff recalled fewer words over the 
course of the Learning Trials, F(1, 57) = 4.42, p = 0.04, ES = 0.07, after Short Delay, 
F(1, 56) = 4.43, p = 0.04, ES = 0.07, and after Long Delay, F(1, 56) = 8.13, p = 0.004, ES
= 0.14. With regard to the CESD, more depressive symptoms were reported in the 
excessively sleepy group using both a cut off score of over 7, F(1, 56) = 10.68, p = 0.002,
ES = 0.16, and over 9, F(1, 56) = 86.64, p = 0.013, ES = 0.11.
Regression Pathway Analysis
The planned Preacher and Hayes (2008) regression pathway analysis was designed to 
investigate whether a proportion of the variance between polysomnogram factors and 
mood could be explained through the degree of valence bias in cognitive-affective 
processing performance content (see Figure 3). Note, Figure 3's unidirectional arrows are 
meant to represent the a priori model based upon van der Helm and Walker (2009). While
these regression analyses on cross-sectional data cannot address the causal elements, the 
results will be reported as being at least consistent or inconsistent with said model. The 
authors suggest placing all potential pathway variables into the analysis, and if significant
or near-significant findings result, post-hoc removal of non-significant pathway variables 
can be conducted in an exploratory fashion. To test this a priori hypothesis, the AHI was 
entered as the predictor variable for CESD score, with inclusion of the four CAVLT 
Valence Factors (affective-valence bias indicators) as potential mediation pathway 
variables, controlling for age. The resulting model was non-significant, with the 
underlying problem being no significant relationship between AHI and CESD (p > 0.10). 
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Based upon the regression findings, REM, AHI, and Sleep Efficiency % were considered 
as alternate predictor variables, with consideration of both PANAS affect subscales (PPA
and PNA) as a dependent variable of mood. Each combination of these alternative 
predictor and dependent variables resulted in the same non-significant model obstacle, 
i.e., the relationship between the polysomnogram indicator and the mood variable (p's > 
0.10). Alternative exploratory analyses were generated to explore alternative relationship 
patterns, and are discussed below. 
Figure 3. Proposed Mediation of Relationship between Sleep Study Indicators and Mood 
Measures via Cognitive-Affective Processing Valence Bias
Note: Controlling for Age. Original measures proposed for the model are bolded
Exploratory
The proposed model was not supported by the data analyses conducted. However, despite
the documented weakness in relation between AHI severity and depressive symptoms 
(CESD), the sleep study and mood constructs did demonstrate other correlations. 
Furthermore, the CAVLT Valence Factors demonstrated significant correlations with the 
sleep study and mood constructs, as well as significant differences within the ANOVA 
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PSG Indicators
AHI
R-AHI
SE%
Mood Self-Report
CESD
PNA
PPA
CAVLT Valence Factors
Learning VF
Short Delay VF
Long Delay VF
Recongition VF
analyses. Taken together, this suggested that further exploratory analyses were warranted,
in order to explore alternative relationships between sleep study indicators (PSG), mood 
(CESD, PNA, PPA), and cognitive-affective processing bias in emotional-valence 
processing (i.e., Valence Factors)
Alternative Pathway Analysis – Subjective Sleep 
As self-reported depression significantly and strongly correlated with self-reported 
subjective sleep measures, the potential for a model adjustment to substitute subjective 
for objective sleep disturbance was explored. While the relationship between the selected 
predictor (ESS or PSQI) and the dependent variable (CESD or PPA) was significant, p's 
< 0.01, as seen in the previous correlation analyses, the predictor → mediators and 
mediators → dependent variable pathway coefficients were non-significant, p's > 0.10. 
Thus, while this pathway analysis redemonstrated a significant relationship between the 
self-reported sleep measures and the self-reported mood measures, there were not 
findings suggestive of a mediation  pathway through any Valence Factors (i.e., 
negative/positive bias in processing of emotional information) in the CAVLT subscores.
Regression: Predicting CAP-emotion/VF with Mood and Polysomnogram
Null findings for the a priori mediation pathway model, using AHI, CESD, and CAVLT 
VFs, were unexpected for reasons based in theoretical expectations but also due to the 
significant correlation and mean-comparison results (specifically, with regard to the 
CAVLT VF variables) of the present study. The latter suggest that the affective bias in 
recall performances are significantly associated with both physiological sleep 
disturbance, as well as self-reported mood. The unexpected null findings relating 
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polysomnogram and mood variables will be commented on in the discussion. For the 
purpose of exploring alternative conceptualizations of these  relationships, stepwise 
hierarchical regression was used as it allowed for interpretation of the best set of 
predictors, an important factor given that our theoretical a priori hypothesis was non-
significant. 
The regression structure consisted of two blocks: 1) forced entry for Age, and 2) 
stepwise entry for CESD (reported depressed mood), PPA (positive affect), AHI, R-AHI, 
and lowO2%. This analysis was run for each CAVLT affective bias indicator (VFs). 
Significant models were found for short delay VF, F(3, 53) = 3.82, p = 0.02, adj R2 = 
0.19, and long delay VF, F(3,53) = 3.58, p = 0.02, adj R2 = 0.18. See Tables 13 and 14 
for regression details. Amount of AHI during REM was significantly predictive of more 
negative bias in short and long delay recall. Self-reported depressive symptom score was 
uniquely predictive of more negative bias in short delay recall, but not for long delay. In 
contrast, hypoxia during sleep accounted for prediction of more negative bias in long 
delay recall but was not significant for the short delay model. No significant models were
found for CAVLT total learning trial or Recognition trial affective bias indicators (VF's).
Table 13
Regression Statistics: Significant Sleep Study Indicators and Self-reported Mood Scores 
that Predict CAVLT Short Delay Recall Valence Factor
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Model # Component B SE Standardized B t p-value
1 Constant -13.04 24.79 -0.53 0.60
Age 0.19 0.46 0.06 0.41 0.68
2 Constant -5.97 23.86 -0.25 0.80
Age 0.34 0.44 0.10 0.77 0.45
R-AHI -0.58 0.24 -0.33 -2.43 0.02
3 Constant 18.97 25.62 0.74 0.46
Age 0.23 0.43 0.07 0.54 0.59
R-AHI -0.66 0.23 -0.37 -2.83 0.01
CESD -1.29 0.58 -0.29 -2.21 0.03
p   <0.05
Note: R-AHI: REM Apnea-Hypnea Index, CESD: Center for Epidemiological Study 
Depression Scale
Table 14
Regression Statistics: Significant Sleep Study Indicators and Self-reported Mood Scores 
that Predict CAVLT Long Delay Recall Valence Factor 
Model # Component B SE Standardized B t p-value
1 Constant -22.43 25.67 -0.87 0.39
Age 0.32 0.47 0.09 0.67 0.51
2 Constant -26.13 24.76 -1.06 0.30
Age 0.52 0.46 0.15 1.12 0.27
Low O2% -0.97 0.43 -0.31 -2.27 0.03
3 Constant -19.61 24.09 -0.81 0.42
Age 0.64 0.45 0.19 1.43 0.16
Low O2% -0.93 0.41 -0.29 -2.24 0.03
R-AHI -0.52 0.24 -0.28 -2.17 0.04
p <0.05
Note: R-AHI: REM Apnea-Hypnea Index, Low O2%: proportion of time spent in 
hypoxic state
Alternate ANCOVA Investigations
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Another statistical approach to investigate potential interaction effects of disturbed 
polysomnogram and depressed mood was conducted through two different sets of 
analyses. The first was to add CES-D as a covariate to the four previously conducted 
ANCOVAs (using AHI severity group as the independent variable and CAVLT VFs as 
dependent variables). Self-reported depression scores on the CESD were not a significant
covariate for any of those analyses (p's > 0.10). Another approach was conducted via the 
creation of a bivariate CESD variable (non-depressed versus probable depression) to 
incorporate into the 4x2 ANCOVA (AHI severity x CESD status). No main or interaction
effects were found for depression status (p's > 0.10). 
Alternate Clinical-vs.-Nonclinical Subgroup Comparisons: 
An exploratory effort using MANCOVA was conducted in order to investigate whether 
CAVLT VFs differed significantly amongst other potential clinical subgroups. A 
MANCOVA (controlling for age) was conducted using clinical cut-off splits for the 
following independent variables: REM-AHI, SE%, lowO2, PSQI, ESS. All four CAVLT 
VFs were entered as dependent variables. No significant main or interaction effects were 
found, p's > 0.10, and the decision was made not to investigate post-hoc contrasts due to 
concerns about avoiding a “fishing-expedition” approach. 
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CHAPTER 5
DISCUSSION, CONCLUSIONS, AND RECOMMENDATIONS
The present study was designed to further investigate the interrelationships between sleep
processes, neurocognition, and mood. Extant research outlines the breadth and severity of
impact that disturbed sleep causes to the effectiveness of processing information and the 
experience of depressive symptoms. More recent research has examined the relationship 
between disturbed sleep and negative affective biases. This dysfunctional process has 
theoretical support as a mechanism underlying the cause and/or maintenance of 
psychiatric conditions that involve negative mood (e.g., depressive and anxiety 
disorders). We constructed a battery designed to measure these constructs and evaluated 
61 patients referred for polysomnogram for diagnostic differential of obstructive sleep 
apnea, a condition associated with both sleep physiology disruption and chronic 
nighttime hypoxia. Notable inclusions in the battery were two novel cognitive-affective 
processing measures, which were counterparts of standard neurocognitive measures of 
memory and verbal fluency. 
The results will be summarized briefly as they apply to specific hypotheses 
(matching the organization of numbered and lettered hypotheses found in Chapter 2), 
organized under the previously outlined four overarching study objectives. Discussion 
will then focus on: 1) the theoretical implications and clinical utility of the findings; 2) 
how the results of this study reflect on the state of current research within the cognitive-
affective processing field, specifically related to the improvements that the present 
measures offer upon previous paradigms, and 3) limitations and directions for additional 
research will be outlined.
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The study offered mixed support for replicating the interrelationships documented
in the research between sleep physiological indicators, subjective sleep measures, 
cognitive performance, and mood: (1a) correlations were significant between objective 
indicators of sleep quality (i.e., polysomnogram), self-reported sleep quality, mood, and 
standard measures of neuropsychological performance; (1b & 1c) using objective sleep 
pathology clinical cutoffs, significant differences between severity groups were not 
detected on two standard cognitive measures (i.e., CVLT-2 and FAS/Animals fluency), 
and three measures of mood (i.e., CESD, PPA, PNA) were not detected.
Results documented and provided support for the validity of the two novel 
measures of cognitive-affective processing; (2a) convergent and divergent validity were 
demonstrated, as well as support for aspects of the measures being sensitive to sleep-
breathing disorder pathology in our sample.
The interrelationship between sleep, mood, and the novel cognitive-affective 
measures were supported; (3a) the cognitive-affective processing measures were 
significantly related to objective indicators of sleep quality (i.e., polysomnogram), self-
reported sleep quality and mood; (3b) the more severe OSA severity groups performed 
significantly worse than less severe OSA groups on the CAVLT, though not the EWFT; 
(3c) the more severe OSA severity groups demonstrated a negative bias in learning and 
recall on the CAVLT, independent of overall production. 
Finally, the study provided mixed support for the proposed model;  (4 a) a lack of 
relationship between objective measures of sleep disturbance and mood meant that 
negative bias in the CAVLT could not be explored as a mediating pathway between the 
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two. However, further exploratory analyses suggest a more complex relationship between
the constructs exists. 
The Relationship of Sleep with Cognition and Mood
The first broad hypothesis was the replicative expectation of a significant 
interrelationship between the constructs of interest. Overall, this hypothesis was 
supported, with significant correlations existing amongst sleep study indicators, self-
reported subjective sleep measures, self-reported mood measures, standard cognitive 
performance, and cognitive-affective processing performance. As expected, objective 
indicators of sleep disturbance were significantly correlated with both fluency and 
memory performance decrements. Of note, amount of sleep time spent in hypoxia 
appeared to be a stronger and broader indicator of cognitive performance than number of 
disturbed-breathing related arousals. This finding is important given the fact that all a 
priori hypotheses relied on AHI as the independent variable subgroup construct. 
Depressive symptom report also correlated with cognitive performance measures, though 
to a less broad and strong degree. The relationship between objective sleep indicators and
negative mood existed, but was narrower and weaker than expected. While subjective 
sleep report demonstrated significant relationship with negative mood indicators, it did 
not relate to cognitive performance. Previous research findings suggest that cognitive 
processing deficits found within different sleep deprivation samples (clinical and 
experimental) are not due to lack of motivation or effort (Harrison & Horne, 2000; 
Wilkinson, 1961). Furthermore, two embedded performance validity indicators within 
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this study's battery identified no sub-optimal performances. Thus, despite the lack of 
performance validity measures in the study's battery, the cognitive findings are thought to
represent true neurocognitive variation, rather than amotivation or lack of engagement.
Examination of these relationships through creation of clinically meaningful OSA
groups (based on AHI severity) showed group differences that were much less consistent 
with replicative expectations. Lack of subjective sleep report differences across AHI 
severity groups suggested the constructs to be significantly independent of each other. 
Unexpectedly, no cognitive performance differences were found across OSA severity 
groups, for memory or semantic/phonemic word-fluency. The only OSA severity group 
differences related to mood were limited to trend significance, with the severe group 
endorsing more depressive symptoms and less positive affect than the other groups. 
When clinical and non-clinical groups were created via subjective sleep report measures, 
no significant standard cognitive performance differences were noted, though use of the 
ESS at two supported clinical cut-offs identified significantly more depressive symptom 
report.
With regard to the null findings for cognitive differences across OSA severity 
groups, there are a number of potential explanations, one being that the decrements in 
neurocognitive functioning are predominantly in those with severe OSA (e.g., as seen in 
Engleman, Kingshott, Martin, & Douglas, 2000). This study’s sample had fairly even 
distribution between severity groups, which would be suitable for evaluating a severity-
dependent pattern of deficit expression. However, if neuropsychological sequelae tend to 
emerge primarily only within severe OSA populations, our study’s sample was too 
skewed (i.e., 75%) toward “non-clinical” distribution. Thus, the relationship between 
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neuropsychopathology and sleep pathology in OSA may not be linear, but resemble a 
rapid accumulation of impairments after a severe-AHI range is present. Compounding 
this issue, the a priori sample size was determined through amalgamation of dichotomous
effect size estimates (i.e., OSA versus HC) from recent meta-analyses, which may have 
been subject to publication bias – i.e., including studies that found significant differences 
due to a maximization approach of using a more severe clinical group and comparing 
them to healthy controls. 
Another possible explanation arises from the findings of Beebe and colleagues 
(2003), who identified resiliency in verbal functions and vulnerability in working-
attention like tasks within OSA studies. It is possible that the memory and fluency tasks 
selected for this study were not as well suited to pick up neurocognitive sequelae as 
initially hypothesized. Resiliency in verbal functions potentially minimized 
initiation/divergence variability within the fluency tasks and recall variability within the 
verbal-memory task. In the context of the significant polysomnogram indicator 
relationships with cognitive performance (not the case with the subjective sleep 
variables), the findings support the argument that subjective measures of sleep quality 
measure a construct that correlates less with neurophysiological sequelae than objective 
measures of sleep quality (e.g., Buysee et al., 2008's null relationship findings between 
subjective and objective sleep indicators).
The even distribution of our sample into the four diangnostic OSA severity 
categories (versus a dichotomous No versus Severe group split) may also explain the null 
findings across OSA severity group for depressive symptoms; again, due to the potential 
non-linear relationship. This explanation is reinforced given the trend significance 
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identified for the Severe group being identified as the potential sole source of variability. 
As previously cited, while depressive symptoms are associated with AHI, the magnitude 
of the effect size is quite small for lower AHI levels (i.e., ~0.3) and only with the more 
severe groups do reliably large effect sizes emerge (i.e., d = ~2-3.0; Engleman, 
Kingshott, Martin, & Douglas, 2000). The lack of findings is not completely 
unprecedented (e.g., Andrews & Oei, 2004), and lends some additional weight to the 
hypothesis that the relationship between chronic sleep fragmentation and depression is 
mediated through secondary conditions acquired through long-term untreated sleep-
disordered breathing conditions (e.g., white matter hyperintensities; Aloia, Arnedt, Davis,
Riggs, & Byrd, 2004). The findings that the subjective sleep measure related to daytime 
sleepiness (i.e., the ESS) identified clinical groups reporting significantly more 
depression is consistent with the hypothesis of previous research that excessive daytime 
sleepiness contributes to quality of life decrements, thus increasing the odds of depressed 
mood (Sforza, de Saint Hilaire, Pelissolo, Rochat, & Ibanez, 2002).  However, it should 
be noted that unlike research proposing those causal chain, this study is not longitudinal, 
and thus cannot provide for causal inferences.
On a final explanative note, beyond the potential for a non-clinical skewing 
within the OSA severity, the sample's mood, cognitive, and health-comorbidity rates 
were all skewed toward non-clinical severity. This “high functioning” group may be 
linked to the non-severe OSA skewing, or be related to a sampling bias toward stronger 
cognitive reserve (e.g., skewness toward high economic status and average education).
Cognitive-Affective Processing Findings
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Given the meticulous effort to match the cognitive-affective processing (CAP) 
measures on both instruction paradigms and stimuli content, the strong basis for expected
acceptable cognitive-affective processing psychometrics was well-founded. The 
affective-memory measure (CAVLT) had strong internal correlations between subscores, 
and moderate-to-strong correlations with the standard memory measure (CVLT). The 
affective-word fluency measure (EWFT), which could be considered a variant of a 
semantic-category fluency task, correlated more strongly with the animal-category task 
than the phonemic fluency task. Correlations between the CAVLT and fluency measures 
were less broad and in the weak-range, demonstrating acceptable divergent validity. 
These findings suggest that the cognitive-affective processing measures are tapping 
constructs closely related to, but significantly different from, those processes validated in 
the CVLT and FAS/Animal fluency tasks.
In contrast with the relatively limited previously discussed findings, cognitive-
affective processing performance demonstrated notable statistically significant 
correlations (see Figure 4) and group differences suggesting the overlapping construct 
was more sensitive to IV’s.  There was a wide variety of success amongst the novel and 
exploratory hypotheses. With regard to sleep, analyses found that objective sleep 
disturbance indicators significantly correlated with affective-memory, both in terms of 
number of words recalled and the number of negative words. However, affective-word 
fluency was more narrowly related, only correlating with sleep efficiency. Subjective 
sleep disturbance was significantly less related to cognitive-affective processing 
measures, being negatively related to only one of the four affective-memory valence 
factors (Long Delay Recall VF). Despite that finding, when a measure of excessive 
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sleepiness (ESS) was used to create clinical and non-clinical groups, the subjectively 
sleepy group underperformed on total word production across the total learning trials, 
short delay recall, and long delay recall.  
 
Figure 4. Graphical Representation of Significant Correlation Findings between Five 
Construct Domains. Note: for purposes of clarity, correlations are not show between 
variables within domains, as well as correlations between Standard Cognitive and 
Cognitive-Affective Processing domains.
When AHI severity groups were compared, the non-OSA group outperformed all 
clinical groups on the affective-memory task's learning trials; however, after a short 
delay, there were no differences for total word output. Instead, the valence of the recalled 
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words differed, with a general pattern of less negative valence within the non-OSA group
(and to a lesser degree, the mild OSA group). After long-delay, the non-OSA group 
recalled more words than the clinical groups, and after controlling for that output 
difference, had less negative delayed recall. Interestingly, there were no group differences
for recognition memory in terms of number of words and word valence. Importantly, 
there were no concreteness-bias differences found for submeasures of affective-memory 
that demonstrated a negative valence bias. This suggests that the valence finding is not 
only independent of amount of information recalled, but also independent of any bias 
related to processing differences due to concreteness versus abstractness of the stimuli, an
important factor considering emotional words are semantically abstract. 
One pattern of note is the negative correlation between REM-related 
polysomnogram pathology (i.e., high REM AHI and low REM%) and valence factors 
(i.e., more negatively biased processing). Alternatively,  AHI (i.e., sleep fragmentation in 
part caused by apnea/hypnea events) and hypoxic blood saturation related more to the 
actual amount of words produced on recall trials. This pattern suggests the possibility of 
parallel impacts to memory processes, mediated by different physiological processes 
disturbed by OSA pathology. Specifically, disrupted sleep architecture (e.g., suppressed 
REM) may be more related to affective biases in memory, whereas breathing-related 
pathology (e.g., hypoxia) may be more related to learning and recall ability in general. 
The OSA clinical group differences are consistent with this impression, though not 
exclusive to it (i.e., the study did not conduct more refined REM or hypoxia based mean-
comparisons to explore this possible interpretation). 
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Taken overall, the more limited learning and recognition findings, in the context 
of significant recall production and affective valence bias in the short/long delay free 
recall trials, suggest a subcortical-frontal retrieval dysfunction mediating CAVLT 
performance. That this retrieval dysfunction could also be affectively-biased, is of 
particular note. The absence of CVLT findings further confirms that the cognitive-
affective processing measure is tapping a different construct (or subdomain) than learning
and memory for neutral verbal information. The ESS differences for CAVLT production, 
given the lack of any standard cognitive measure findings but significant relationship to 
negative mood, lends credence to this cognitive-affective processing measure evaluating 
neurocognitive processes impacted by both physiological and psychological pathology, 
though specific relationships are beyond comment at this point. 
With regard to mood, depressive symptoms demonstrated a small correlation with
reduced overall word recall after long delay, but were primarily associated with affective-
memory in terms of negative words produced and negative bias during recall and 
recognition tasks. Negative mood indicators were not associated with affective-word 
fluency. Given the significant correlational findings for the standard long delay recall and
verbal fluency measures, this suggests non-overlapping variability being tapped by the 
CAVLT and CVLT with regard to potential impacts of depression on performance.
After the promising findings regarding the cognitive-affective processing 
measures relating to both sleep and mood measures, it was surprising to not confirm the 
proposed mediation model as posited. Unexpectedly, AHI was not found to significantly 
predict degree of depression, thus no pathway could be established via CAVLT valence 
bias. Upon expansion of the model to include promising polysomnogram indicators 
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predicting mood measures, one relationship was found (i.e., sleep efficiency predicting 
lower negative affect), but in this case the CAVLT valence factors did not have 
significant path effects between either predictor or dependent variable. Using either 
subjective sleep report as a predictor of any of the three mood indicators resulted in a 
similar problem, i.e., the presence of a significant relationship between IV and DV but no
pathway via any of the CAVLT valence factors. While regression analyses themselves 
cannot confirm a causal model, the failure of the mediation model suggests there is a lack
of conceptual fit with our a priori framework.
We hypothesized that sleep disturbance and mood may both be related to 
cognitive-affective processes, but perhaps produce independent impact on cognitive-
affective processing within our sample. Regressions were successful in demonstrating 
that REM AHI and hypoxia, along with depressive symptoms, were uniquely predictive 
of negative affective bias at delayed recall. Additional exploratory hypotheses were not 
supported, including analysis of whether depression as a covariate impacted OSA group 
differences in cognitive-affective processing scores, as well as including a dichotomous 
depression variable to investigate potential main/interaction effects on CAP scores. This 
further suggested that the increased negative bias in affective processing associated with 
disturbed sleep physiology was independent of negative mood (i.e., the possibility that 
any relationship between polysomnogram and negatively-biased CAP was due to co-
occurring depression leading to a bias toward negative information). A final multivariate 
analysis did not find enough promising results to warrant further group comparisons 
amongst other bivariate polysomnogram and reported-sleep quality variables with regard 
to cognitive-affective processing scores, though this does not rule out their potential 
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impact, given power limitations for multivariate analyses of that size. Due to the lack of 
relationship between objective sleep and depression, an attractive alternative order of 
variables could not be explored (i.e., depressed mood mediating the relationship between 
sleep pathology and negative bias on the CAVLT). However, the reader is reminded that 
multiple alternative longitudinal research studies have identified disturbed sleep 
occurring prior to depression , suggesting a causal relationship (e.g,.  Paunio et al, 2009; 
Peppard, Szklo-Coxe, Hla, & Young, 2006). The same limiations due to potential non-
linear relationships and the non-pathologicaly skewed sample outlined above also apply 
to potential contributors to the null-findings within the proposed model.
Relating Findings to Theory and Clinical Use
The model described by van der Helm and Walker (2009) that suggests disturbed 
sleep causes cognitive-affective processing dysfunction, which leads to the onset and 
maintenance of mood disorders, received mixed support from the findings of this study. 
Due to the cross-sectional nature of this study's methodology, true causal features of the 
van der Helm and Walker (2009) model cannot be commented on. However, the extent 
and pattern of relationships demonstrated in this study is not mutually exclusive with the 
overall conceptualization of a causal sleep, cognitive-affecitve processing bias, and 
depression model. Valence-biased information processing within the CAVLT related to 
sleep physiological indicators and mood measures, as we expected. However, the 
unexpected failure to find a significant relationship between sleep physiology and 
depression broke down the prospective pathway model for our sample. In an effort to 
explore a potential alternative model, subjective sleep quality was substituted in place of 
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objective sleep physiological indicators. However, while this model demonstrated the 
appropriate predictor to DV relationship, the CAP valence bias pathways broke down. 
The mean comparisons between OSA severity groups suggests that detectable 
neuropsychopathology may be limited to the severe OSA group, which suggests that 
clinical consideration of the model should not be thrown out at this point – rather, a more 
complex model may be better suited.
Thus, an alternative approach was explored in order to determine whether the 
constructs could be related to each other in a different manner. Hierarchical regression 
demonstrated that REM AHI, hypoxia, and depressive symptoms were unique predictors 
of the valence bias on delayed recall tasks of the CAVLT. Null findings resulted from 
adding the depression symptoms inventory (CESD) to the previous ANCOVA analyses 
for CAVLT valence bias in the form of an additional covariate, as well as a dichotomous 
IV. This further supported the lack of interaction between AHI and depressed mood in 
our sample. However, the initial investigation of correlations amongst the constructs did 
find a small correlation between negative affect and non-AHI indicators (i.e., REM-AHI 
and sleep efficiency). So, while we failed to confirm a proposed model with our sample 
(see Figure 3), these findings allow some crude alternative modeling specific to this 
sample (Figure 5). Interpreting these results cautiously, we first must consider the 
possibility that the lack of relationship between AHI and depressed mood is an aberration
within the sample, for reasons outlined previously (i.e., severity distribution). An 
alternative, though not mutually exclusive, consideration is that the model is actually 
nested within a more complex framework of related constructs. Figure 5 is an example 
that fits the data collected within our sample. Of note, there is an indirect relationship 
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between AHI and Depressed Mood via related constructs, though the direct relationship 
hypothesized was not found. In this sense, while the study could not offer strong support 
for the proposed model, it instead might be seen as providing methodologically useful 
information (i.e., alternative variables to focus on within the mood and sleep physiology 
constructs) in future investigations of CAP functioning/mediation in the same or different
patient populations (expanded upon below). Furthermore, as the data collected for this 
study was cross-sectional, Figure 5 does not imply unidirectional/causal relationships; 
use of longitudinal methodologies in future research would add clarity in that aspect.
Figure 5. Rough Diagram of Alternative to Proposed Model
Note: original model constructs included are bold
 
From a clinical practice perspective, the findings provide variable confirmation of
the neuropsychological impacts of OSA. However, the findings are significantly limited 
in the applicability to individual patients, both due to effect size and variable intra-
construct patterns. While there was correlational evidence connecting disordered sleep 
and cognitive decrements, OSA severity groups were not detectably different at a group 
level. This finding suggests that while overall functioning and quality of life issues may 
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be clinically relevant to the neuropsychological case conceptualization of a patient with 
untreated OSA, only a small amount of variance within a patient's neurocognitive 
performance on memory or verbal fluency tasks might be attributable to severity of OSA 
(though as mentioned previously, within severe OSA groups, these differences may be 
larger and more reliable). Of note, a number of cognitive-affective processing 
performance submeasures were significantly different across OSA severity categories 
(e.g., CAVLT Learning and Long Delay Recall trials). This was in addition to CAP 
valence bias existing independent of production (i.e., the Valence Factors for the CAVLT
submeasures). Thus, the neuropsychological test paradigm was supported as a means of 
detecting neurocognitive (affective) disturbance secondary to sleep physiology 
pathology. 
However, from a single-patient perspective, the CAVLT production and valence 
score differences had effect sizes that were still far below a level that might be useful for 
detecting a recognizable and reliable OSA profile pattern (see Zakzanis, 2001). While 
explaining depressive presentation due to untreated OSA was not supported by our 
findings, polysomnogram indicators were significantly related to related the PANAS 
affect constructs, supporting continued clinical attention to the interaction of sleep quality
and emotional experience. In that context, it may be that the CESD was not capturing the 
potential affective or mood changes related to any negative bias in the processing of 
emotional information in the world (or on the cognitive-affective processing measures in 
the lab/clinic). For instance, a construct such as pessimism could feasibly be a result of 
negative bias in processing, which is a psychological construct intricately related to 
clinical depression (Abramson, Metalsky, & Alloy, 1989). Alternatively, the study’s 
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premise that an OSA population would be ideal to test the CAP-mediated model may be 
flawed. Picking a mood or neurological population to run through polysomnograph and 
neuropsychological evaluation would have been more ideal, though would have 
significantly higher costs associated with dozens of non-clinically indicated sleep studies.
The pattern of cognitive and cognitive-affective processing performance across 
severity groups is notable for an apparent cliff or threshold for the OSA severity. Rather 
than a dose-effect pattern (i.e., progressive deficits across mild, moderate, and severe 
groups), our data suggests that a tipping-point is reached with regard to neurocognitive 
functioning for the severe OSA group. Two possible explanations for the abrupt 
detectability of neurocognitive changes are 1) the pattern reflects a required “minimum” 
level of sleep-disordered breathing pathology being met, after which neurocognitive 
functions begin to change and/or, 2) the pattern reflects a breaking point for the brain, 
which has been compensating for the progressive pathological load by recruiting 
additional neurocognitive (and perhaps neurophysiological) resources. Neuroimaging 
research into the apparent normal cognitive performance within mild traumatic brain 
injury and aging populations provides support for the latter explanation (e.g., Park & 
Reuter-Lorenz, 2009; Maruishi, Miyatani, Nakao & Muranaka, 2007).
Finally, the findings provide intiail support for a measure (the CAVLT) that has 
promising clinical utility from a neuropsychological perspective. For instance, with 
regard to mood disorders and posttraumatic stress disorder, the ability to quantify one 
potential underlying etiology or exacerbating facotr (negative CAP), might help with 
differential diagnosis and assessment of prodromal information processing changes. 
Treatment-response prediction would also be served, if additional research does indeed 
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identify subgroups of sleep disordered patients who are suffering negative CAP and thus 
potentially at risk for depression. These individuals might be referred to sleep 
interventions prior to antidepressant therapies. Finally, within neuriological and 
rehabilitation settings, evaluation of communication style deficits would be vauable 
within the sub-acute rehabilitation setting and for family/vocational recommendations 
during disposition planning.
Relating Findings to Research Utility
If research on the intersect between cognition and affect (i.e., cognitive-affective 
processing, or, the processing of emotionally-valenced information) is to be integrated 
more successfully into the clinical domain, the measures produced should be crafted with 
consideration of research methodology. Specifically, the research must build upon past 
approaches, fill in missing elements in present literature, and advance novel 
methodologies. This dissertation provided advancements in each of these areas, though 
the limitations subsequently discussed leave room for a number of future research 
directions. One important research consideration was made clear from the variety of 
polysomnogram indicators involved in identifying significant cognitive/depressive 
differences. Neuropsychological research with OSA samples should avoid dependency on
only one indicator of sleep disturbance severity, due to the multiple parallel pathological 
and disruptive influences sleep-disordered breathing creates (e.g., hypoxia, sleep 
architecture disturbance, reduced total sleep time). 
Memory measures for words with affective-valence or emotional qualities exist in
the research, but are typically created solely for use within the research group's study or 
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studies (i.e., as a means of operationalizing affective bias in information processing), and 
not intended for clinical  use. In effect, this kind of research demonstrates the impact of 
various independent variables or manipulations on memory processes for affectively-
valenced stimuli, but does not go the extra step of suggesting an optimal methodology to 
use in measuring affective-memory construct going forward. Only two existing studies 
assembled affective word memory tests with the goal of wider use in research and clinic 
(i.e., Affective Auditory Verbal List test, AAVL; Snyder & Harrison, 1997; Emotion 
Verbal Learning Test, EVLT; Strauss & Allen, 2013). Both measures offer excellent 
advancement in affective-memory research, but we argue the CAVLT construction is 
better suited for a number of reasons. 
The AAVL was designed with a list-learning paradigm paralleling Rey's Auditory
Verbal Learning Test (RAVLT; Rey, 1964). Specifically, the protocol is nearly the same 
as the CVLT-2 or CAVLT, but uses 15 words that do not relate semantically into 
categories. Two lists were developed, using high familiarity words of high or low 
pleasantness ratings. The researchers estimated the RAVL words to represent an equally 
familiar, but neutral set of words. The EVLT design mirrors that of the CVLT-2 more 
closely, utilizing emotional categories. The CAVLT offers advantages compared to both 
of these alternative measures from a methodological standpoint, thereby allowing for 
future research to better explore the mechanisms of affective-memory. For instance, the 
AAVL forms are categorically positive or negative, requiring both to be administered to 
evaluate cognitive-affective processing functioning across the full valence spectrum. The 
CAVLT incorporates the full valence spectrum into the word-list, allowing for internal 
comparisons. Additionally, the AAVL is methodologically analogous to a list-learning 
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paradigm that does not allow for as many memory subprocesses to be evaluated and 
compared. Specifically, the categorical approach that the CAVLT use, taken from the 
CVLT-2, allows for evaluation of cued recall and category-comparisons. While the 
EVLT also uses this category approach, it sacrifices co-evaluation of neutral stimuli in 
exchange for more specific emotion categories (i.e., happy/sad/anger/anxiety vs. 
positive/negative in the CAVLT). The CAVLT neutral word categories allow for 
comparison of emotion versus non-emotion word recall. The splitting of the non-emotion 
word categories into abstract and concrete categories allows for control of any linguistic 
processing factors that may be underlying difference in the emotion word memory (i.e,. 
concreteness of the words). Finally, while the EVLT construction did ensure that word 
length, frequency, and emotional intensity were equivalent amongst the categories, it 
does not ensure equivalence between CVLT-2 words and the chosen emotion words. The 
CAVLT's word selection allows interpretation of performance differences to be more 
attributed to the cognitive-affective processing differences, rather than methodological 
differences, a strength in future cognitive-affective processing research conducted with 
populations where CVLT-2 data has been widely collected.
The EWFT has narrow use in the literature thus far (e.g., Abeare et al., 2009; 
Freund & Abeare, unpublished dissertation; Abeare et al., unpublished manuscript). The 
counterpart measures (FAS, Animals) are widely used in research, for both their ease of 
administration and sensitivity to neurocognitive dysfunction (for review, see Tombaugh, 
Kozak, & Rees, 1999). As there are no direct alternatives to the EWFT in the research, 
the argument we make for future use of the EWFT in research is based upon proposed 
incremental validity beyond standard verbal fluency measures. The only significant 
114
results related to any of these measures in the present study were correlative, higher sleep
efficiency was positively related to emotional word production and hypoxia was related 
to lower animal word fluency. No significant findings resulted from the phonemic 
fluency measure. The relative lack of findings limits the production of new arguments for
inclusion of the EWFT in future research, above and beyond inclusion of cognitive-
affective processing measures within batteries in general, and argument outlined in the 
introduction of this manuscript. However, we can support the notion that the EWFT may 
be tapping overlapping neurocognitive systems that any semantic/category fluency 
measure captures. Whether the inclusion of an affective process within the paradigm is 
differentially impacted (compared to neutral category fluency) is not yet clear. 
One promising finding was the valence factor differences found within the 
CAVLT when deeper analysis of production was analyzed. In order to conduct a similar 
level of analysis, Abeare and colleagues are currently producing a scoring system that 
would allow for analysis of various affective-linguistic characteristics of the words 
produced during an EWFT trial. Based on that finding, as well as research indicating that 
poor sleep leads to less inhibition of negative information (e.g., Anderson & Platten, 
2011), we expect to find an overall negative bias in the affective-valence of the words 
produced by those with more severe OSA, despite no quantitative production differences.
Applications of that scoring system to the content of this study's data (and future 
research) should allow for capturing more subtle differences in affective-word fluency 
that might be significantly related to constructs of clinical and research interest.
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Limitations and Future Direction of Research
A number of factors should be discussed in the context of limiting the 
interpretations and conclusions of the present study to appropriate bounds. The sample's 
demographics were determined through the clinical referral process, and therefore 
mirrored the OSA patient population's heterogenous nature with regard to age. While age 
was controlled for during analyses, in the context of a sample size that just met power-
estimates requirements, the age-distribution could reflect other age-related factors that 
might influence neuropsychological factors that were not controlled for (e.g., chronic 
medical conditions, pain, vulnerability to circadian changes). Additionally, the 
homogenous ethnicity of our sample (i.e., 58 of 61 participants were white) does not 
reflect the epidemiological incidence rate of OSA.  In fact, Blacks and Hispanics in North
America have a higher risk for OSA than whites, though this is thought to reflect 
socioeconomic status and access to healthcare, the latter being related to higher incidents 
of obesity and other comorbid medical conditions related to OSA risk (Punjabi, 2008; 
Ralls & Grigg-Damberger, 2012).  The ethnic makeup of our sample suggests a sampling 
bias within the referrals to the sleep clinic, or, more likely, within those agreeing to 
participate in the study. 
Related to the sample's demographics, was the fact that normative transformations
could not be made with the novel measures at this point in their development. Under ideal
circumstances, both raw and normative score comparisons would be explored due to the 
novel nature of many of the hypotheses, thus reducing type II error. As noted above, 
while valence analysis was possible for the CAVLT, the necessary scoring system was 
not yet available for the EWFT (though is nearing completed development in this author's
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associated lab). This limited the interpretations related to affective-word fluency within 
the sample to a shallower level (i.e., raw production). Finally, the limited and weak 
correlations between physiological sleep disturbance and depressive symptomatology in 
this sample was a barrier to fully exploring the model hypothesized (per van der Helm & 
Walker, 2009). While the use of sleep disorder patients was advantageous for certain 
constructs (e.g., naturalistic sleep disturbance, easy access to polysomnogram data), the 
narrow and suppressed depression severity likely limited our ability to fully investigate 
variance mediated by CAP valence bias. Finally, while analyses were based on a priori 
directional hypotheses, and we did use multivariate variance analysis prior to 
comparisons, the exploratory analyses must be interpreted cautiously . Our findings must 
therefore be taken as suggestive of potential patterns and rather than absolutes. In 
contrast, our negative findings for a few of the replicative hypotheses (e.g., 
polysomnogram and depression) are more notable and the impressions related to them 
deserve stronger consideration, given the liberal significance approach selected.
The results of this study, as well as continued work within the associated lab, 
allow for a number of concrete proposals for future research to be presented, falling into 
two broad categories. First, regarding cognitive-affective processing measures and 
psychometrics, normative data is currently being collected for the CAVLT and 
EWFT(along with the other non-discussed CAP measures included in the battery).  A 
CAP battery is currently being administered to student volunteers at the University (by 
this authors associated lab), and will be a first step toward allowing normative 
comparisons. Additionally, ongoing development of the EWFT linguistic-affective 
scoring protocol will allow for the norms to include valence factors and other affective-
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process indicators that might be of use in model development/evaluation and clinical 
practice. Secondly, from a model and theoretical standpoint, additional research should 
improve upon this study's methodology to better explore a cognitive-affective processing 
mediated model for the sleep-mood disorder relationship. This might include using 
known psychiatric groups (e.g., depression, anxiety, PTSD) and acquired brain injury 
groups (e.g., TBI, right-hemisphere stroke, neurodegenerative disorders), which would 
provide a much deeper and broader set of affective dysregulation. These populations also 
are likely to have comorbid sleep disturbance, which would facilitate investigation into 
the discussed model. Alternatively, a more severe sleep disorder sample might result in a 
similar depth of mood disorder symptomatology to allow exploration of the model. 
Further integration of physiological measures, and inclusion of functional 
imaging/mapping, would allow for exploration of how our cognitive-affective processing 
measures differ at a neural network level from other standard counterparts. This would 
provide information that could guide future hypotheses about types of conditions and 
injuries that might have clinical/functional decrements associated with as-of-yet 
unquantified biases in their processing of affective stimuli. This author's associated lab 
recently acquired simultaneous EEG - near infrared spectroscopy, which will be 
incorporated in future studies, to facilitate pursuit in these directions. For example, using 
this functional imaging technology with healthy groups during norm collection could 
provide neuroanatomical convergent validity data, if CAP-related areas of the brain are 
recruited during CAVLT versus CVLT performance. Follow-up investigation of 
compensatory hypotheses as applied to concussion, sleep-deprivation, and normal aging 
populations would similarly lednt themselves to the concurrent imaging research 
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methodology.  Finally, exploring what ecological and/or psychosocial functioning 
constructs are associated with the cognitive-affective processing measures would 
reinforce the importance of exploring the proposed model and provide guidance in further
hypothesis generation. 
Conclusions
In this study, novel measures of cognitive-affective processing (memory and word
fluency) were constructed and administered to patients with obstructive sleep apnea, 
along with standard neurocognitive measures of memory and word fluency, self-reported 
sleep quality, and self-reported mood. The polysomnogram (sleep physiology) data of 
each patient was obtained, and all constructs analyzed, in hopes of validating the new 
cognitive-affective processing (CAP) measures and evaluating the applicability of a 
CAP-mediated relationship between sleep and depression. Mixed findings suggested that 
cognitive-affective processing was related to both sleep physiology and depression, but 
unexpected null findings between sleep and mood impeded the evaluation of a pathway 
model. Exploratory analyses suggest there may be a more complex model relating the 
three constructs of interest, incorporating multiple sleep physiological indicators (e.g., 
REM sleep pathology, hypoxia, disturbed sleep architecture) and emotional constructs 
beyond just depression (i.e., positive and negative affect). 
Of additional interest, cognitive-affective processing differences between OSA 
severity groups were broader and more significant than those detected for standard 
neurocognitive measures, suggesting potential better sensitivity toward dysfunction 
secondary to sleep-disordered breathing. Dysfunction across constructs was 
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predominately found in the severe OSA group, suggesting that a threshold-model (rather 
than dose-dependent model) of OSA pathology might best explain neuropsychological 
pathological expression. This hypothesis suggests that mild and moderate OSA 
populations might be eligible targets for neuro-compensation research already being 
conducted in mild TBI and ageing populations. 
Additionally, this study provides initial support for a neuropsychological measure 
of how humans process emotionally-laden information. The measure has significant 
potential for use in research, specifically in exploring whether biases in processing 
certain valenced emotional information contributes to the onset or maintenance of mood 
and personality disorders. Clinical application will follow advances in the research. 
Incorporation of the new measures into practice will ideally allow neuropsychologists to 
improve differentials, treatment-response prediction, and functional coping 
recommendations. The goals of future research will be to generate normative data and 
expand the psychometrics of the CAP measures produced by this author and his 
supervisor. In addition, the biased cognitive-affective processing model of negative mood
will be evaluated within psychiatric and neurological samples. Integration of functional 
imaging in both research directions will further elucidate the mechanisms underpinning 
normal and dysfunctional cognitive-affective processing. 
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Appendix A: Additional Sleep Physiology Information
Sleep
Sleep Stages and Characteristics
Sleep in mammalian species has been generally categorized into two separate types - 
rapid eye movement (REM) sleep, and non-rapid eye movement (NREM) sleep, which 
has predominently been further subdivided in primates into four, progressively deeper, 
stages (Rechtschaffen & Kales, 1968). Research in human sleep patterns has identified a 
90 minute alternating, ultraradian cycle between NREM and REM sleep. The length of 
this cycle generally does not change throughout a normal sleep session, however, the 
ratio of NREM to REM sleep shifts from predominantly stage 3 and 4 NREM sleep early 
in the sleep session to stage 2 NREM and REM sleep in the latter half of the sleep 
session. Thus far, the purpose or principal behind this sleep-type organization is not well 
understood (Walker, 2009).  
More recently, NREM sleep stages have undergone a terminology transition; the 
American Academy of Sleep Medicine (2007) concluded that there no significant 
physiological or clinical differentiation existed for NREM stage 3 and stage 4 sleep, thus 
they were combined into a final NREM sleep stage termed N3. The original NREM stage
1 and stage 2 sleep terms were altered to N1 and N2, respectively. In this review, the new
terminology will be used, unless otherwise noted.
Electroencephalographic & Associated Physiological Characteristics
Progression through sleep stages usually is tracked using electroencephalographic (EEG) 
activity and patterns, with progression through NREM sleep being associated with a 
slowing of brain wave frequency. The most recent scoring manual of the AASM (2007) 
provides classification guidelines in part based upon EEG phenomena, as well as certain 
physiological activity. During alert wakefulness, desynchronized beta waves (12-30 Hz) 
with a high mixture of frequencies dominate EEG readings. In stage N1, the brain 
transitions from alpha waves (8-12 Hz; associated with relaxed wakefulness with closed 
eyes) to theta waves (4-7 Hz). This stage is characterized as a state of 
drowsiness/somnolence and is associated with hypnic jerks (also known as positive 
myoclonus), and some loss in conscious environmental awareness and muscle tone. If 
aroused during this stage, most individuals will report having been fully awake. Stage N2
(see Figure 2*inset sleep graph of spindles & k-complexes) is characterized by EEG 
waves in the 11-16 Hz range (12-14 Hz is most common). Sleep spindles, brief bursts of 
activity, occur during this stage, and are thought to represent the brain inhibiting 
processing and response to external stimuli in order to maintain a tranquil state (Dang-
Vu, McKinney, Buxton, Solet, & Ellenbogen, 2010). K-complexes are also present, 
which are thought to represent a brief evaluation of how dangerous external stimuli are 
before an inhibition of cortical arousal (Cash, Halgren, Dehghani, Rossetti, Thesen, 
Wang, et al., 2009). Roughly 50 percent of a normal sleep session is spent in N2 sleep 
(NIH, 2007). Reports of dreaming during N1 and N2 sleep is rare (AASM, 2007).
The AASM (2007) characterizes stage N3 (formerly stages 3 and 4) as the deepest
stage of sleep, and is often referred to as slow-wave sleep (SWS) due to the occurrence of
low frequency brain waves (0-4 Hz), with a minimum of 20% activity being delta waves 
(.5-2 Hz). Delta waves begin emerging at the onset of N3, eventually dominating the 
EEG. During delta wave sleep, global inhibition of neurons occurs via the release of 
gamma-aminobutyric acid (GABA), which will be discussed further in the neurobiology 
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section (Hobson & Pace-Schott, 2002). The global slowing represents a mass cortical 
synchronization (Steriade & Amzica, 1998), which is thought to represent an 
organizational processing related to daytime cognition and will be discussed later. N3 
sleep is often when parasomnias (e.g., night terrors, somniloquy, sleepwalking, nocturnal 
enuresis) occur. Though dreaming was previously thought not to occur during any stage 
of NREM sleep, recent research has suggested that more disconnected, and less vivid and
memorable dreams can occur during this stage (McNamara, McLaren, & Durso, 2007).
A shift in frequency occurs during REM sleep, with a reemergence of theta waves
(4-7 Hz) along with the occurrence of high frequency gamma waves (30-80 Hz) that 
demonstrate synchronic activity (Llinas & Ribary, 1993). Another defining phenomena of
REM sleep is the presence of bursts of rapid eye movement in rhythm with phasic 
endogenous waveforms. The waveforms primarily occur in the pons, lateral geniculate 
nuclei of the thalamus, and the occipital cortex, and thus are sometimes referred to as 
PGO waves (Callaway, Lydic, Baghdoyan, & Hobson, 1987). A typical sleep session will
have REM sleep make up 20-25% (90-120 minutes) of sleep time, over the course of 4-5 
progressively longer REM periods. A period of light sleep or brief arousal often occurs 
following a period of REM. Vivid and easily recalled dreams occur during this stage of 
sleep. During periods of REM sleep an increase in the variability of breathing rate, heart 
rate, and temperature occurs, along with increased blood flow and engorgement in the 
genitals (AASM, 2007). Descending muscle atonia also occurs, which has been 
hypothesized to be a protective process designed to prevent acting out dream sequences 
(Mahowald & Schenck, 2009). Thus, failure of this process is thought to be the cause of 
REM behavior disorder (Schenck & Mahowald, 2002). 
Neurochemical Characteristics
Wakefulness is associated with ascending, efferent projections from the reticular 
activating system, located in the brainstem. These ascending projections arrive in the 
hypothalamus, thalamus, and basal forebrain, which eventually continue to the cortex. 
The neurotransmitters associated with the reticular formation include the catecholemines,
histamine, acetycholine, asparate, and glutamate. Behavioral consequences like increased
arousal after use of amphetamines and somnolence after use of anti-histamines primarily 
impact this system.
As an individual progresses through the different stages of sleep, dramatic 
changes occur to the neurochemical makeup of the brain. Saper, Chou, and Scammell 
(2001) offered a review that concluded the sleep-wake cycle is regulated by a 
reciprocally inhibitory sleep/wake switch made up of the ventrolateral preoptic nucleus 
(activated during sleep; GABA-ergic and galanergic) and the posterior lateral 
hypothalamus (activated during arousal and wakefulness maintenance; consists of orexin 
and hypocretin neurons). During NREM sleep GABAergic neurons in the cortex, 
thalamus, hypothalamus, and brain are at their highest activation. An increase of 
intracerebroventricular adenosine levels has also been associated with increased NREM 
sleep time (Rosenthal, 1998). Different studies of NREM sleep have found a decrease in 
the activity of subcortical cholinergic systems found in the forebrain and brainstem 
(Hobson, McCarley, & Wyzinski, 1975; Lydi & Baghdoyan, 1988). Additionally, 
compared to wakeful activation levels, the noradrenergic locus coeruleus neurons and 
serotonergic Raphe neurons have decreased firing rates (Aston-Jones & Bloom, 1981; 
Shima, Nakahama, & Yamamoto, 1986). 
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The acetycholinergic neurons in the pontine tegmentum (specifically, the 
medullary reticular and lateral pontine areas) have been termed "REM on cells," and 
innervate hypothalamus, hippocampus, and thalamus. Rising levels of physostigmine (a 
catabolic enzyme inhibitor) during NREM precipitate the initiation of REM sleep. 
Additionally, research has demonstrated that introducing carbochal (a muscarinic agonist)
to REM on cells causes REM sleep to occur (Rosenthal, 1998). During REM sleep, both 
of the previously mentioned aminergic centers are significantly inhibited and the 
cholinergic systems become as (or more) activated as wakeful levels. This results in a 
neurochemical environment dominated by acetylcholine with little, if any, amingergic 
modulation (Kametani & Kawamura, 1990; Marrosu, Portas, Mascia, Casu, Fa, 
Giagheddu, et al., 1995). The Raphe and locus coeruleus contain serotonergic and 
noradrenergic cells that have been labeled "REM off cells," which are completely or 
largely inactive during REM sleep, with higher degrees of activation during NREM and 
wakeful periods (Rosenthal, 1998). The finding that serotonin and norepinepherine levels
impact REM sleep is supported by research demonstrating that anti-depressants that 
increase these two neurotransmitters decrease the percentage of REM sleep individuals 
experience, and that this decrease is proportional to the effectiveness of the drug (Benca, 
Obermeyer, Thisted, & Gillin, 1991; Vogel, Thurmund, Gibbons, Sloan, Boyd, & 
Walker, 1975).
Functional Anatomical Characteristics
NREM and REM sleep have been found to have distinctly different functional anatomy 
patterns, across a variety of neuroimaging techniques. Generally speaking, reduced 
activity in the prefrontal and temporal lobes, basal ganglia, thalamus, and brainstem 
occurs during NREM (specifically, stage N3). In contrast, REM sleep is associated with 
elevated activity in the mediobasal prefrontal lobes, occipital cortex, thalamic nuclei, and 
pontine tegmentum. Additionally, affect-related areas like the anterior cigulate cortex, 
amygdala, and hippocampus are activated. Conversely, the posterior cigulate, parietal 
cortex, and dorsolateral prefrontal cortex are the least activated during REM sleep 
(Nofzinger, 2005).
Sleep-Wake Cycle
Three separate yet networked neuroanatomical systems regulate the sleep-wake cycle in 
humans (Borbely & Achermann, 1999; Pace-Schott & Hobson, 2002). A homeostatic 
regulation system is responsible for intensity, length, and quantity of sleep. The cyclical 
vacillation between REM and NREM sleep within each sleep period is controlled by an 
ultradian system. Finally, a circadian system manages the timing of sleep and wake 
periods within the overall day-night cycle. Preoptic neural circuitry has been associated 
with the homeostatic functions, mesencephalic and pontine rostral brainstem areas with 
the REM/NREM regulation, and anterio-hypothalamic elements with circadian functions.
With the REM/NREM relationship discussed in detail previously, the present section will
focus on the remaining two drives, how the two drives interact to consolidate sleep, and 
finally, the current conceptualization of how the switch between sleep and wake occurs.
Homeostatic Regulation
There exists no exact understanding of the physiological processes responsible for the 
sleep drive that humans (and all mammals) experience, it is currently conceptualized as a 
homeostatic pressure that accrues during wakefulness and dissipates during sleep periods.
This propensity for sleep can be thought of as how much an individual is in need of sleep 
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to regain homeostatic balance. The power of delta EEG waves (mentioned previously) 
have been demonstrated as a marker for the degree of homeostatic pressure (Fuller, 
Gooley, & Saper, 2012). While no cellular substrate for the process has thus been 
identified, adenosine has been identified as a molecular-level somnogen at the cellular 
level. During wakeful periods, it is hypothesized to naturally accumulate to levels that 
impact sleep/wake related areas of the brain. This nucleoside has an activating effect on 
VLPO neurons bordering the basal forebrain and an  inhibitory effect on wake-promoting
areas of the basal forebrain (Porkka-Heiskanen, Strecker, Thakkar, Bjorkum, Greene, & 
McCarley, 1997). Thus, during wakeful accumulation of adenosine, a drive towards sleep
accrues. 
Consistent with this model, research has demonstrated that blood serum levels of 
adenosine rise during extended periods of wakefulness, decrease during sleep, that 
adenosine agonists promote sleepiness when injected intraventricularly, and that 
adenosine antagonists (e.g., the commonly known substance caffeine) increase 
wakefulness and decrease sleepiness when introduced near the VLPO (Porkka-
Heiskanen, Alanko, Kalinchuk, & Stenberg, 2002). At the same time, the cellular basis 
for homeostatic pressure to sleep has not been identified, as recent research pointing out 
that accumulation of adenosine in the basal forebrain is not required for sleep propensity 
(Blanco-Centurion, Xu, Murillo-Rodriguez, Gerashchenko, Shiromani, Salin-Pascual, 
Hof, & Shiromani, 2006). 
Circadian Regulation
Reactive homeostatic drives are useful for restoring physiological equilibrium. However, 
there exists another regulatory process, termed the circadian timing system, that provides 
temporal organization of most biochemical, physiological, and neurobehavioral 
processes. The advantage of temporal organization, as opposed to homeostatic reaction, is
its predictive and anticipatory nature (Moore-Ede, Sulzman, & Fuller, 1982). For 
example, prior to waking, the circadian timing system (CTS) cues processes that will be 
advantageous to the wakeful state (e.g., increased sympathetic autonomic activity, rise in 
body temperature, increased circulating cortisol levels). 
The CTS is comprised of three components, the central of which is the 
suprachismatic nucleus (SCN) of the anterior hypothalamus, which acts as a circadian 
pacemaker - coordinating circadian oscillator subcomponents via control over melatonin 
secretion by the pineal gland (Rossenwasser & Turek, 2005). The SCN is responsible for 
establishing the sleep-wake circadian rhythm. Support for SCN regulation of the 24.2 
hour sleep-wake cycle has been demonstrated via continuation of the cycle in the absence
of temporal environmental cues, but only when the nucleus is intact (Mistlberger, 2005).  
The SCN is entrained (i.e. synchronized) via physiological and environmental signals, 
these include the retinohypothalamic tract (responsive to light-dark cycles), 
geniculohypothalamic tract (secondary light-dark cycle entrainment, with a moderating 
effect rather than direct influence), mesencephalic raphe nuclei (seratonergic modulation 
of photic inputs and mediation of behavioral activity-states), and other neurochemical-
specific afferent tracts (histaminergic projections from the hypothalamus, cholinergic 
projections from basal forebrain and pontine tegmentum, and noradrenergic projections 
from the brainstem) (Bina, Rusak, & Semba, 1993; Moga & Moore, 1997; Morin & 
Allen, 2006; Morin & Pace, 2002; Stephan & Zucker, 1972; Wada, Inagaki, Itowi, & 
Yamatodani, 1991). The subcomponent circadian-oscillators in peripheral tissues are in 
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turn entrained by physiological signals from the pacemaker component. Peripheral 
circadian oscillators are understood to also contain endogenous, cellular-level pacemaker 
"clock cells," independent of the circadian system as a whole (Herzog, 2007). The SCN is
thus thought to entrain the various peripheral cellular oscillators rather than sustain their 
rhythmic activity (Okamura, 2004). Finally, the third component of the CTS are the 
efferent projections that serve to regulate otherwise non-rhythmic physiological and 
behavioral systems (e.g., body temperature, autonomic/endocrine systems, feeding, 
sleep/wake state, locomotor activity). Most SCN efferent projections reach regions of the 
thalamus, basal forebrain, preoptic area, and hypothalamus (Morin & Allen, 2006). 
Current understanding of the circadian system posits that it promotes both wakefulness 
and sleep - at opposite phases (Mistlberger, 2005).
Sleep-Wake "Switch"
Saper, Chou, and Scammell (2001) reviewed recent literature on sleep regulation and 
identified a substantial amount of evidence that a reciprocal inhibition model of sleep and
arousal systems exists. GABAergic and galaninergic neurons of the ventrolateral preoptic
nucleus (VLPO) are active and necessary for normal sleep. In contrast, hypocretin/orexin 
(exchangeable names) neurons within the posterior lateral hypothalamus (PLHT) are 
necessary for maintaining normal wakefulness. These two systems are thought to exist in 
a sustained state of balanced reciprocal inhibition (a bistable feedback loop) when not 
influenced from external pressures. Once either of the systems is excited, it inhibits the 
other, thereby resulting in further excitation due to decreased inhibitory afferents from its 
partner. 
This neuroanatomical equivalent of a "flip-flop" circuit has the advantage of 
resulting in two potential firing patterns and an avoidance of an intermediary state. The 
result is a behaviorally stable wakeful or sleep state, with switches occurring rapidly and 
therefore transition periods being brief. Additionally, the self-reinforcing characteristic 
means the wakeful/sleep states are relatively resistant to switching due to normal 
projection fluctuations occurring over the day and night. Instead, the switch can only be 
"flipped" by the large, accumulating, physiological pressure from homeostatic and 
circadian inputs. Dysfunction of either system decreases the balance of the switch, 
lowering the threshold for one behavioral state to be initiated and raising the needed 
pressure to "flip" the switch to the other. To summarize the effects of both the individual 
wakeful/sleep systems, and their reciprocal relationship, let us consider a lesion to the 
VLPO. This would result in decreased sleep-encouraging projections, more wakefulness, 
and therefore increased homeostatic pressure for sleep on the flip-flop circuit. This results
in the circuit nearing its switch-point more often, and more episodes of falling asleep, 
however, due to the self-reinforcing characteristic of the switch having been weakened, 
this sleep-state is interrupted more often. The overall result being shortened periods of 
wakefulness and sleep, switching more frequently.
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Appendix B: Demographics
DATE: ____________________
TIME:________________________
Please provide the following information. You are not obligated to answer questions that 
you do not feel comfortable answering. 
1) Gender: __Female __Male
__Other:__________________________________
2) Age: ______
3) Country of birth:  _____________________________________________________
Length of residence in Canada:  _______________
4) Ethnicity:
__ Caucasian/White __ African-Canadian/Black __ Asian/Southeast Asian
__Hispanic __ First Nation/Indigenous __ Arabic
__ Other: 
5) First language:  _______________
Other languages spoken:  
If English is 2nd language, at what age did you begin speaking it? 
6) Highest grade completed in high school: _____
If you attended school after high school was it a (check all that apply):
__Technical or Vocational School?
__ College or University?
How many years of education did you complete after high school? _______
7) History of military service? 
 __ No     
__ Yes; please specify length of service, and if you were deployed in combat:  
__________________________________________________________________
8) What is your current occupation, if you are retired, what was your primary occupation 
before you retired? 
_______________________________________________________________________
_______________________________________________________________________
__
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9) Approximately what was the total combined income of all members of this family in 
2011? 
___  0 - $10,000
__  $10,001 - $15,000
__  $15,001 - $20,000
__  $20,001 - $30,000
__  $30,001 - $40,000
__  $40,001 - $50,000
__  $50,001 - $75,000
__  $75,001 or more
10) List of current medications (if you cannot remember the name, please describe what 
the medication looks like and what reason it is being taken):  
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
____
11) Have you ever been assessed, diagnosed, and/or treated for a psychological disorder 
(e.g., Attention-deficit hyperactivity disorder, Depression, Anxiety, Bipolar Disorder, 
Schizophrenia, etc.)?
 
__ No     
 __ Yes; please specify disorder/s, and whether you currently use or in the past 
used medication to treat the symptoms:  
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
12) Do you smoke tobacco products currently? 
__ Yes; specify type and amount per week: ____________________
__ No
If you smoked in the past, how much, for what period of time, and when did you 
quit?
___________________________
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13) Do you drink alcoholic beverages currently?
__ Yes; specify type and amount per week: ___________________
__ No     
If you drank in the past, how much, for what period of time, and when did you 
quit?
__________________________________________________________________
14) Do you use any other recreational drugs (e.g. cocaine, marijuana, heroin, etc.) 
currently?
__ Yes; specify type and amount per week: _________________
__ No     
If you used the past, how much, for what period of time, and when did you quit?
__________________________________________________________________
15) Have you ever suffered a hard hit to the head (sometimes called a concussion)?  
__ No     
__ Yes; How many instances (estimate if you need)?________
Did you lose consciousness? 
__ No
__ Yes, for how long? _______
 
16) Have you ever suffered from seizures or any other neurological conditions (e.g., 
cerebral-vascular accidents, strokes, traumatic brain injuries, etc.)?  
__ No     
__ Yes; please specify condition and the time period it occurred: 
__________________________________________________________________
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17) Do any of your blood relatives suffer from psychological disorders (e.g., Depression, 
Bipolar Disorder, Schizophrenia, etc.)?  
__ No     
__ Yes; please specify relation and disorder:
__________________________________________________________________
18) Do any of your blood relatives suffer from neurological disorders (e.g., Alzheimer's 
disease, Parkinson's disease, other dementias, etc.)?  
__ No     
__ Yes; please specify relation and disorder: 
__________________________________________________________________
19) Do you suffer from any sort of chronic pain?  
__ No     
__ Yes; please specify source of pain and whether it is controlled with 
medication: 
__________________________________________________________________
__________________________________________________________________
Are you in pain today? 
__ No     
__ Yes; please draw an X on the line below indicating the severity of pain 
you are in at this moment
|---------------------------------------------------------------------------------------------------------|
No Pain       Worst Pain 
Imaginable
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20) Are you diagnosed with any sleep-related disorder?  
__ No     
__ Yes; please specify type of disorder and when you were diagnosed: 
__________________________________________________________________
21) Approximately what month & year did you undergo a sleep study, also called a 
polysomnogram study? 
(This would have entailed you coming into a sleep lab, being hooked up to many wires, 
and monitored throughout the night)
Year: ____ Month: ____ Day (if you can recall): ____
22) How many hours of sleep did you get last night? ______ Hours
Was your sleep last night restful?  
__ Yes     
__ No; why? 
_______________________________________________________
23) How many times do you take a nap each week? _____ times per week
How many minutes do your naps usually last? _____ minutes
24) Do you have a Continuous Positive Airway Pressure (CPAP) device?
__ Yes
__ No; why not? (e.g., doctor never prescribed one; too expensive; it got lost; it 
broke, etc.)_________________________________________________________
25) Has your physician ever recommended you use a Continuous Positive Air Pressure 
(CPAP) device? 
__ No  
__ Yes; 
Please specify how long ago the CPAP was suggested/prescribed 
________
How often do you use your CPAP?
__ every night (7 nights per week)
__ most (5-6 nights per week) 
__ every other night (3-4 nights per week)
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__ infrequently (1-2 nights per week)
__  rarely to never (0-1 nights per week)
If you are currently using a CPAP, how many nights have you used it in 
the past week? 
____ nights (1-7)
If you do not use your CPAP every night, what stops you? Mark those 
descriptors that if improved, would result in you using your CPAP significantly more 
often. 
__ too uncomfortable __ too loud 
__ too embarrassing __ I forget to put it on before 
sleeping
__ I do not understand how to use it, I was not given enough 
instruction
__ I do not understand how to use it, I have forgotten the 
instructions I was given
26) How tall are you? __________ How much do you weigh? __________
27) List any cardio-vascular or metabolic disorders or diseases (e.g., diabetes, congestive 
heart disease, arthrosclerosis, history of heart attack, history of stroke)
_______________________________________________________________________
_______________________________________________________________________
__
28) List any respiratory disorders, diseases, or problems you have (e.g., asthma, Chronic 
Obstructive Pulmonary Disorder - COPD, chronic bronchitis, emphysema, etc.)
_______________________________________________________________________
_______________________________________________________________________ 
29) Do you exercise regularly?
__ No
__ Yes
How many days per week? __________ (1-7)
On days you do exercise, how long does your workout last on average? ________
What types of exercise do you use (check all that apply)?
__ Brisk walking __ Jogging/Running
__ Swimming __ Bicycling
__ Other cardio (e.g., jumping jacks, lunges, aerobics, stair-
climbing, etc.)
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__ Weight-lifting __ Other:_____________
30) Please place a check mark next to any of the below medical conditions that you have 
been diagnosed with:
__    Myocardial infarction 
(heart attack)
__    Congestive heart failure
__    Peripheral vascular disease 
(also known as peripheral arterial disease, peripheral artery occlusive disease) 
__    Cerebrovascular disease
__    Dementia
__    Chronic pulmonary disease
__    Connective tissue disease
__    Peptic ulcer disease
__    Mild liver disease (without portal hypertension, inlcudes chronic hepatitis)
__    Diabetes without end-organ damage (excludes diet-controlled alone)
__    Hemiplegia (one-sided paralysis of limbs/trunk of body)
__    Moderate or severe renal disease
__    Diabetes with end-organ damage (retinopathy, neuropathy, nephropathy, or brittle 
diabetes)
__    Tumor without metastasis (found within last 5 years)
__    Leukemia (acute or chronic)
__    Lymphoma
__    Moderate or severe liver disease
__    Metastatic solid tumor
__    AIDS (not just HIV positive)
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Appendix C: Pittsburgh Sleep-Quality Index (PSQI)
INSTRUCTIONS: 
The following questions relate to your usual sleep habits during the past month only. 
Your answers should indicate the most accurate reply for the majority of days and nights 
in the past month. Please answer all questions. 
1. During the past month, what time have you usually gone to bed at night? 
BED TIME ___________ 
2. During the past month, how long (in minutes) has it usually taken you to fall asleep 
each night? 
NUMBER OF MINUTES ___________ 
3. During the past month, what time have you usually gotten up in the morning? 
GETTING UP TIME ___________ 
4. During the past month, how many hours of actual sleep did you get at night? (This may
be 
different than the number of hours you spent in bed.) 
HOURS OF SLEEP PER NIGHT ___________ 
For each of the remaining questions, check the one best response. Please answer all 
questions. 
5. During the past month, how often have you had trouble sleeping because you . . . 
a) Cannot get to sleep within 30 minutes 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
b) Wake up in the middle of the night or early morning 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
c) Have to get up to use the bathroom 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
d) Cannot breathe comfortably 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
e) Cough or snore loudly 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
f) Feel too cold 
Not during the Less than Once or twice Three or more 
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past month_____ once a week_____ a week_____ times a week_____ 
g) Feel too hot 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
h) Had bad dreams 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
i) Have pain 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
j) Other reason(s), please describe__________________________________________ 
How often during the past month have you had trouble sleeping because of this? 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
6. 
During the past month, how would you rate your sleep quality overall? 
Very good _____Fairly good _____Fairly bad ___Very bad ___________ 
7. 
During the past month, how often have you taken medicine to help you sleep (prescribed 
or 
"over the counter")? 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
8. 
During the past month, how often have you had trouble staying awake while driving, 
eating 
meals, or engaging in social activity? 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
9. 
During the past month, how much of a problem has it been for you to keep up enough 
enthusiasm to get things done? 
No problem at all __________ 
Only a very slight problem __________ 
Somewhat of a problem __________ 
A very big problem __________ 
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10. Do you have a bed partner or room mate? 
No bed partner or room mate __________ 
Partner/room mate in other room __________ 
Partner in same room, but not same bed __________ 
Partner in same bed __________ 
If you have a room mate or bed partner, ask him/her how often in the past month you 
have had . . . 
a) Loud snoring 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
b) Long pauses between breaths while asleep 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
c) Legs twitching or jerking while you sleep 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
d) Episodes of disorientation or confusion during sleep 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
e) Other restlessness while you sleep; please 
describe__________________________________ 
Not during the Less than Once or twice Three or more 
past month_____ once a week_____ a week_____ times a week_____ 
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Appendix D: Epworth Sleepiness Scale (ESS)
How likely are you to doze off or fall asleep in the following situations, in contrast to 
feeling just tired? This refers to your usual way of life in recent times. Even if you have 
not done some of these things recently, try to work out how they would have affected 
you. Use the following scale to choose the most appropriate number for each situation.
0 = would never doze
1 = slight chance of dozing
2 = moderate chance of dozing
3 = high chance of dozing
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 Situation  Chance of Dozing
 Sitting and reading
 Watching TV
 Sitting, inactive, in a public place (e.g., a theater or a meeting)
 As a passenger in a car for an hour without a break
 Lying down to rest in the afternoon when circumstances permit
 Sitting and talking with someone
 Sitting quietly after a lunch without alcohol
 In a car, while stopped for a few minutes in traffic
 Total
 
Appendix E: Center for Epidemiological Studies Depression Scale (CES-D)
Below is a list of the ways you might have felt or behaved. Please tell me how often you 
have felt this way during the past week.
Rarely or
none of 
the time 
(less 
than 1 
day )
Some or a 
little of the
time (1-2 
days)
Occasionally
or a 
moderate 
amount of 
time (3-4 
days)
Most or 
all of the 
time (5-7 
days)
1. I was bothered by things that usually don’t
bother me.
2. I did not feel like eating; my appetite 
was poor.
3. I felt that I could not shake off the blues 
even with help from my family or friends.
4. I felt I was just as good as other people.
5. I had trouble keeping my mind on what I 
was doing.
6. I felt depressed.
7. I felt that everything I did was an effort.
8. I felt hopeful about the future.
9. I thought my life had been a failure.
10. I felt fearful.
11. My sleep was restless.
12. I was happy.
13. I talked less than usual.
14. I felt lonely.
15. People were unfriendly.
16. I enjoyed life.
17. I had crying spells.
18. I felt sad.
19. I felt that people dislike me.
20. I could not get “going.”
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Appendix F: Positive and Negative Affect Schedule - Expanded (PANAS-X)
This scale consists of a number of words and phrases that describe different feelings and 
emotions. Read each item and then mark the appropriate answer in the space next to that 
word. Indicate to what extent you have felt this way during the past few weeks. Use the 
following scale to record your answers: 
        1     2         3        4        5 
very slightly a little moderately quite a bit 
extremely 
or not at all 
1. ______ cheerful 
2. ______ disgusted 
3. ______ attentive 
4. ______ bashful 
5. ______ sluggish 
6. ______ daring 
7. ______ surprised 
8. ______ strong 
9. ______ scornful 
10. ______ relaxed 
11. ______ irritable 
12. ______ delighted 
13. ______ inspired 
14. ______ fearless 
15. ______ disgusted 
with self 
16. ______ sad 
17. ______ calm 
18. ______ afraid 
19. ______ tired 
20. ______ amazed 
21. ______ shaky 
22. ______ happy 
23. ______ timid 
24. ______ alone 
25. ______ alert 
26. ______ upset 
27. ______ angry 
28. ______ bold 
29. ______ blue 
30. ______ shy 
31. ______ active 
32. ______ guilty 
33. ______ joyful 
34. ______ nervous 
35. ______ lonely 
36. ______ sleepy 
37. ______ excited 
38. ______ hostile 
39. ______ proud 
40. ______ jittery 
41. ______ lively 
42. ______ ashamed 
43. ______ at ease 
44. ______ scared 
45. ______ drowsy 
46. ______ angry at self 
47. ______ enthusiastic 
48. ______ downhearted
49. ______ sheepish 
50. ______ distressed 
51. ______ 
blameworthy 
52. ______ determined 
53. ______ frightened 
54. ______ astonished 
55. ______ interested 
56. ______ loathing 
57. ______ confident 
58. ______ energetic 
59. ______ 
concentrating 
60. ______ dissatisfied 
with self
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Appendix G: North American Adult Reading Test (NAART)
Please read the following words aloud:
DEBT
DEBRIS
AISLE
REIGN
DEPOT
SIMILE
LINGERIE
RECIPE
GOUGE
HEIR
SUBTLE
CATACOMB
BOUQUET
GAUGE
COLONEL
SUBPOENA
PLACEBO
PROCREATE
PSALM
BANAL
RARELY
GIST
CORPS
HORS D'OUERVE
SIEVE
HIATUS
GAUCHE
ZEALOT
PARADIGM
FACADE
CELLIST
INDICT
DETENTE
IMPUGN
CAPON
RADIX
AEON
EPITOME
EQUIVICAL
REIFY
INDICES
ASSIGNATE
TOPIARY
CAVEAT
SUPERFLOUS
LEVIATHAN
PRELATE
QUADRUPED
SIDEREAL
ABSTEMIOUS
BEATIFY
GAOLED
DEMESNE
SYNCOPE
ENNUI
DRACHIM
CIDEVANT
EPERGNE
VIVACE
TALIPES
SYNECDOCHE
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Appendix H: California Verbal Learning Test - Second Edition (CVLT-2)
The details of this measure have been redacted from the appendix to comply with 
copyright law. Committee members were provided an example copy for review purposes.
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Appendix I: FAS & Animal Fluency
In a moment, I will give you a letter. List as many words that you can think of that begin 
with that letter, you will have 1 minute. Do not give me proper nouns (e.g., Boston, 
Betty), or simply change the ending of a word repeatedly (e.g., eat, eats, eating, eaten). 
Now tell me as many animals as you can in 1 minute.
F A S Animals
15
30
45
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Appendix J: Cognitive-Affective Verbal Learning Test (CAVLT)
Instructions: I am going to read a list of words to you. Listen carefully, because after I 
am done, I would like you to repeat back as many words as you can remember. Do not 
worry about the order of the words, just try to repeat back as many as you can remember. 
Are you ready? Trial 1
I will now read that same list of words again. Repeat back as many of the words as you 
can remember, in any order. Do not leave out words simply because you repeated them in
the last trial. 
Are you ready? Trials 2-5
1st Trial 2nd Trial 3rd Trial 4th Trial 5th Trial
column
triumphant
context
theory
aroused
sad
method
engine
happy
utensil
lonely
misery
reserved
tool
afraid
proud
170
Now I am going to read a second list of words to you. When I am done, I would like you 
to repeat back as many words as you can remember from this second list as you can. Do 
not give words from the first list, just this second list.
Are you ready? Distracter Trial
Now I would like you to repeat back the words from the first list, the one I read to you 
multiple times. Do not repeat back words from the second list, just the first list. Short 
Delay Free Recall
Now tell me words from the first list that were (+/-/nonemotion) words. Short Delay 
Cued Recalls
Distracter SDFR SDC+ SDC- LDNE
despise
pleasure
journal
confident
noisy
terrific
helpless
hatred
industry
elbow
depression
detail
statue
umbrella
kindness
serious
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After 20 minutes. Remember earlier I read two lists of words to you? The first list I read 
to you multiple times, tell me all the words you remember from that first list, the one I 
read to you multiple times. Long Delay Free Recall
Now tell me words from the first list that were (+/-/nonemotion) words. Long Delay 
Cued Recalls
LDFR LDFR LDC+ LDC- LDCNE
I am going to read you a long list of word. It will contain all the words from the first list, 
the one we repeated multiple times, as well as many other words. For each word say 
"Yes" if the word was on the first list, or "No" if it was not on the first list. Recognition 
List 
terrified locker helpless detail
time triumphant utensil engine
sad reserved hatred odd
aroused lucky month confident
elbow misery terrific tool
kindness romantic concentrate pleasure
journal column lonely
clock happy serious
method delight depression
afraid unhappy history
grief rejected swamp
umbrella proud noisy
context statue theory
success industry despise
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Recognition Total
Correct Breakdown
Neg
Emotions
Pos
Emotions
NonEm
Conc
NonEm
Abs
False Positive
False Negative
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Appendix K: Emotion Word Fluency Test (EWFT)
For this next task, I would like you to give me as many different EMOTION words as 
you can in 1 minute.
Emotions
15”
30”
45”
60”
Emotions:         Total Correct Perseverations Non-Emotion Words
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Appendix L: Sample Polysomnogram Report
Split Night Polysomnography Report
History: Upon review of the available data, the patient reports symptoms including: 
snoring and daytime sleepiness. The Epworth Sleepiness score is 19 / 24.
Technical Summary: Attended in-laboratory recording montage included: EEG, EOG, 
EMG, EKG, nasal thermistor flow, nasal pressure, pharyngeal snoring, respiratory effort 
(2 channels), anterior tibialis EMG, SaO2 and body position. Continuous Positive Airway
Pressure (CPAP) was initiated after the patient demonstrated clinically significant 
obstructive sleep apnea. This study was performed in accordance with the AASM scoring
manual.
Pre-CPAP All Night
Baseline 
Duration 
184.0
min 
Total RDI 93.2 WASO 51.0 min Total 
Recording 
Time 
412.0 
min 
Sleep Time 114.0
min 
NREM RDI 95.8 Stage N1 49.1 % Total Sleep 
Time 
238.0
min 
Sleep 
Efficiency 
62.0% Stage R 
RDI 
66.0 Stage N2 42.1 % Sleep 
Efficiency 
63.8% 
Sleep 
Latency 
10.5 min Supine RDI 91.11 Stage N3 0.00 % 
Obstructive 
Apnea 
3 Non-supine
RDI 
107.4 Stage R 8.8 % 
Mixed 
Apnea 
0 Medicare 
AHI 
88.9 Stage R 
Latency 
132.0 min 
Central 
Apnea 
16 Min 
%SaO2 
69 % PLM index 0.0
Hypopnea 158 Baseline 
%SaO2 
92 % PLM 
arousal 
index 
0.0
Snoring: Frequent and loud during the diagnostic portion of the study.
PAP was titrated from 5 to 11 cm of water pressure. At a CPAP pressure of 10 cm of 
water, supine-REM sleep was observed with very rare respiratory events. Lower 
pressures were associated with respiratory events.
EKG Findings: Single-lead demonstrated isolated premature atrial and ventricular 
complexes.
EEG Findings: Three channel EEG demonstrated no seizure activity.
Further Interpretive Notes: The patient reported that sleep was better than usual, awoke 
feeling rested and would be willing to wear CPAP at home.
Diagnosis: Obstructive Sleep Apnea 327.23
Discussion: Treatment for severe obstructive sleep apnea is often warranted even in the 
absence of clinical symptoms. Recommended options include positive airway pressure, 
custom-made oral appliances, or upper airway surgery. Regardless of treatment approach 
for the obstructive sleep apnea, maximization of nasal airway patency, weight loss if 
appropriate, and avoidance of sedatives and alcohol in proximity to bedtime are strongly 
encouraged.
• This study shows the effectiveness of CPAP in treating sleep-disordered breathing. 
Consider a trial of CPAP at 10 cm of water pressure during sleep with clinical follow-up 
to assess treatment response.
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Appendix M: Phone Script
Telephone Recruitment Script
Hello Mr./Ms. _______, my name is _______ and I am a researcher associated with the 
University of Windsor and the Windsor Regional Hospital. Do you have a moment to 
talk, or is there a better time I could reach you?
We obtained your number from the Windsor Regional Hospital and Dr.'s Anil Dhar & 
Winston Rajkumar, of the Windsor Pulmonology & Sleep Clinic. The reason we are 
contacting you is that you may be eligible to participate in a research project investigating
certain characteristics related to obstructive sleep apnea, sleep quality, thinking, and 
mood. Could I tell you a little more about the project and its potential benefits for the 
field and yourself?
Other research has found that when sleep is poor, individuals sometimes experience more
problems than usual with certain types of thinking, such as sustaining attention and 
processing information quickly. Additionally, sleep has sometimes been found to be 
related to mood. You may in fact have had firsthand experience with these phenomena, 
for example, having a night where you slept very little, and the next day feeling grumpy 
and/or finding it hard to think straight. As you likely know, sleep apnea disrupts sleep 
often throughout the night. 
Regardless of when you were diagnosed with sleep apnea and how frequently you follow 
your treatment regimen, we would really appreciate your involvement in the study. Could
I tell you about what participating would entail?
If you agree to participate, we would arrange a date and time that work for you to come 
to the hospital to meet with a researcher. Once there, you would fill out a series of 
questionnaires asking about your sleep quality, daytime sleepiness, and mood lately. The 
hospital has data on how well you slept during your sleep evaluation, which we will look 
at with your permission. Finally, the researcher would lead you through a series of 
cognitive tasks, designed to measure how well you perform in different domains of 
thinking, such as memory, attention, and language. Your name will not be attached to 
ANY of the data we collect. The whole session should not last longer than 2 or 2.5 hours.
Could I tell you about what potential benefits participating has?
First off, there is free parking; second, we will provide you a free Tim Horton's gift card 
for 1 small item as thanks for participating (there is even a Tim's in the hospital, if you 
would like). But also, by participating, you would be helping researchers learn more 
about possible cognitive complications associated with a sleep problem that you have 
experienced. This could guide screening and treatment options for healthcare providers 
and apnea sufferers in the future. Additionally, there is a personal benefit that we can 
offer you, if you wish. Individuals who suspect that their thinking abilities have changed 
(such as recently noticing a lot of trouble with memory) due to age, a disorder or disease, 
an injury to the head, etc., often go to a clinical psychologist to have testing done and 
help handle any changes to their thinking. If you participate, you can request us to take a 
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look at your scores, and we will offer an opinion on whether you might benefit from at 
least discussing your cognitive health with your primary care physician. We will also 
give you some clinical psychologist referral information you can discuss with him or her. 
All of that is only done if you ask us to. To be clear, our assessment would not be like 
that conducted in a patient-clinician relationship, but merely a screening system that 
MAY indicate you could benefit from talking with your physician about your cognitive 
health.
Do you have any questions or concerns about participating that I could answer for you?
Could I arrange a time and date for an appointment right now?
We appreciate your involvement, and look forward to meeting you. If you would like, we
can call the day before to remind you of the appointment, would you like that?
Thank you. 
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Appendix N: Brochure
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Appendix O: Referral Information
Referral Information
You have expressed interest in further information related to cognitive health, the 
following information should assist you with the suggested process.
Suggested Referral Process:
The best first step is to contact your primary care physician, or another physician who 
you see regularly. 
Inform him or her that you recently participated in a study related to cognition, and are 
interested in discussing the possible benefits of undergoing neuropsychological 
evaluation to evaluate your current cognitive health.
Discuss with your doctor whether he or she also feels a referral might be useful for you 
and your healthcare team.
Your doctor will likely have his or her own preferred referral sources for cognitive health
screening and/or neuropsychological evaluation services. However, below are some 
popular programs through the Windsor Regional Hospital that may be appropriate to 
contact as a referral source, depending on your eligibilities:
---------------------------------
The Geriatric Assessment - Consultation Program (GAP)
Service Director: Rose Grant-Rennie,
Phone: (519) 257-5112
Fax: (519) 257-5242
The Community Psychogeriatric Outreach Program
Service Director: Bill Marcotte
Phone: (519) 257-5105
Fax: (519) 257-5197
The Acquired Brain Injury Program (ABI)
Service Director: John Norton
Phone: Program Secretary - (519) 257-5458
Manager: Chris Edwards - (519) 254-5577 Extension, 75230
Fax: (519) 257-5242
---------------------------------
Alternatively, there are private neuropsychologist service providers who can be contacted
by your doctor or yourself: 
Hobbs & Associates
Phone: (519) 948-1212
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Referral Information
You have expressed interest in further information related to psychological health, the 
following information should assist you with the suggested process.
Suggested Referral Process:
The best first step is to contact your primary care physician, or another physician who 
you see regularly. 
However, if an emergency arises related to your mood (e.g., suicidal 
thoughts), please immediately call 911 or 999 or go immediately to 
your nearest Emergency Department.
Inform him or her that you recently participated in a study related to cognition, and are 
interested in discussing the possible benefits of receiving psychological services.
Discuss with your doctor whether he or she also feels a referral might be useful for you 
and your healthcare team.
Your doctor will likely have his or her own preferred referral sources for psychological 
services. However, below are some popular programs through the Windsor Regional 
Hospital that may be appropriate to contact as a referral source, depending on your 
eligibilities:
---------------------------------
The Specialized Inpatient Mental Health Care Program
Service Director: Judy Smith
Phone: (519) 254-5577 Extension 75186
Fax: (519) 257-5197
Geriatric Mental Health Outreach Team
Service Director: Bill Marcotte
Phone: (519) 257-5105
Fax: (519) 257-5197
---------------------------------
Alternatively, there are private psychology service providers who can be contacted by 
your doctor or yourself: 
Sandwich Community Health Centre
Phone: (519) 258-6002
180
VITA AUCTORIS 
NAME: Ciaran Michael Considine
PLACE OF BIRTH: Maidstone, England
YEAR OF BIRTH: 1987 
EDUCATION: 
University of Michigan, B.A., High Honors, Ann Arbor, 
MI, 2008
University of Windsor, M.A., Windsor, ON, 2011
University of Windsor, Ph.D., Windsor, ON, 2015
181
